smpdb_id,name,category,parent_key
SMP00278,Lepirudin Action Pathway,drug_action,DB00001
SMP00474,Cetuximab Action Pathway,drug_action,DB00002
SMP00277,Bivalirudin Action Pathway,drug_action,DB00006
SMP00280,Alteplase Action Pathway,drug_action,DB00009
SMP00284,Urokinase Action Pathway,drug_action,DB00013
SMP00285,Reteplase Action Pathway,drug_action,DB00015
SMP00281,Anistreplase Action Pathway,drug_action,DB00029
SMP00283,Tenecteplase Action Pathway,drug_action,DB00031
SMP00265,Abciximab Action Pathway,drug_action,DB00054
SMP00266,Eptifibatide Action Pathway,drug_action,DB00063
SMP00476,Trastuzumab Action Pathway,drug_action,DB00072
SMP00282,Streptokinase Action Pathway,drug_action,DB00086
SMP00420,Bevacizumab Action Pathway,drug_action,DB00112
SMP00007,Beta-Alanine Metabolism,metabolic,DB00114
SMP00012,Catecholamine Biosynthesis,metabolic,DB00114
SMP00013,Cysteine Metabolism,metabolic,DB00114
SMP00129,Malate-Aspartate Shuttle,metabolic,DB00114
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB00114
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00114
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00114
SMP00239,Saccharopinuria/Hyperlysinemia II,disease,DB00114
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB00114
SMP00346,Porphyria Variegata (PV),disease,DB00114
SMP00349,Gaucher Disease,disease,DB00114
SMP00350,Pyruvate Carboxylase Deficiency,disease,DB00114
SMP00360,Hyperprolinemia Type II,disease,DB00114
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00114
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB00114
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB00114
SMP00503,Hypophosphatasia,disease,DB00114
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00114
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00114
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00114
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00114
SMP00557,Sucrase-isomaltase deficiency,disease,DB00114
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00114
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00114
SMP00722,"Cystinosis, ocular nonnephropathic",disease,DB00114
SMP00837,threonine biosynthesis,metabolic,DB00114
SMP02363,Porphyrin Metabolism ,metabolic,DB00114
SMP02378,Sphingolipid Metabolism ,metabolic,DB00114
SMP12047,Glycine Betaine Biosynthesis I,metabolic,DB00114
SMP12467,Butanoate Metabolism,metabolic,DB00114
SMP01898,adenosylcobalamin salvage from cobinamide,metabolic,DB00115
SMP00123,Betaine Metabolism,metabolic,DB00116
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB00116
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB00116
SMP00427,Azathioprine Action Pathway,drug_action,DB00116
SMP00513,Xanthinuria type II,disease,DB00116
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00116
SMP00925,Folate Biosynthesis,metabolic,DB00116
SMP02369,One Carbon Pool by Folate I ,metabolic,DB00116
SMP63637,Methionine Metabolism,metabolic,DB00116
SMP00033,Methionine Metabolism,metabolic,DB00116
SMP00050,Purine Metabolism,metabolic,DB00116
SMP00144,Adenosine Deaminase Deficiency,disease,DB00116
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00116
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB00116
SMP00341,Hypermethioninemia,disease,DB00116
SMP00432,Methotrexate Action Pathway,drug_action,DB00116
SMP00828,GLYCINE BIOSYNTHESIS,metabolic,DB00116
SMP02092,S-adenosyl-L-methionine cycle,metabolic,DB00116
SMP02364,Pantothenate and CoA Biosynthesis ,metabolic,DB00116
SMP00044,Histidine Metabolism,metabolic,DB00116
SMP00053,Folate Metabolism,metabolic,DB00116
SMP00168,AICA-Ribosiduria,disease,DB00116
SMP00428,Mercaptopurine Action Pathway,drug_action,DB00116
SMP00430,Thioguanine Action Pathway,drug_action,DB00116
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00116
SMP00512,Xanthinuria type I,disease,DB00116
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB00116
SMP00724,"Folate malabsorption, hereditary",disease,DB00116
SMP00801,Folate Metabolism,metabolic,DB00116
SMP02428,Glycine Metabolism,metabolic,DB00116
SMP00711,Tobramycin Action Pathway,drug_action,DB00117
SMP00713,Arbekacin Action Pathway,drug_action,DB00117
SMP00727,Methacycline Action Pathway,drug_action,DB00117
SMP00824,tRNA Charging 2,metabolic,DB00117
SMP63638,Methylhistidine Metabolism,metabolic,DB00117
SMP00007,Beta-Alanine Metabolism,metabolic,DB00117
SMP00249,Clindamycin Action Pathway,drug_action,DB00117
SMP00254,Gentamicin Action Pathway,drug_action,DB00117
SMP00257,Netilmicin Action Pathway,drug_action,DB00117
SMP00291,Doxycycline Action Pathway,drug_action,DB00117
SMP00292,Minocycline Action Pathway,drug_action,DB00117
SMP00295,Lymecycline Action Pathway,drug_action,DB00117
SMP00712,Tigecycline Action Pathway,drug_action,DB00117
SMP02335,Histidine Biosynthesis,metabolic,DB00117
SMP00044,Histidine Metabolism,metabolic,DB00117
SMP00253,Amikacin Action Pathway,drug_action,DB00117
SMP00258,Spectinomycin Action Pathway,drug_action,DB00117
SMP00351,GABA-Transaminase Deficiency,disease,DB00117
SMP00492,Ureidopropionase Deficiency,disease,DB00117
SMP00830,histidine biosynthesis,metabolic,DB00117
SMP01000,Secondary Metabolites: Histidine biosynthesis,metabolic,DB00117
SMP02429,Histidine Metabolism,metabolic,DB00117
SMP63599,Beta-Alanine Metabolism,metabolic,DB00117
SMP00191,Histidinemia,disease,DB00117
SMP00248,Clarithromycin Action Pathway,drug_action,DB00117
SMP00250,Erythromycin Action Pathway,drug_action,DB00117
SMP00251,Roxithromycin Action Pathway,drug_action,DB00117
SMP00255,Kanamycin Action Pathway,drug_action,DB00117
SMP00256,Neomycin Action Pathway,drug_action,DB00117
SMP00262,Clomocycline Action Pathway,drug_action,DB00117
SMP00006,Tyrosine Metabolism,metabolic,DB00118
SMP00044,Histidine Metabolism,metabolic,DB00118
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB00118
SMP00207,Prolidase Deficiency (PD),disease,DB00118
SMP00327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB00118
SMP00428,Mercaptopurine Action Pathway,drug_action,DB00118
SMP00430,Thioguanine Action Pathway,drug_action,DB00118
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00118
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00118
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB00118
SMP00785,Biotin metabolism,metabolic,DB00118
SMP00953,Porphyrin metabolism,metabolic,DB00118
SMP02042,Thiamin diphosphate biosynthesis,metabolic,DB00118
SMP02121,Cyclopropane Fatty Acid (CFA) Biosynthesis,metabolic,DB00118
SMP02372,Ubiquinone Biosynthesis ,metabolic,DB00118
SMP02381,Steroid Biosynthesis ,metabolic,DB00118
SMP02512,Lysolipid incorporation into ER PC(10:0/10:0),metabolic,DB00118
SMP02514,Lysolipid incorporation into ER PC(16:0/16:0),metabolic,DB00118
SMP02516,Lysolipid incorporation into ER PC(16:1(11Z)/16:1(11Z)),metabolic,DB00118
SMP02517,Lysolipid incorporation into ER PC(18:0/18:0),metabolic,DB00118
SMP02527,"Lysolipid incorporation into Mitochondria PC(18:2(9Z,11Z)/18:2(9Z,11Z))",metabolic,DB00118
SMP02534,Phosphatidylcholine biosynthesis PC(12:0/12:0),metabolic,DB00118
SMP02545,Phosphatidylcholine biosynthesis PC(14:0/14:1(11Z)),metabolic,DB00118
SMP02552,Phosphatidylcholine biosynthesis PC(10:0/15:1(11Z)),metabolic,DB00118
SMP02557,Phosphatidylcholine biosynthesis PC(12:0/15:1(9Z)),metabolic,DB00118
SMP02565,Phosphatidylcholine biosynthesis PC(15:0/15:1(9Z)),metabolic,DB00118
SMP02581,Phosphatidylcholine biosynthesis PC(15:1(9Z)/15:1(9Z)),metabolic,DB00118
SMP02591,Phosphatidylcholine biosynthesis PC(15:0/16:1(11Z)),metabolic,DB00118
SMP02592,Phosphatidylcholine biosynthesis PC(15:1(9Z)/16:0),metabolic,DB00118
SMP02599,Phosphatidylcholine biosynthesis PC(16:1(9Z)/16:1(11Z)),metabolic,DB00118
SMP00013,Cysteine Metabolism,metabolic,DB00119
SMP00217,Sialuria or French Type Sialuria,disease,DB00119
SMP00350,Pyruvate Carboxylase Deficiency,disease,DB00119
SMP00459,Pyruvaldehyde Degradation,metabolic,DB00119
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB00119
SMP00562,"Fructose-1,6-diphosphatase deficiency",disease,DB00119
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00119
SMP00572,Fanconi-bickel syndrome,disease,DB00119
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00119
SMP00722,"Cystinosis, ocular nonnephropathic",disease,DB00119
SMP00816, D-glucarate and D-galactarate degradation,metabolic,DB00119
SMP00835,tryptophan metabolism,metabolic,DB00119
SMP00857,S-adenosyl-L-methionine biosynthesis,metabolic,DB00119
SMP00925,Folate Biosynthesis,metabolic,DB00119
SMP00957,propanoate metabolism,metabolic,DB00119
SMP00997,Secondary Metabolites: Ubiquinol biosynthesis,metabolic,DB00119
SMP01930,tryptophan metabolism II,metabolic,DB00119
SMP02017,ketogluconate metabolism,metabolic,DB00119
SMP02044,N-acetylneuraminate and N-acetylmannosamine and N-acetylglucosamine degradation,metabolic,DB00119
SMP02050,Secondary Metabolites: Ubiquinol biosynthesis 2,metabolic,DB00119
SMP02062,Enterobactin Biosynthesis,metabolic,DB00119
SMP02095,pyruvate decarboxylation to acetyl CoA,metabolic,DB00119
SMP02122,L-cysteine degradation,metabolic,DB00119
SMP02295,The Oncogenic Action of Fumarate,disease,DB00119
SMP02334,tetrahydrofolate biosynthesis,metabolic,DB00119
SMP02352,Tyrosine metabolism,metabolic,DB00119
SMP02427,Glutamic acid metabolism,metabolic,DB00119
SMP12467,Butanoate Metabolism,metabolic,DB00119
SMP14205,Phosphatidylcholine Biosynthesis,metabolic,DB00119
SMP00001,Citrullinemia Type I,disease,DB00119
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB00120
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB00120
SMP02310,Methionine metabolism and salvage,metabolic,DB00120
SMP00206,Phenylketonuria,disease,DB00120
SMP00820,tRNA charging,metabolic,DB00120
SMP00827,phenylalanine biosynthesis,metabolic,DB00120
SMP02442,Phenylalanine metabolism,metabolic,DB00120
SMP12021,Flavonoid Biosynthesis (Dihydroflavonol Biosynthesis),metabolic,DB00120
SMP12024,Flavanone Biosynthesis,metabolic,DB00120
SMP63474,"Tropane, Piperidine and Pyridine Alkaloid Biosynthesis",metabolic,DB00120
SMP63649,Phenylalanine and Tyrosine Metabolism,metabolic,DB00120
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB00120
SMP00808,inner membrane transport,metabolic,DB00120
SMP00824,tRNA Charging 2,metabolic,DB00120
SMP00938,Phenylalanine metabolism,metabolic,DB00120
SMP02349,Phenylalanine metabolism,metabolic,DB00120
SMP02353,Tryptophan metabolism,metabolic,DB00120
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00121
SMP00350,Pyruvate Carboxylase Deficiency,disease,DB00121
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB00121
SMP00562,"Fructose-1,6-diphosphatase deficiency",disease,DB00121
SMP00564,"Multiple carboxylase deficiency, neonatal or early onset form",disease,DB00121
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00121
SMP02295,The Oncogenic Action of Fumarate,disease,DB00121
SMP63602,Biotin Metabolism,metabolic,DB00121
SMP00016,Propanoate Metabolism,metabolic,DB00121
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00121
SMP00057,Citric Acid Cycle,metabolic,DB00121
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00121
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00121
SMP00196,Leigh Syndrome,disease,DB00121
SMP00198,Malonic Aciduria,disease,DB00121
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00121
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00121
SMP00452,Threonine and 2-Oxobutanoate Degradation,metabolic,DB00121
SMP00466,Transfer of Acetyl Groups into Mitochondria,metabolic,DB00121
SMP00581,"Glycogenosis, Type IA. Von gierke disease",disease,DB00121
SMP00785,Biotin metabolism,metabolic,DB00121
SMP02298,Glutaminolysis and Cancer,disease,DB00121
SMP63681,Transfer of Acetyl Groups into Mitochondria,metabolic,DB00121
SMP00055,Alanine Metabolism,metabolic,DB00121
SMP00066,Biotin Metabolism,metabolic,DB00121
SMP00072,Glutamate Metabolism,metabolic,DB00121
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB00121
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB00121
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB00121
SMP00174,Biotinidase Deficiency,disease,DB00121
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB00122
SMP02512,Lysolipid incorporation into ER PC(10:0/10:0),metabolic,DB00122
SMP02514,Lysolipid incorporation into ER PC(16:0/16:0),metabolic,DB00122
SMP02516,Lysolipid incorporation into ER PC(16:1(11Z)/16:1(11Z)),metabolic,DB00122
SMP02517,Lysolipid incorporation into ER PC(18:0/18:0),metabolic,DB00122
SMP14237,Phosphatidylcholine Biosynthesis PC(14:0/22:1(13Z)),metabolic,DB00122
SMP14249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB00122
SMP14252,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:1(9Z)),metabolic,DB00122
SMP14264,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB00122
SMP14276,Phosphatidylcholine Biosynthesis PC(15:0/15:0),metabolic,DB00122
SMP14292,"Phosphatidylcholine Biosynthesis PC(15:0/20:4(8Z,11Z,14Z,17Z))",metabolic,DB00122
SMP14293,"Phosphatidylcholine Biosynthesis PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB00122
SMP14301,Phosphatidylcholine Biosynthesis PC(15:0/24:0),metabolic,DB00122
SMP14304,Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)),metabolic,DB00122
SMP14307,Phosphatidylcholine Biosynthesis PC(16:0/16:1(9Z)),metabolic,DB00122
SMP14310,Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)),metabolic,DB00122
SMP14316,Phosphatidylcholine Biosynthesis PC(16:0/20:1(11Z)),metabolic,DB00122
SMP14321,"Phosphatidylcholine Biosynthesis PC(16:0/20:4(8Z,11Z,14Z,17Z))",metabolic,DB00122
SMP14322,"Phosphatidylcholine Biosynthesis PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB00122
SMP14332,Phosphatidylcholine Biosynthesis PC(16:1(9Z)/14:0),metabolic,DB00122
SMP14347,"Phosphatidylcholine Biosynthesis PC(16:1(9Z)/20:3(5Z,8Z,11Z))",metabolic,DB00122
SMP14348,"Phosphatidylcholine Biosynthesis PC(16:1(9Z)/20:3(8Z,11Z,14Z))",metabolic,DB00122
SMP14353,Phosphatidylcholine Biosynthesis PC(16:1(9Z)/22:1(13Z)),metabolic,DB00122
SMP14355,"Phosphatidylcholine Biosynthesis PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))",metabolic,DB00122
SMP14365,Phosphatidylcholine Biosynthesis PC(18:0/16:1(9Z)),metabolic,DB00122
SMP14366,Phosphatidylcholine Biosynthesis PC(18:0/18:0),metabolic,DB00122
SMP14374,Phosphatidylcholine Biosynthesis PC(18:0/20:1(11Z)),metabolic,DB00122
SMP14388,Phosphatidylcholine Biosynthesis PC(18:0/24:0),metabolic,DB00122
SMP14393,Phosphatidylcholine Biosynthesis PC(18:1(11Z)/16:0),metabolic,DB00122
SMP14398,"Phosphatidylcholine Biosynthesis PC(18:1(11Z)/18:2(9Z,12Z))",metabolic,DB00122
SMP00527,"Hyperlysinemia I, Familial",disease,DB00123
SMP63605,Carnitine Synthesis,metabolic,DB00123
SMP63635,Lysine Degradation,metabolic,DB00123
SMP00037,Lysine Degradation,metabolic,DB00123
SMP00719,2-aminoadipic 2-oxoadipic aciduria,disease,DB00123
SMP00820,tRNA charging,metabolic,DB00123
SMP02434,Lysine Metabolism,metabolic,DB00123
SMP00465,Carnitine Synthesis,metabolic,DB00123
SMP00528,Hyperlysinemia II or Saccharopinuria,disease,DB00123
SMP00571,Pyridoxine dependency with seizures,disease,DB00123
SMP02053,aminopropylcadaverine biosynthesis,metabolic,DB00123
SMP00239,Saccharopinuria/Hyperlysinemia II,disease,DB00123
SMP00564,"Multiple carboxylase deficiency, neonatal or early onset form",disease,DB00123
SMP00795,Lysine Degradation I,metabolic,DB00123
SMP02063,Fructoselysine and Psicoselysine Degradation,metabolic,DB00123
SMP63602,Biotin Metabolism,metabolic,DB00123
SMP00066,Biotin Metabolism,metabolic,DB00123
SMP00174,Biotinidase Deficiency,disease,DB00123
SMP00186,Glutaric Aciduria Type I,disease,DB00123
SMP00794,Lysine Biosynthesis,metabolic,DB00123
SMP00808,inner membrane transport,metabolic,DB00123
SMP00824,tRNA Charging 2,metabolic,DB00123
SMP02337,lysine metabolism,metabolic,DB00123
SMP00001,Citrullinemia Type I,disease,DB00125
SMP00002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00125
SMP00067,Aspartate Metabolism,metabolic,DB00125
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00125
SMP00824,tRNA Charging 2,metabolic,DB00125
SMP00003,Argininosuccinic Aciduria,disease,DB00125
SMP00207,Prolidase Deficiency (PD),disease,DB00125
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00125
SMP02303,Glutamate Metabolism,metabolic,DB00125
SMP02420,Proline Metabolism,metabolic,DB00125
SMP63626,Glycine and Serine Metabolism,metabolic,DB00125
SMP00192,Hypoacetylaspartia,disease,DB00125
SMP00223,Non Ketotic Hyperglycinemia,disease,DB00125
SMP00357,Argininemia,disease,DB00125
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00125
SMP12004,Arginine and Proline Metabolism,metabolic,DB00125
SMP63686,Urea Cycle,metabolic,DB00125
SMP63777,Nitric Oxide Signaling Pathway,signaling,DB00125
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00125
SMP00360,Hyperprolinemia Type II,disease,DB00125
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00125
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00125
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00125
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00125
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00125
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00125
SMP00812,arginine metabolism,metabolic,DB00125
SMP02416,Arginine Metabolism,metabolic,DB00125
SMP63596,Arginine and Proline Metabolism,metabolic,DB00125
SMP00004,Glycine and Serine Metabolism,metabolic,DB00125
SMP00012,Catecholamine Biosynthesis,metabolic,DB00126
SMP02295,The Oncogenic Action of Fumarate,disease,DB00126
SMP12035,Xanthophyll Cycle,metabolic,DB00126
SMP63653,Phytanic Acid Peroxisomal Oxidation,metabolic,DB00126
SMP00006,Tyrosine Metabolism,metabolic,DB00126
SMP00451,Refsum Disease,disease,DB00126
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00126
SMP00814,Ascorbate metabolism,metabolic,DB00126
SMP63605,Carnitine Synthesis,metabolic,DB00126
SMP00169,Alkaptonuria,disease,DB00126
SMP00190,Hawkinsinuria,disease,DB00126
SMP00450,Phytanic Acid Peroxisomal Oxidation,metabolic,DB00126
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB00126
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB00126
SMP12022,Leucopelargonidin and Leucocyanidin Biosynthesis,metabolic,DB00126
SMP00030,Oxidation of Branched Chain Fatty Acids,metabolic,DB00126
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00126
SMP02292,The Oncogenic Action of Succinate,disease,DB00126
SMP12070,Gibberellin Biosynthesis II (Early C-13 Hydroxylation),metabolic,DB00126
SMP12071,"Gibberellin Biosynthesis III (Non C-3, Non C-13 Hydroxylation)",metabolic,DB00126
SMP63606,Catecholamine Biosynthesis,metabolic,DB00126
SMP63684,Tyrosine Metabolism,metabolic,DB00126
SMP00218,Tyrosinemia Type I,disease,DB00126
SMP00429,Disulfiram Action Pathway,drug_action,DB00126
SMP00465,Carnitine Synthesis,metabolic,DB00126
SMP00497,Tyrosine hydroxylase deficiency,disease,DB00126
SMP12021,Flavonoid Biosynthesis (Dihydroflavonol Biosynthesis),metabolic,DB00126
SMP12025,Flavonol Biosynthesis,metabolic,DB00126
SMP12069,Gibberellin Biosynthesis I (Early C-3 Hydroxylation),metabolic,DB00126
SMP12446,Ascorbate Metabolism,metabolic,DB00126
SMP00445,Spermidine and Spermine Biosynthesis,metabolic,DB00127
SMP02307,Beta-Alanine metabolism,metabolic,DB00127
SMP63671,Spermidine and Spermine Biosynthesis,metabolic,DB00127
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB00128
SMP00192,Hypoacetylaspartia,disease,DB00128
SMP00203,Molybdenum Cofactor Deficiency,disease,DB00128
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00128
SMP00218,Tyrosinemia Type I,disease,DB00128
SMP00357,Argininemia,disease,DB00128
SMP00429,Disulfiram Action Pathway,drug_action,DB00128
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB00128
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB00128
SMP00833,Asparagine biosynthesis,metabolic,DB00128
SMP12004,Arginine and Proline Metabolism,metabolic,DB00128
SMP63579,Ammonia Recycling,metabolic,DB00128
SMP63668,Purine Metabolism,metabolic,DB00128
SMP63686,Urea Cycle,metabolic,DB00128
SMP00003,Argininosuccinic Aciduria,disease,DB00128
SMP00006,Tyrosine Metabolism,metabolic,DB00128
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00128
SMP00168,AICA-Ribosiduria,disease,DB00128
SMP00207,Prolidase Deficiency (PD),disease,DB00128
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00128
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00128
SMP00351,GABA-Transaminase Deficiency,disease,DB00128
SMP00428,Mercaptopurine Action Pathway,drug_action,DB00128
SMP00430,Thioguanine Action Pathway,drug_action,DB00128
SMP00492,Ureidopropionase Deficiency,disease,DB00128
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00128
SMP00512,Xanthinuria type I,disease,DB00128
SMP02047,purine nucleotides de novo biosynthesis 2,metabolic,DB00128
SMP02298,Glutaminolysis and Cancer,disease,DB00128
SMP02420,Proline Metabolism,metabolic,DB00128
SMP00357,Argininemia,disease,DB00129
SMP02307,Beta-Alanine metabolism,metabolic,DB00129
SMP12004,Arginine and Proline Metabolism,metabolic,DB00129
SMP63686,Urea Cycle,metabolic,DB00129
SMP00003,Argininosuccinic Aciduria,disease,DB00129
SMP00207,Prolidase Deficiency (PD),disease,DB00129
SMP02303,Glutamate Metabolism,metabolic,DB00129
SMP02420,Proline Metabolism,metabolic,DB00129
SMP00001,Citrullinemia Type I,disease,DB00129
SMP00002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00129
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00129
SMP63671,Spermidine and Spermine Biosynthesis,metabolic,DB00129
SMP00020,Arginine and Proline Metabolism,metabolic,DB00129
SMP00059,Urea Cycle,metabolic,DB00129
SMP00205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00129
SMP00208,Prolinemia Type II,disease,DB00129
SMP00361,Hyperprolinemia Type I,disease,DB00129
SMP00445,Spermidine and Spermine Biosynthesis,metabolic,DB00129
SMP00813,ornithine metabolism,metabolic,DB00129
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00129
SMP00360,Hyperprolinemia Type II,disease,DB00129
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00129
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00129
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00129
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00129
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00129
SMP00812,arginine metabolism,metabolic,DB00129
SMP02416,Arginine Metabolism,metabolic,DB00129
SMP63596,Arginine and Proline Metabolism,metabolic,DB00129
SMP00009,Ammonia Recycling,metabolic,DB00130
SMP00059,Urea Cycle,metabolic,DB00130
SMP00175,Canavan Disease,disease,DB00130
SMP00205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00130
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB00130
SMP00537,Myoadenylate deaminase deficiency,disease,DB00130
SMP00809,Aspartate metabolism,metabolic,DB00130
SMP00820,tRNA charging,metabolic,DB00130
SMP02291,The oncogenic action of 2-hydroxyglutarate,disease,DB00130
SMP02331,Amino sugar and nucleotide sugar metabolism,metabolic,DB00130
SMP02358,The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,disease,DB00130
SMP02359,The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,disease,DB00130
SMP02370,pyrimidine metabolism ,metabolic,DB00130
SMP02403,Nitrogen Metabolism,metabolic,DB00130
SMP12014,Folate Biosynthesis,metabolic,DB00130
SMP63472,Vitamin B6 Metabolism ,metabolic,DB00130
SMP63590,Glutamate Metabolism,metabolic,DB00130
SMP63597,Aspartate Metabolism,metabolic,DB00130
SMP63650,Phenylacetate Metabolism,metabolic,DB00130
SMP00046,Pyrimidine Metabolism,metabolic,DB00130
SMP00126,Phenylacetate Metabolism,metabolic,DB00130
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB00130
SMP00192,Hypoacetylaspartia,disease,DB00130
SMP00203,Molybdenum Cofactor Deficiency,disease,DB00130
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00130
SMP00240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB00130
SMP00357,Argininemia,disease,DB00130
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB00130
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB00130
SMP00833,Asparagine biosynthesis,metabolic,DB00130
SMP00003,Argininosuccinic Aciduria,disease,DB00131
SMP00016,Propanoate Metabolism,metabolic,DB00131
SMP00044,Histidine Metabolism,metabolic,DB00131
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB00131
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00131
SMP00168,AICA-Ribosiduria,disease,DB00131
SMP00185,Glutaric Aciduria Type I,disease,DB00131
SMP00196,Leigh Syndrome,disease,DB00131
SMP00198,Malonic Aciduria,disease,DB00131
SMP00207,Prolidase Deficiency (PD),disease,DB00131
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00131
SMP00253,Amikacin Action Pathway,drug_action,DB00131
SMP00258,Spectinomycin Action Pathway,drug_action,DB00131
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00131
SMP00428,Mercaptopurine Action Pathway,drug_action,DB00131
SMP00430,Thioguanine Action Pathway,drug_action,DB00131
SMP00480,Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,metabolic,DB00131
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00131
SMP00512,Xanthinuria type I,disease,DB00131
SMP00518,Glucose-6-phosphate dehydrogenase deficiency,disease,DB00131
SMP00519,Ribose-5-phosphate isomerase deficiency,disease,DB00131
SMP00540,Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),disease,DB00131
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB00131
SMP00635,Valproic Acid Metabolism Pathway,drug_metabolism,DB00131
SMP00741,Emtricitabine Action Pathway,drug_action,DB00131
SMP00745,Stavudine Action Pathway,drug_action,DB00131
SMP00746,Zalcitabine Action Pathway,drug_action,DB00131
SMP00781,fatty acid oxidation,metabolic,DB00131
SMP00785,Biotin metabolism,metabolic,DB00131
SMP00807,glycolysis and pyruvate dehydrogenase,metabolic,DB00131
SMP12486,"Triacylglycerol Degradation TG(16:0/18:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12522,"Triacylglycerol Degradation TG(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12549,"Triacylglycerol Degradation TG(16:0/18:3(9Z,12Z,15Z)/20:1(13Z))",metabolic,DB00132
SMP12689,"Triacylglycerol Degradation TG(18:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))",metabolic,DB00132
SMP12690,"Triacylglycerol Degradation TG(18:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12692,"Triacylglycerol Degradation TG(18:0/18:3(9Z,12Z,15Z)/20:1(11Z))",metabolic,DB00132
SMP12702,"Triacylglycerol Degradation TG(18:0/20:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12786,"Triacylglycerol Degradation TG(18:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12810,"Triacylglycerol Degradation TG(18:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12833,"Triacylglycerol Degradation TG(18:1(9Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))",metabolic,DB00132
SMP12838,"Triacylglycerol Degradation TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:0)",metabolic,DB00132
SMP12906,"Triacylglycerol Degradation TG(18:1(11Z)/16:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12942,"Triacylglycerol Degradation TG(18:1(11Z)/18:1(11Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12966,"Triacylglycerol Degradation TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP12974,"Triacylglycerol Degradation TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:1(9Z))",metabolic,DB00132
SMP13026,"Triacylglycerol Degradation TG(18:1(11Z)/22:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13038,"Triacylglycerol Degradation TG(18:1(11Z)/22:1(13Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13050,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/16:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13062,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/18:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13098,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13116,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/16:0)",metabolic,DB00132
SMP13124,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z))",metabolic,DB00132
SMP13127,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:1(13Z))",metabolic,DB00132
SMP13158,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/20:1(13Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13170,"Triacylglycerol Degradation TG(18:2(9Z,12Z)/22:0/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13230,"Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/18:1(11Z)/18:3(9Z,12Z,15Z))",metabolic,DB00132
SMP13262,"Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:1(9Z))",metabolic,DB00132
SMP13267,"Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0)",metabolic,DB00132
SMP13268,"Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z))",metabolic,DB00132
SMP13269,"Triacylglycerol Degradation TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z))",metabolic,DB00132
SMP00029,Selenoamino Acid Metabolism,metabolic,DB00133
SMP00033,Methionine Metabolism,metabolic,DB00133
SMP00034,Sphingolipid Metabolism,metabolic,DB00133
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB00133
SMP00341,Hypermethioninemia,disease,DB00133
SMP00808,inner membrane transport,metabolic,DB00133
SMP00821,cysteine biosynthesis ,metabolic,DB00133
SMP00824,tRNA Charging 2,metabolic,DB00133
SMP00828,GLYCINE BIOSYNTHESIS,metabolic,DB00133
SMP00829,serine biosynthesis and metabolism,metabolic,DB00133
SMP01045,phospholipid biosynthesis CL(14:0/15:0cyclo/14:0/17:0cycw7c),metabolic,DB00133
SMP01050,phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/19:0cycv8c)) 1440195714,metabolic,DB00133
SMP01054,phospholipid biosynthesis CL(14:0/16:0/19:0cycv8c/14:0),metabolic,DB00133
SMP01070,phospholipid biosynthesis CL(15:0cyclo/14:0/16:1(9Z)/16:1(9Z)),metabolic,DB00133
SMP01078,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/19:0cycv8c),metabolic,DB00133
SMP01079,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/16:1(9Z)),metabolic,DB00133
SMP01082,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/14:0),metabolic,DB00133
SMP01083,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/17:0cycw7c),metabolic,DB00133
SMP01092,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/16:0),metabolic,DB00133
SMP01099,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/16:1(9Z)),metabolic,DB00133
SMP01109,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/19:0cycv8c),metabolic,DB00133
SMP01113,phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/17:0cycw7c),metabolic,DB00133
SMP01118,phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/16:1(9Z)),metabolic,DB00133
SMP01124,phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/16:1(9Z)),metabolic,DB00133
SMP01128,phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/16:0),metabolic,DB00133
SMP01129,phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/18:1(9Z)),metabolic,DB00133
SMP01133,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/14:0/15:0cyclo),metabolic,DB00133
SMP01136,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/16:1(9Z)),metabolic,DB00133
SMP01138,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/18:1(9Z)),metabolic,DB00133
SMP01142,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/14:0),metabolic,DB00133
SMP00253,Amikacin Action Pathway,drug_action,DB00134
SMP00258,Spectinomycin Action Pathway,drug_action,DB00134
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00134
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB00134
SMP00785,Biotin metabolism,metabolic,DB00134
SMP00953,Porphyrin metabolism,metabolic,DB00134
SMP02042,Thiamin diphosphate biosynthesis,metabolic,DB00134
SMP12046,Thio-Molybdenum Cofactor Biosynthesis,metabolic,DB00134
SMP63626,Glycine and Serine Metabolism,metabolic,DB00134
SMP00033,Methionine Metabolism,metabolic,DB00134
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB00134
SMP00341,Hypermethioninemia,disease,DB00134
SMP00711,Tobramycin Action Pathway,drug_action,DB00134
SMP00713,Arbekacin Action Pathway,drug_action,DB00134
SMP00727,Methacycline Action Pathway,drug_action,DB00134
SMP00824,tRNA Charging 2,metabolic,DB00134
SMP00834,methionine biosynthesis,metabolic,DB00134
SMP02055,Thiazole Biosynthesis I ,metabolic,DB00134
SMP02092,S-adenosyl-L-methionine cycle,metabolic,DB00134
SMP63671,Spermidine and Spermine Biosynthesis,metabolic,DB00134
SMP00123,Betaine Metabolism,metabolic,DB00134
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB00134
SMP00249,Clindamycin Action Pathway,drug_action,DB00134
SMP00254,Gentamicin Action Pathway,drug_action,DB00134
SMP00257,Netilmicin Action Pathway,drug_action,DB00134
SMP00291,Doxycycline Action Pathway,drug_action,DB00134
SMP00292,Minocycline Action Pathway,drug_action,DB00134
SMP00295,Lymecycline Action Pathway,drug_action,DB00134
SMP00712,Tigecycline Action Pathway,drug_action,DB00134
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00134
SMP00006,Tyrosine Metabolism,metabolic,DB00135
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00135
SMP02213,Operon: biosynthesis of aromatic amino acids inactivation,signaling,DB00135
SMP00012,Catecholamine Biosynthesis,metabolic,DB00135
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB00135
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB00135
SMP02352,Tyrosine metabolism,metabolic,DB00135
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00135
SMP00206,Phenylketonuria,disease,DB00135
SMP00820,tRNA charging,metabolic,DB00135
SMP02442,Phenylalanine metabolism,metabolic,DB00135
SMP02457,Tyrosine metabolism,metabolic,DB00135
SMP63606,Catecholamine Biosynthesis,metabolic,DB00135
SMP63684,Tyrosine Metabolism,metabolic,DB00135
SMP00218,Tyrosinemia Type I,disease,DB00135
SMP00429,Disulfiram Action Pathway,drug_action,DB00135
SMP00497,Tyrosine hydroxylase deficiency,disease,DB00135
SMP00716,Thyroid hormone synthesis,metabolic,DB00135
SMP00826,tyrosine biosynthesis,metabolic,DB00135
SMP63471,Isoquinoline Alkaloid Biosynthesis,metabolic,DB00135
SMP63649,Phenylalanine and Tyrosine Metabolism,metabolic,DB00135
SMP63679,Thyroid hormone synthesis,metabolic,DB00135
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB00135
SMP00169,Alkaptonuria,disease,DB00135
SMP00190,Hawkinsinuria,disease,DB00135
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB00135
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB00135
SMP00808,inner membrane transport,metabolic,DB00135
SMP00824,tRNA Charging 2,metabolic,DB00135
SMP02055,Thiazole Biosynthesis I ,metabolic,DB00135
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00139
SMP00057,Citric Acid Cycle,metabolic,DB00139
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00139
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00139
SMP00207,Prolidase Deficiency (PD),disease,DB00139
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00139
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00139
SMP00451,Refsum Disease,disease,DB00139
SMP00940,sulfur metabolism (butanesulfonate),metabolic,DB00139
SMP01018,TCA cycle (ubiquinol-2),metabolic,DB00139
SMP01904,2-Oxopent-4-enoate metabolism ,metabolic,DB00139
SMP02069,propanoyl CoA degradation,metabolic,DB00139
SMP02298,Glutaminolysis and Cancer,disease,DB00139
SMP02303,Glutamate Metabolism,metabolic,DB00139
SMP02382,Sulfur metabolism,metabolic,DB00139
SMP63605,Carnitine Synthesis,metabolic,DB00139
SMP00071,Ketone Body Metabolism,metabolic,DB00139
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00139
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00139
SMP00360,Hyperprolinemia Type II,disease,DB00139
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00139
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00139
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00139
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00139
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00139
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00139
SMP00569,Succinyl CoA: 3-ketoacid CoA transferase deficiency,disease,DB00139
SMP00812,arginine metabolism,metabolic,DB00139
SMP00936,Oxidative phosphorylation,metabolic,DB00139
SMP00957,propanoate metabolism,metabolic,DB00139
SMP63462,Riboflavin Metabolism,metabolic,DB00140
SMP01985,Flavin biosynthesis,metabolic,DB00140
SMP63663,Riboflavin Metabolism,metabolic,DB00140
SMP00070,Riboflavin Metabolism,metabolic,DB00140
SMP02354,riboflavin metabolism,metabolic,DB00140
SMP00217,Sialuria or French Type Sialuria,disease,DB00141
SMP02076,"1,6-anhydro-<i>N</i>-acetylmuramic acid recycling",metabolic,DB00141
SMP00240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB00141
SMP00914,Amino sugar and nucleotide sugar metabolism III,metabolic,DB00141
SMP00216,Sialuria or French Type Sialuria,disease,DB00141
SMP00534,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",disease,DB00141
SMP00906,Amino sugar and nucleotide sugar metabolism II,metabolic,DB00141
SMP63580,Amino Sugar Metabolism,metabolic,DB00141
SMP00045,Amino Sugar Metabolism,metabolic,DB00141
SMP00390,Tay-Sachs Disease,disease,DB00141
SMP00808,inner membrane transport,metabolic,DB00141
SMP00905,Amino sugar and nucleotide sugar metabolism I,metabolic,DB00141
SMP00007,Beta-Alanine Metabolism,metabolic,DB00142
SMP00013,Cysteine Metabolism,metabolic,DB00142
SMP00015,Glutathione Metabolism,metabolic,DB00142
SMP00075,Arachidonic Acid Metabolism,metabolic,DB00142
SMP00106,Meloxicam Action Pathway,drug_action,DB00142
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB00142
SMP00129,Malate-Aspartate Shuttle,metabolic,DB00142
SMP00183,Gamma-Glutamyltransferase Deficiency,disease,DB00142
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00142
SMP00217,Sialuria or French Type Sialuria,disease,DB00142
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00142
SMP00239,Saccharopinuria/Hyperlysinemia II,disease,DB00142
SMP00350,Pyruvate Carboxylase Deficiency,disease,DB00142
SMP00360,Hyperprolinemia Type II,disease,DB00142
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00142
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB00142
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB00142
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB00142
SMP00427,Azathioprine Action Pathway,drug_action,DB00142
SMP00501,Gamma-glutamyl-transpeptidase deficiency,disease,DB00142
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00142
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00142
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00142
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00142
SMP00513,Xanthinuria type II,disease,DB00142
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00142
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB00142
SMP00702,Nepafenac Action Pathway,drug_action,DB00142
SMP00708,Salicylate-sodium Action Pathway,drug_action,DB00142
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00142
SMP00015,Glutathione Metabolism,metabolic,DB00143
SMP00075,Arachidonic Acid Metabolism,metabolic,DB00143
SMP00106,Meloxicam Action Pathway,drug_action,DB00143
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB00143
SMP00183,Gamma-Glutamyltransferase Deficiency,disease,DB00143
SMP00459,Pyruvaldehyde Degradation,metabolic,DB00143
SMP00501,Gamma-glutamyl-transpeptidase deficiency,disease,DB00143
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB00143
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00143
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB00143
SMP00702,Nepafenac Action Pathway,drug_action,DB00143
SMP00708,Salicylate-sodium Action Pathway,drug_action,DB00143
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00143
SMP00196,Leigh Syndrome,disease,DB00143
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00143
SMP00337,Glutathione Synthetase Deficiency,disease,DB00143
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00143
SMP00500,5-oxoprolinase deficiency,disease,DB00143
SMP00640,Acetaminophen Metabolism Pathway,drug_metabolism,DB00143
SMP00700,Lornoxicam Action Pathway,drug_action,DB00143
SMP00701,Phenylbutazone Action Pathway,drug_action,DB00143
SMP00707,Salsalate Action Pathway,drug_action,DB00143
SMP00710,Acetaminophen  Action Pathway,drug_action,DB00143
SMP02125,methylglyoxal degradation I,metabolic,DB00143
SMP00072,Glutamate Metabolism,metabolic,DB00143
SMP00098,Ketorolac Action Pathway,drug_action,DB00143
SMP00101,Suprofen Action Pathway,drug_action,DB00143
SMP00116,Valdecoxib Action Pathway,drug_action,DB00143
SMP00143,5-Oxoprolinuria,disease,DB00143
SMP00289,Diflunisal Action Pathway,drug_action,DB00143
SMP01060,phospholipid biosynthesis CL(14:0/18:1(9Z)/14:0/14:0),metabolic,DB00144
SMP01077,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/18:1(9Z)),metabolic,DB00144
SMP01088,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/16:0),metabolic,DB00144
SMP01090,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/18:1(9Z)),metabolic,DB00144
SMP01114,phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/18:1(9Z)),metabolic,DB00144
SMP01122,phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/16:0),metabolic,DB00144
SMP01145,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/16:1(9Z)),metabolic,DB00144
SMP01188,phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/14:0),metabolic,DB00144
SMP01221,phospholipid biosynthesis CL(16:0/14:0/14:0/16:0),metabolic,DB00144
SMP01248,phospholipid biosynthesis CL(16:0/15:0cyclo/16:1(9Z)/16:0),metabolic,DB00144
SMP01266,phospholipid biosynthesis CL(16:0/16:0/14:0/14:0),metabolic,DB00144
SMP01268,phospholipid biosynthesis CL(16:0/16:0/14:0/16:1(9Z)),metabolic,DB00144
SMP01271,phospholipid biosynthesis CL(16:0/16:0/14:0/18:1(9Z)),metabolic,DB00144
SMP01296,phospholipid biosynthesis CL(16:0/16:0/18:1(9Z)/16:0),metabolic,DB00144
SMP01297,phospholipid biosynthesis CL(16:0/16:0/18:1(9Z)/16:1(9Z)),metabolic,DB00144
SMP01299,phospholipid biosynthesis CL(16:0/16:0/18:1(9Z)/18:1(9Z)),metabolic,DB00144
SMP01309,phospholipid biosynthesis CL(16:0/16:1(9Z)/14:0/14:0),metabolic,DB00144
SMP01312,phospholipid biosynthesis CL(16:0/16:1(9Z)/16:0/14:0),metabolic,DB00144
SMP01313,phospholipid biosynthesis CL(16:0/16:1(9Z)/16:0/16:1(9Z)),metabolic,DB00144
SMP01372,phospholipid biosynthesis CL(16:0/18:1(9Z)/14:0/16:0),metabolic,DB00144
SMP01373,phospholipid biosynthesis CL(16:0/18:1(9Z)/14:0/18:1(9Z)),metabolic,DB00144
SMP01379,phospholipid biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z)),metabolic,DB00144
SMP01387,phospholipid biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z)),metabolic,DB00144
SMP01428,phospholipid biosynthesis CL(16:0/19:0cycv8c/19:0cycv8c/17:0cycw7c),metabolic,DB00144
SMP01464,phospholipid biosynthesis CL(16:1(9Z)/15:0cyclo/16:0/16:1(9Z)),metabolic,DB00144
SMP01466,phospholipid biosynthesis CL(16:1(9Z)/15:0cyclo/16:1(9Z)/15:0cyclo),metabolic,DB00144
SMP01467,phospholipid biosynthesis CL(16:1(9Z)/15:0cyclo/16:1(9Z)/16:0),metabolic,DB00144
SMP01468,phospholipid biosynthesis CL(16:1(9Z)/15:0cyclo/16:1(9Z)/16:1(9Z)),metabolic,DB00144
SMP01502,phospholipid biosynthesis CL(16:1(9Z)/16:0/16:1(9Z)/16:1(9Z)),metabolic,DB00144
SMP01509,phospholipid biosynthesis (CL(18:1(9Z)/14:0/14:0/18:1(9Z))),metabolic,DB00144
SMP00033,Methionine Metabolism,metabolic,DB00145
SMP00050,Purine Metabolism,metabolic,DB00145
SMP00055,Alanine Metabolism,metabolic,DB00145
SMP00072,Glutamate Metabolism,metabolic,DB00145
SMP00143,5-Oxoprolinuria,disease,DB00145
SMP00144,Adenosine Deaminase Deficiency,disease,DB00145
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00145
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB00145
SMP00313,Lactic Acidemia,disease,DB00145
SMP00341,Hypermethioninemia,disease,DB00145
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00145
SMP00385,Homocarnosinosis,disease,DB00145
SMP00808,inner membrane transport,metabolic,DB00145
SMP00824,tRNA Charging 2,metabolic,DB00145
SMP00828,GLYCINE BIOSYNTHESIS,metabolic,DB00145
SMP00853,glutathione metabolism,metabolic,DB00145
SMP02377,purine nucleotides de novo biosynthesis ,metabolic,DB00145
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB00145
SMP00203,Molybdenum Cofactor Deficiency,disease,DB00145
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00145
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00145
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB00145
SMP00223,Non Ketotic Hyperglycinemia,disease,DB00145
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB00145
SMP00342,Hereditary Coproporphyria (HCP),disease,DB00145
SMP00352,Primary Hyperoxaluria Type I,disease,DB00145
SMP00465,Carnitine Synthesis,metabolic,DB00145
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00145
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB00145
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB00145
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00147
SMP00503,Hypophosphatasia,disease,DB00147
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00147
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00147
SMP02387,Vitamin B6,metabolic,DB00147
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB00147
SMP00521,3-hydroxyisobutyric acid dehydrogenase deficiency,disease,DB00147
SMP00522,3-hydroxyisobutyric aciduria,disease,DB00147
SMP63472,Vitamin B6 Metabolism ,metabolic,DB00147
SMP63592,Vitamin B6 Metabolism,metabolic,DB00147
SMP63689,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00147
SMP00140,3-Methylglutaconic Aciduria Type III,disease,DB00147
SMP00200,Methylmalonic Aciduria,disease,DB00147
SMP00238,Isovaleric Aciduria,disease,DB00147
SMP00384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB00147
SMP00523,Isobutyryl-coa dehydrogenase deficiency,disease,DB00147
SMP00524,Isovaleric acidemia,disease,DB00147
SMP00017,Vitamin B6 Metabolism,metabolic,DB00147
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB00147
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB00147
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB00147
SMP00199,Maple Syrup Urine Disease,disease,DB00147
SMP00236,Propionic Acidemia,disease,DB00147
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00148
SMP00223,Non Ketotic Hyperglycinemia,disease,DB00148
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00148
SMP12004,Arginine and Proline Metabolism,metabolic,DB00148
SMP00207,Prolidase Deficiency (PD),disease,DB00148
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00148
SMP63626,Glycine and Serine Metabolism,metabolic,DB00148
SMP00004,Glycine and Serine Metabolism,metabolic,DB00148
SMP00020,Arginine and Proline Metabolism,metabolic,DB00148
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00148
SMP00208,Prolinemia Type II,disease,DB00148
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00148
SMP00244,Sarcosinemia,disease,DB00148
SMP00361,Hyperprolinemia Type I,disease,DB00148
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00148
SMP00360,Hyperprolinemia Type II,disease,DB00148
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00148
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00148
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00148
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00148
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00148
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00148
SMP63596,Arginine and Proline Metabolism,metabolic,DB00148
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00149
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00149
SMP00253,Amikacin Action Pathway,drug_action,DB00149
SMP00258,Spectinomycin Action Pathway,drug_action,DB00149
SMP00682,Leucine Stimulation on Insulin Signaling,signaling,DB00149
SMP02298,Glutaminolysis and Cancer,disease,DB00149
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00149
SMP00249,Clindamycin Action Pathway,drug_action,DB00149
SMP00254,Gentamicin Action Pathway,drug_action,DB00149
SMP00257,Netilmicin Action Pathway,drug_action,DB00149
SMP00291,Doxycycline Action Pathway,drug_action,DB00149
SMP00292,Minocycline Action Pathway,drug_action,DB00149
SMP00295,Lymecycline Action Pathway,drug_action,DB00149
SMP00712,Tigecycline Action Pathway,drug_action,DB00149
SMP02374,Leucine Biosynthesis ,metabolic,DB00149
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB00149
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB00149
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB00149
SMP00199,Maple Syrup Urine Disease,disease,DB00149
SMP00236,Propionic Acidemia,disease,DB00149
SMP00711,Tobramycin Action Pathway,drug_action,DB00149
SMP00713,Arbekacin Action Pathway,drug_action,DB00149
SMP00727,Methacycline Action Pathway,drug_action,DB00149
SMP00824,tRNA Charging 2,metabolic,DB00149
SMP00996,Secondary Metabolite: Leucine biosynthesis,metabolic,DB00149
SMP00140,3-Methylglutaconic Aciduria Type III,disease,DB00149
SMP00200,Methylmalonic Aciduria,disease,DB00149
SMP00238,Isovaleric Aciduria,disease,DB00149
SMP00248,Clarithromycin Action Pathway,drug_action,DB00149
SMP00250,Erythromycin Action Pathway,drug_action,DB00149
SMP00820,tRNA charging,metabolic,DB00150
SMP00063,Tryptophan Metabolism,metabolic,DB00150
SMP02338,NAD metabolism,metabolic,DB00150
SMP02445,Tryptophan metabolism,metabolic,DB00150
SMP00808,inner membrane transport,metabolic,DB00150
SMP00824,tRNA Charging 2,metabolic,DB00150
SMP02353,Tryptophan metabolism,metabolic,DB00150
SMP02415,Alanine metabolism,metabolic,DB00150
SMP00835,tryptophan metabolism,metabolic,DB00150
SMP00981,Trp Operon,signaling,DB00150
SMP00982,Trp Operon Inactivation,signaling,DB00150
SMP01930,tryptophan metabolism II,metabolic,DB00150
SMP63693,Tryptophan Metabolism,metabolic,DB00150
SMP00091,Quinethazone Action Pathway,drug_action,DB00151
SMP00105,Metolazone Action Pathway,drug_action,DB00151
SMP00189,Hartnup Disorder,disease,DB00151
SMP00193,Iminoglycinuria,disease,DB00151
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00151
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB00151
SMP00223,Non Ketotic Hyperglycinemia,disease,DB00151
SMP00455,Homocysteine Degradation,metabolic,DB00151
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00151
SMP00583,Blue diaper syndrome,disease,DB00151
SMP00723,Cystinuria,disease,DB00151
SMP00941,sulfur metabolism (propanesulfonate),metabolic,DB00151
SMP00942,sulfur metabolism (ethanesulfonate),metabolic,DB00151
SMP01941,glutathione metabolism II,metabolic,DB00151
SMP02307,Beta-Alanine metabolism,metabolic,DB00151
SMP63622,Glutathione Metabolism,metabolic,DB00151
SMP00004,Glycine and Serine Metabolism,metabolic,DB00151
SMP00110,Indapamide Action Pathway,drug_action,DB00151
SMP00121,Trichlormethiazide Action Pathway,drug_action,DB00151
SMP00133,Amiloride Action Pathway,drug_action,DB00151
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00151
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00151
SMP00244,Sarcosinemia,disease,DB00151
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00151
SMP00499,Beta-mercaptolactate-cysteine disulfiduria,disease,DB00151
SMP00514,Gamma-cystathionase deficiency (CTH),disease,DB00151
SMP00515,"Homocystinuria, cystathionine beta-synthase deficiency",disease,DB00151
SMP00820,tRNA charging,metabolic,DB00151
SMP00848,Pantothenate and CoA Biosynthesis,metabolic,DB00151
SMP00943,sulfur metabolism (isethionate),metabolic,DB00151
SMP00076,Thiamine Metabolism,metabolic,DB00152
SMP63677,Thiamine Metabolism,metabolic,DB00152
SMP02385,Vitamin B1/Thiamine metabolism,metabolic,DB00152
SMP00018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00154
SMP63593,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00154
SMP00003,Argininosuccinic Aciduria,disease,DB00155
SMP00207,Prolidase Deficiency (PD),disease,DB00155
SMP02420,Proline Metabolism,metabolic,DB00155
SMP00192,Hypoacetylaspartia,disease,DB00155
SMP00357,Argininemia,disease,DB00155
SMP12004,Arginine and Proline Metabolism,metabolic,DB00155
SMP63686,Urea Cycle,metabolic,DB00155
SMP00001,Citrullinemia Type I,disease,DB00155
SMP00002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB00155
SMP00067,Aspartate Metabolism,metabolic,DB00155
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00155
SMP00020,Arginine and Proline Metabolism,metabolic,DB00155
SMP00059,Urea Cycle,metabolic,DB00155
SMP00175,Canavan Disease,disease,DB00155
SMP00205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB00155
SMP00208,Prolinemia Type II,disease,DB00155
SMP00361,Hyperprolinemia Type I,disease,DB00155
SMP00809,Aspartate metabolism,metabolic,DB00155
SMP63597,Aspartate Metabolism,metabolic,DB00155
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00155
SMP00360,Hyperprolinemia Type II,disease,DB00155
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00155
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00155
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00155
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00155
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00155
SMP00812,arginine metabolism,metabolic,DB00155
SMP02416,Arginine Metabolism,metabolic,DB00155
SMP63596,Arginine and Proline Metabolism,metabolic,DB00155
SMP00253,Amikacin Action Pathway,drug_action,DB00156
SMP00258,Spectinomycin Action Pathway,drug_action,DB00156
SMP00452,Threonine and 2-Oxobutanoate Degradation,metabolic,DB00156
SMP02118,L-threonine degradation to methylglyoxal,metabolic,DB00156
SMP02375,isoleucine biosynthesis ,metabolic,DB00156
SMP02428,Glycine Metabolism,metabolic,DB00156
SMP00711,Tobramycin Action Pathway,drug_action,DB00156
SMP00713,Arbekacin Action Pathway,drug_action,DB00156
SMP00727,Methacycline Action Pathway,drug_action,DB00156
SMP00808,inner membrane transport,metabolic,DB00156
SMP00824,tRNA Charging 2,metabolic,DB00156
SMP00992,Secondary Metabolites: threonine biosynthesis from aspartate,metabolic,DB00156
SMP02430,Isoleucine Biosynthesis ,metabolic,DB00156
SMP00249,Clindamycin Action Pathway,drug_action,DB00156
SMP00254,Gentamicin Action Pathway,drug_action,DB00156
SMP00257,Netilmicin Action Pathway,drug_action,DB00156
SMP00291,Doxycycline Action Pathway,drug_action,DB00156
SMP00292,Minocycline Action Pathway,drug_action,DB00156
SMP00295,Lymecycline Action Pathway,drug_action,DB00156
SMP00712,Tigecycline Action Pathway,drug_action,DB00156
SMP00837,threonine biosynthesis,metabolic,DB00156
SMP00957,propanoate metabolism,metabolic,DB00156
SMP02322,threonine metabolism,metabolic,DB00156
SMP00248,Clarithromycin Action Pathway,drug_action,DB00156
SMP00250,Erythromycin Action Pathway,drug_action,DB00156
SMP00251,Roxithromycin Action Pathway,drug_action,DB00156
SMP00255,Kanamycin Action Pathway,drug_action,DB00156
SMP00256,Neomycin Action Pathway,drug_action,DB00156
SMP00262,Clomocycline Action Pathway,drug_action,DB00156
SMP00714,Paromomycin Action Pathway,drug_action,DB00156
SMP00010,Nucleotide Sugars Metabolism,metabolic,DB00157
SMP00039,Glycerolipid Metabolism,metabolic,DB00157
SMP00043,Galactose Metabolism,metabolic,DB00157
SMP00063,Tryptophan Metabolism,metabolic,DB00157
SMP00064,Fructose and Mannose Degradation,metabolic,DB00157
SMP00073,Butyrate Metabolism,metabolic,DB00157
SMP00074,Retinol Metabolism,metabolic,DB00157
SMP00128,Gluconeogenesis,metabolic,DB00157
SMP00140,3-Methylglutaconic Aciduria Type III,disease,DB00157
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB00157
SMP00191,Histidinemia,disease,DB00157
SMP00200,Methylmalonic Aciduria,disease,DB00157
SMP00203,Molybdenum Cofactor Deficiency,disease,DB00157
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00157
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB00157
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00157
SMP00218,Tyrosinemia Type I,disease,DB00157
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB00157
SMP00223,Non Ketotic Hyperglycinemia,disease,DB00157
SMP00238,Isovaleric Aciduria,disease,DB00157
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB00157
SMP00336,Vitamin A Deficiency,disease,DB00157
SMP00342,Hereditary Coproporphyria (HCP),disease,DB00157
SMP00357,Argininemia,disease,DB00157
SMP00371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB00157
SMP00372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,disease,DB00157
SMP00384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB00157
SMP00424,Citalopram Action Pathway,drug_action,DB00157
SMP00429,Disulfiram Action Pathway,drug_action,DB00157
SMP00442,Etoposide Action Pathway,drug_action,DB00157
SMP02369,One Carbon Pool by Folate I ,metabolic,DB00158
SMP00432,Methotrexate Action Pathway,drug_action,DB00158
SMP00543,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00158
SMP01750,One Carbon Pool by Folate I,metabolic,DB00158
SMP00053,Folate Metabolism,metabolic,DB00158
SMP00724,"Folate malabsorption, hereditary",disease,DB00158
SMP00801,Folate Metabolism,metabolic,DB00158
SMP00018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00159
SMP63593,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB00159
SMP00003,Argininosuccinic Aciduria,disease,DB00160
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00160
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00160
SMP00253,Amikacin Action Pathway,drug_action,DB00160
SMP00258,Spectinomycin Action Pathway,drug_action,DB00160
SMP00337,Glutathione Synthetase Deficiency,disease,DB00160
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB00160
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00160
SMP00500,5-oxoprolinase deficiency,disease,DB00160
SMP00785,Biotin metabolism,metabolic,DB00160
SMP00791,D-alanine Metabolism,metabolic,DB00160
SMP00810,L-alanine metabolism,metabolic,DB00160
SMP02298,Glutaminolysis and Cancer,disease,DB00160
SMP02428,Glycine Metabolism,metabolic,DB00160
SMP12046,Thio-Molybdenum Cofactor Biosynthesis,metabolic,DB00160
SMP63626,Glycine and Serine Metabolism,metabolic,DB00160
SMP00015,Glutathione Metabolism,metabolic,DB00160
SMP00183,Gamma-Glutamyltransferase Deficiency,disease,DB00160
SMP00249,Clindamycin Action Pathway,drug_action,DB00160
SMP00254,Gentamicin Action Pathway,drug_action,DB00160
SMP00257,Netilmicin Action Pathway,drug_action,DB00160
SMP00291,Doxycycline Action Pathway,drug_action,DB00160
SMP00292,Minocycline Action Pathway,drug_action,DB00160
SMP00295,Lymecycline Action Pathway,drug_action,DB00160
SMP00350,Pyruvate Carboxylase Deficiency,disease,DB00160
SMP00501,Gamma-glutamyl-transpeptidase deficiency,disease,DB00160
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB00160
SMP00712,Tigecycline Action Pathway,drug_action,DB00160
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00160
SMP02352,Tyrosine metabolism,metabolic,DB00160
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00161
SMP00249,Clindamycin Action Pathway,drug_action,DB00161
SMP00254,Gentamicin Action Pathway,drug_action,DB00161
SMP00257,Netilmicin Action Pathway,drug_action,DB00161
SMP00291,Doxycycline Action Pathway,drug_action,DB00161
SMP00292,Minocycline Action Pathway,drug_action,DB00161
SMP00295,Lymecycline Action Pathway,drug_action,DB00161
SMP00712,Tigecycline Action Pathway,drug_action,DB00161
SMP02388,Valine Degradation,metabolic,DB00161
SMP00016,Propanoate Metabolism,metabolic,DB00161
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00161
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00161
SMP00198,Malonic Aciduria,disease,DB00161
SMP00253,Amikacin Action Pathway,drug_action,DB00161
SMP00258,Spectinomycin Action Pathway,drug_action,DB00161
SMP00810,L-alanine metabolism,metabolic,DB00161
SMP00832,Valine Biosynthesis,metabolic,DB00161
SMP02460,Valine Degradation,metabolic,DB00161
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB00161
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB00161
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB00161
SMP00199,Maple Syrup Urine Disease,disease,DB00161
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB00161
SMP00236,Propionic Acidemia,disease,DB00161
SMP00711,Tobramycin Action Pathway,drug_action,DB00161
SMP00713,Arbekacin Action Pathway,drug_action,DB00161
SMP00727,Methacycline Action Pathway,drug_action,DB00161
SMP00824,tRNA Charging 2,metabolic,DB00161
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB00161
SMP00247,Azithromycin Action Pathway,drug_action,DB00161
SMP63662,Retinol Metabolism,metabolic,DB00162
SMP00074,Retinol Metabolism,metabolic,DB00162
SMP00336,Vitamin A Deficiency,disease,DB00162
SMP00503,Hypophosphatasia,disease,DB00165
SMP02387,Vitamin B6,metabolic,DB00165
SMP00017,Vitamin B6 Metabolism,metabolic,DB00165
SMP63472,Vitamin B6 Metabolism ,metabolic,DB00165
SMP63592,Vitamin B6 Metabolism,metabolic,DB00165
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00167
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00167
SMP00253,Amikacin Action Pathway,drug_action,DB00167
SMP00258,Spectinomycin Action Pathway,drug_action,DB00167
SMP02375,isoleucine biosynthesis ,metabolic,DB00167
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB00167
SMP00249,Clindamycin Action Pathway,drug_action,DB00167
SMP00254,Gentamicin Action Pathway,drug_action,DB00167
SMP00257,Netilmicin Action Pathway,drug_action,DB00167
SMP00291,Doxycycline Action Pathway,drug_action,DB00167
SMP00292,Minocycline Action Pathway,drug_action,DB00167
SMP00295,Lymecycline Action Pathway,drug_action,DB00167
SMP00712,Tigecycline Action Pathway,drug_action,DB00167
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB00167
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB00167
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB00167
SMP00199,Maple Syrup Urine Disease,disease,DB00167
SMP00236,Propionic Acidemia,disease,DB00167
SMP00711,Tobramycin Action Pathway,drug_action,DB00167
SMP00713,Arbekacin Action Pathway,drug_action,DB00167
SMP00727,Methacycline Action Pathway,drug_action,DB00167
SMP00824,tRNA Charging 2,metabolic,DB00167
SMP02390,Isoleucine degradation,metabolic,DB00167
SMP02430,Isoleucine Biosynthesis ,metabolic,DB00167
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB00167
SMP00247,Azithromycin Action Pathway,drug_action,DB00167
SMP00252,Telithromycin Action Pathway,drug_action,DB00167
SMP00259,Streptomycin Action Pathway,drug_action,DB00167
SMP00290,Demeclocycline Action Pathway,drug_action,DB00167
SMP00293,Oxytetracycline Action Pathway,drug_action,DB00167
SMP00095,Alendronate Action Pathway,drug_action,DB00169
SMP00107,Zoledronate Action Pathway,drug_action,DB00169
SMP00511,Wolman disease,disease,DB00169
SMP00089,Pravastatin Action Pathway,drug_action,DB00169
SMP00112,Risedronate Action Pathway,drug_action,DB00169
SMP00209,Hypercholesterolemia,disease,DB00169
SMP00092,Rosuvastatin Action Pathway,drug_action,DB00169
SMP00119,Fluvastatin Action Pathway,drug_action,DB00169
SMP00387,CHILD Syndrome,disease,DB00169
SMP00509,Hyper-IgD syndrome,disease,DB00169
SMP00111,Cerivastatin Action Pathway,drug_action,DB00169
SMP00117,Pamidronate Action Pathway,drug_action,DB00169
SMP00131,Atorvastatin Action Pathway,drug_action,DB00169
SMP00508,Cholesteryl ester storage disease,disease,DB00169
SMP00510,Mevalonic aciduria,disease,DB00169
SMP63670,Steroid Biosynthesis,metabolic,DB00169
SMP00023,Steroid Biosynthesis,metabolic,DB00169
SMP00079,Ibandronate Action Pathway,drug_action,DB00169
SMP00082,Simvastatin Action Pathway,drug_action,DB00169
SMP00099,Lovastatin Action Pathway,drug_action,DB00169
SMP00319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB00169
SMP00386,Desmosterolosis,disease,DB00169
SMP00388,"Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)",disease,DB00169
SMP00389,Smith-Lemli-Opitz Syndrome (SLOS),disease,DB00169
SMP00003,Argininosuccinic Aciduria,disease,DB00171
SMP00011,Inositol Metabolism,metabolic,DB00171
SMP00016,Propanoate Metabolism,metabolic,DB00171
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB00171
SMP00040,Glycolysis,metabolic,DB00171
SMP00044,Histidine Metabolism,metabolic,DB00171
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB00171
SMP00053,Folate Metabolism,metabolic,DB00171
SMP00057,Citric Acid Cycle,metabolic,DB00171
SMP00089,Pravastatin Action Pathway,drug_action,DB00171
SMP00112,Risedronate Action Pathway,drug_action,DB00171
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB00171
SMP00168,AICA-Ribosiduria,disease,DB00171
SMP00173,Beta-Ketothiolase Deficiency,disease,DB00171
SMP00185,Glutaric Aciduria Type I,disease,DB00171
SMP00187,Glycerol Kinase Deficiency,disease,DB00171
SMP00196,Leigh Syndrome,disease,DB00171
SMP00198,Malonic Aciduria,disease,DB00171
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB00171
SMP00207,Prolidase Deficiency (PD),disease,DB00171
SMP00209,Hypercholesterolemia,disease,DB00171
SMP00216,Sialuria or French Type Sialuria,disease,DB00171
SMP00231,Famotidine Action Pathway,drug_action,DB00171
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB00171
SMP00253,Amikacin Action Pathway,drug_action,DB00171
SMP00258,Spectinomycin Action Pathway,drug_action,DB00171
SMP00301,Esmolol Action Pathway,drug_action,DB00171
SMP00302,Metoprolol Action Pathway,drug_action,DB00171
SMP00307,Propranolol Action Pathway,drug_action,DB00171
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB00171
SMP00207,Prolidase Deficiency (PD),disease,DB00172
SMP00253,Amikacin Action Pathway,drug_action,DB00172
SMP00258,Spectinomycin Action Pathway,drug_action,DB00172
SMP02420,Proline Metabolism,metabolic,DB00172
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00172
SMP00711,Tobramycin Action Pathway,drug_action,DB00172
SMP00713,Arbekacin Action Pathway,drug_action,DB00172
SMP00727,Methacycline Action Pathway,drug_action,DB00172
SMP00824,tRNA Charging 2,metabolic,DB00172
SMP00248,Clarithromycin Action Pathway,drug_action,DB00172
SMP00250,Erythromycin Action Pathway,drug_action,DB00172
SMP00251,Roxithromycin Action Pathway,drug_action,DB00172
SMP00255,Kanamycin Action Pathway,drug_action,DB00172
SMP00256,Neomycin Action Pathway,drug_action,DB00172
SMP00262,Clomocycline Action Pathway,drug_action,DB00172
SMP00714,Paromomycin Action Pathway,drug_action,DB00172
SMP00726,Rolitetracycline Action Pathway,drug_action,DB00172
SMP00729,Chloramphenicol Action Pathway,drug_action,DB00172
SMP12004,Arginine and Proline Metabolism,metabolic,DB00172
SMP00020,Arginine and Proline Metabolism,metabolic,DB00172
SMP00208,Prolinemia Type II,disease,DB00172
SMP00247,Azithromycin Action Pathway,drug_action,DB00172
SMP00252,Telithromycin Action Pathway,drug_action,DB00172
SMP00259,Streptomycin Action Pathway,drug_action,DB00172
SMP00290,Demeclocycline Action Pathway,drug_action,DB00172
SMP00293,Oxytetracycline Action Pathway,drug_action,DB00172
SMP00294,Tetracycline Action Pathway,drug_action,DB00172
SMP00361,Hyperprolinemia Type I,disease,DB00172
SMP00728,Lincomycin Action Pathway,drug_action,DB00172
SMP00730,Troleandomycin Action Pathway,drug_action,DB00172
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB00173
SMP00537,Myoadenylate deaminase deficiency,disease,DB00173
SMP00848,Pantothenate and CoA Biosynthesis,metabolic,DB00173
SMP02088,purine ribonucleosides degradation,metabolic,DB00173
SMP00168,AICA-Ribosiduria,disease,DB00173
SMP00428,Mercaptopurine Action Pathway,drug_action,DB00173
SMP00430,Thioguanine Action Pathway,drug_action,DB00173
SMP00512,Xanthinuria type I,disease,DB00173
SMP02077,methylphosphonate degradation I,metabolic,DB00173
SMP02081,adenine and adenosine salvage I,metabolic,DB00173
SMP00050,Purine Metabolism,metabolic,DB00173
SMP00144,Adenosine Deaminase Deficiency,disease,DB00173
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00173
SMP02092,S-adenosyl-L-methionine cycle,metabolic,DB00173
SMP02097,Spermidine biosynthesis and metabolism ,metabolic,DB00173
SMP02364,Pantothenate and CoA Biosynthesis ,metabolic,DB00173
SMP12058,Cytokinins Degradation,metabolic,DB00173
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB00173
SMP00427,Azathioprine Action Pathway,drug_action,DB00173
SMP00513,Xanthinuria type II,disease,DB00173
SMP00857,S-adenosyl-L-methionine biosynthesis,metabolic,DB00173
SMP02083,adenine and adenosine salvage II,metabolic,DB00173
SMP02084,adenine and adenosine salvage III,metabolic,DB00173
SMP02087,Citrate lyase activation,metabolic,DB00173
SMP02310,Methionine metabolism and salvage,metabolic,DB00173
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB00173
SMP00203,Molybdenum Cofactor Deficiency,disease,DB00173
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00173
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB00173
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB00173
SMP00253,Amikacin Action Pathway,drug_action,DB00174
SMP00258,Spectinomycin Action Pathway,drug_action,DB00174
SMP00067,Aspartate Metabolism,metabolic,DB00174
SMP00711,Tobramycin Action Pathway,drug_action,DB00174
SMP00713,Arbekacin Action Pathway,drug_action,DB00174
SMP00727,Methacycline Action Pathway,drug_action,DB00174
SMP00808,inner membrane transport,metabolic,DB00174
SMP00824,tRNA Charging 2,metabolic,DB00174
SMP02206,Asparagine metabolism,metabolic,DB00174
SMP00249,Clindamycin Action Pathway,drug_action,DB00174
SMP00254,Gentamicin Action Pathway,drug_action,DB00174
SMP00257,Netilmicin Action Pathway,drug_action,DB00174
SMP00291,Doxycycline Action Pathway,drug_action,DB00174
SMP00292,Minocycline Action Pathway,drug_action,DB00174
SMP00295,Lymecycline Action Pathway,drug_action,DB00174
SMP00712,Tigecycline Action Pathway,drug_action,DB00174
SMP02421,Asparagine metabolism,metabolic,DB00174
SMP00192,Hypoacetylaspartia,disease,DB00174
SMP00248,Clarithromycin Action Pathway,drug_action,DB00174
SMP00250,Erythromycin Action Pathway,drug_action,DB00174
SMP00251,Roxithromycin Action Pathway,drug_action,DB00174
SMP00255,Kanamycin Action Pathway,drug_action,DB00174
SMP00256,Neomycin Action Pathway,drug_action,DB00174
SMP00262,Clomocycline Action Pathway,drug_action,DB00174
SMP00714,Paromomycin Action Pathway,drug_action,DB00174
SMP00726,Rolitetracycline Action Pathway,drug_action,DB00174
SMP00729,Chloramphenicol Action Pathway,drug_action,DB00174
SMP00833,Asparagine biosynthesis,metabolic,DB00174
SMP63579,Ammonia Recycling,metabolic,DB00174
SMP00009,Ammonia Recycling,metabolic,DB00174
SMP00089,Pravastatin Action Pathway,drug_action,DB00175
SMP00165,Valsartan Action Pathway,drug_action,DB00177
SMP00154,Ramipril Action Pathway,drug_action,DB00178
SMP00597,Ramipril Metabolism Pathway,drug_metabolism,DB00178
SMP00431,Nicotine Action Pathway,drug_action,DB00184
SMP00628,Nicotine Metabolism Pathway,drug_metabolism,DB00184
SMP00301,Esmolol Action Pathway,drug_action,DB00187
SMP00637,Tramadol Metabolism Pathway,drug_metabolism,DB00193
SMP00671,Tramadol Action Action Pathway,drug_action,DB00193
SMP00299,Betaxolol Action Pathway,drug_action,DB00195
SMP00250,Erythromycin Action Pathway,drug_action,DB00199
SMP63604,Caffeine Metabolism,metabolic,DB00201
SMP00028,Caffeine Metabolism,metabolic,DB00201
SMP00247,Azithromycin Action Pathway,drug_action,DB00207
SMP00261,Ticlopidine Action Pathway,drug_action,DB00208
SMP00611,Ticlopidine Metabolism Pathway,drug_metabolism,DB00208
SMP00228,Pantoprazole Action Pathway,drug_action,DB00213
SMP00615,Pantoprazole Metabolism Pathway,drug_metabolism,DB00213
SMP00118,Torsemide Action Pathway,drug_action,DB00214
SMP00424,Citalopram Action Pathway,drug_action,DB00215
SMP00627,Citalopram Metabolism Pathway,drug_metabolism,DB00215
SMP00099,Lovastatin Action Pathway,drug_action,DB00227
SMP00081,Methyclothiazide Action Pathway,drug_action,DB00232
SMP00743,Nevirapine  Action Pathway,drug_action,DB00238
SMP00642,Nevirapine Metabolism Pathway,drug_metabolism,DB00238
SMP00618,Fosphenytoin (Antiarrhythmic) Metabolism Pathway,drug_metabolism,DB00252
SMP00326,Fosphenytoin (Antiarrhythmic) Action Pathway,drug_action,DB00252
SMP00327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB00252
SMP00291,Doxycycline Action Pathway,drug_action,DB00254
SMP00295,Lymecycline Action Pathway,drug_action,DB00256
SMP00302,Metoprolol Action Pathway,drug_action,DB00264
SMP00270,Dicumarol Action Pathway,drug_action,DB00266
SMP00656,Dicoumarol Action Pathway,drug_action,DB00266
SMP00378,Isradipine Action Pathway,drug_action,DB00270
SMP00736,Betazole Action Pathway,drug_action,DB00272
SMP00163,Olmesartan Action Pathway,drug_action,DB00275
SMP63604,Caffeine Metabolism,metabolic,DB00277
SMP00028,Caffeine Metabolism,metabolic,DB00277
SMP00276,Argatroban Action Pathway,drug_action,DB00278
SMP00716,Thyroid hormone synthesis,metabolic,DB00279
SMP63679,Thyroid hormone synthesis,metabolic,DB00279
SMP00325,Disopyramide Action Pathway,drug_action,DB00280
SMP00398,Lidocaine (Local Anaesthetic) Action Pathway,drug_action,DB00281
SMP00328,Lidocaine (Antiarrhythmic) Action Pathway,drug_action,DB00281
SMP00620,Lidocaine (Local Anaesthetic) Metabolism Pathway,drug_metabolism,DB00281
SMP00117,Pamidronate Action Pathway,drug_action,DB00282
SMP58891,Clemastine H1-Antihistamine Action,drug_action,DB00283
SMP00636,Venlafaxine Metabolism Pathway,drug_metabolism,DB00285
SMP00405,Codeine Action Pathway,drug_action,DB00295
SMP00407,Heroin Action Pathway,drug_action,DB00295
SMP00623,Heroin Metabolism Pathway,drug_metabolism,DB00295
SMP00406,Morphine Action Pathway,drug_action,DB00295
SMP00621,Codeine Metabolism Pathway,drug_metabolism,DB00295
SMP00622,Morphine Metabolism Pathway,drug_metabolism,DB00295
SMP00404,Ropivacaine Action Pathway,drug_action,DB00296
SMP00393,Bupivacaine Action Pathway,drug_action,DB00297
SMP00630,Tenofovir Metabolism Pathway,drug_metabolism,DB00300
SMP00287,Tranexamic Acid Action Pathway,drug_action,DB00302
SMP00332,Ibutilide Action Pathway,drug_action,DB00308
SMP00438,Vindesine Action Pathway,drug_action,DB00309
SMP00122,Chlorthalidone Action Pathway,drug_action,DB00310
SMP00635,Valproic Acid Metabolism Pathway,drug_metabolism,DB00313
SMP00640,Acetaminophen Metabolism Pathway,drug_metabolism,DB00316
SMP00710,Acetaminophen  Action Pathway,drug_action,DB00316
SMP00473,Gefitinib Action Pathway,drug_action,DB00317
SMP00621,Codeine Metabolism Pathway,drug_metabolism,DB00318
SMP00405,Codeine Action Pathway,drug_action,DB00318
SMP00410,Hydromorphone Action Pathway,drug_action,DB00327
SMP00104,Indomethacin Action Pathway,drug_action,DB00328
SMP00408,Methadone Action Pathway,drug_action,DB00333
SMP00624,Methadone Metabolism Pathway,drug_metabolism,DB00333
SMP00298,Atenolol Action Pathway,drug_action,DB00335
SMP00226,Omeprazole Action Pathway,drug_action,DB00338
SMP00613,Omeprazole Metabolism Pathway,drug_metabolism,DB00338
SMP59058,Cetirizine H1-Antihistamine Action,drug_action,DB00341
SMP60208,Terfenadine H1-Antihistamine Action,drug_action,DB00342
SMP00359,Diltiazem Action Pathway,drug_action,DB00343
SMP00647,Thioguanine Metabolism Pathway,drug_metabolism,DB00352
SMP00430,Thioguanine Action Pathway,drug_action,DB00352
SMP58964,Buclizine H1-Antihistamine Action,drug_action,DB00354
SMP00063,Tryptophan Metabolism,metabolic,DB00360
SMP00218,Tyrosinemia Type I,disease,DB00360
SMP00429,Disulfiram Action Pathway,drug_action,DB00360
SMP12004,Arginine and Proline Metabolism,metabolic,DB00360
SMP63777,Nitric Oxide Signaling Pathway,signaling,DB00360
SMP00005,Pterine Biosynthesis,metabolic,DB00360
SMP00006,Tyrosine Metabolism,metabolic,DB00360
SMP00207,Prolidase Deficiency (PD),disease,DB00360
SMP00490,Segawa syndrome,disease,DB00360
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00360
SMP00169,Alkaptonuria,disease,DB00360
SMP00190,Hawkinsinuria,disease,DB00360
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00360
SMP00489,Hyperphenylalaninemia due to dhpr-deficiency,disease,DB00360
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB00360
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB00360
SMP00020,Arginine and Proline Metabolism,metabolic,DB00360
SMP00208,Prolinemia Type II,disease,DB00360
SMP00361,Hyperprolinemia Type I,disease,DB00360
SMP00486,Dopa-responsive dystonia,disease,DB00360
SMP00487,Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,disease,DB00360
SMP00488,Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),disease,DB00360
SMP63657,Pterine Biosynthesis,metabolic,DB00360
SMP63684,Tyrosine Metabolism,metabolic,DB00360
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00360
SMP00360,Hyperprolinemia Type II,disease,DB00360
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00360
SMP00491,Sepiapterin reductase deficiency,disease,DB00360
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00360
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00360
SMP00439,Vinorelbine Action Pathway,drug_action,DB00361
SMP58803,Doxylamine H1-Antihistamine Action,drug_action,DB00366
SMP00012,Catecholamine Biosynthesis,metabolic,DB00368
SMP00401,Prilocaine Action Pathway,drug_action,DB00368
SMP00407,Heroin Action Pathway,drug_action,DB00368
SMP00408,Methadone Action Pathway,drug_action,DB00368
SMP00413,Alfentanil Action Pathway,drug_action,DB00368
SMP00414,Carfentanil Action Pathway,drug_action,DB00368
SMP00671,Tramadol Action Action Pathway,drug_action,DB00368
SMP00683,Levallorphan Action Pathway,drug_action,DB00368
SMP00006,Tyrosine Metabolism,metabolic,DB00368
SMP00396,Dibucaine Action Pathway,drug_action,DB00368
SMP00402,Procaine Action Pathway,drug_action,DB00368
SMP00405,Codeine Action Pathway,drug_action,DB00368
SMP00410,Hydromorphone Action Pathway,drug_action,DB00368
SMP00416,Remifentanil Action Pathway,drug_action,DB00368
SMP00422,Imipramine Action Pathway,drug_action,DB00368
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00368
SMP00672,Propoxyphene Action Pathway,drug_action,DB00368
SMP00675,Diphenoxylate Action Pathway,drug_action,DB00368
SMP00679,3-Methylthiofentanyl Action Pathway,drug_action,DB00368
SMP00681,Ethylmorphine Action Pathway,drug_action,DB00368
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00368
SMP00397,Levobupivacaine Action Pathway,drug_action,DB00368
SMP00412,Oxymorphone Action Pathway,drug_action,DB00368
SMP00415,Fentanyl Action Pathway,drug_action,DB00368
SMP00426,Fluoxetine Action Pathway,drug_action,DB00368
SMP00431,Nicotine Action Pathway,drug_action,DB00368
SMP00673,Levorphanol Action Pathway,drug_action,DB00368
SMP00674,Anileridine Action Pathway,drug_action,DB00368
SMP00678,Methadyl Acetate Action Pathway,drug_action,DB00368
SMP00684,Buprenorphine Action Pathway,drug_action,DB00368
SMP62885,Mirtazapine H1-Antihistamine Action,drug_action,DB00370
SMP00607,Capecitabine Metabolism Pathway,drug_metabolism,DB00371
SMP00469,Capecitabine Action Pathway,drug_action,DB00371
SMP00659,Timolol Action Pathway,drug_action,DB00373
SMP00329,Mexiletine Action Pathway,drug_action,DB00379
SMP00376,Amlodipine Action Pathway,drug_action,DB00381
SMP00132,Triamterene Action Pathway,drug_action,DB00384
SMP00380,Nimodipine Action Pathway,drug_action,DB00393
SMP00577,Corticosterone methyl oxidase I deficiency (CMO I),disease,DB00396
SMP00566,17-alpha-hydroxylase deficiency (CYP17),disease,DB00396
SMP63672,Steroidogenesis,metabolic,DB00396
SMP00130,Steroidogenesis,metabolic,DB00396
SMP00373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,disease,DB00396
SMP00576,21-hydroxylase deficiency (CYP21),disease,DB00396
SMP00717,Apparent mineralocorticoid excess syndrome,disease,DB00396
SMP00718,3-Beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB00396
SMP00371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB00396
SMP00372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,disease,DB00396
SMP00575,11-beta-hydroxylase deficiency (CYP11B1),disease,DB00396
SMP00578,Corticosterone methyl oxidase II deficiency - CMO II,disease,DB00396
SMP00648,Sorafenib Metabolism Pathway,drug_metabolism,DB00398
SMP00107,Zoledronate Action Pathway,drug_action,DB00399
SMP00381,Nisoldipine Action Pathway,drug_action,DB00401
SMP57580,Dexbrompheniramine H1-Antihistamine Action,drug_action,DB00405
SMP00272,Enoxaparin Action Pathway,drug_action,DB00407
SMP00275,Ardeparin Action Pathway,drug_action,DB00407
SMP00653,Rosiglitazone Metabolism Pathway,drug_metabolism,DB00412
SMP00134,Spironolactone Action Pathway,drug_action,DB00421
SMP57581,Triprolidine H1-Antihistamine Action,drug_action,DB00427
SMP59694,Cyproheptadine H1-Antihistamine Action,drug_action,DB00434
SMP00207,Prolidase Deficiency (PD),disease,DB00435
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB00435
SMP12004,Arginine and Proline Metabolism,metabolic,DB00435
SMP63777,Nitric Oxide Signaling Pathway,signaling,DB00435
SMP00020,Arginine and Proline Metabolism,metabolic,DB00435
SMP00208,Prolinemia Type II,disease,DB00435
SMP00361,Hyperprolinemia Type I,disease,DB00435
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB00435
SMP00360,Hyperprolinemia Type II,disease,DB00435
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB00435
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB00435
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB00435
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB00435
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB00435
SMP63596,Arginine and Proline Metabolism,metabolic,DB00435
SMP00090,Bendroflumethiazide Action Pathway,drug_action,DB00436
SMP00111,Cerivastatin Action Pathway,drug_action,DB00439
SMP00446,Gemcitabine Action Pathway,drug_action,DB00441
SMP00603,Gemcitabine Metabolism Pathway,drug_metabolism,DB00441
SMP00602,Teniposide Metabolism Pathway,drug_metabolism,DB00444
SMP00443,Teniposide Action Pathway,drug_action,DB00444
SMP00729,Chloramphenicol Action Pathway,drug_action,DB00446
SMP00227,Lansoprazole Action Pathway,drug_action,DB00448
SMP00614,Lansoprazole Metabolism Pathway,drug_metabolism,DB00448
SMP00716,Thyroid hormone synthesis,metabolic,DB00451
SMP63679,Thyroid hormone synthesis,metabolic,DB00451
SMP00256,Neomycin Action Pathway,drug_action,DB00452
SMP00262,Clomocycline Action Pathway,drug_action,DB00453
SMP60195,Loratadine H1-Antihistamine Action,drug_action,DB00455
SMP00422,Imipramine Action Pathway,drug_action,DB00458
SMP00625,Imipramine Metabolism Pathway,drug_metabolism,DB00458
SMP00114,Nabumetone Action Pathway,drug_action,DB00461
SMP00098,Ketorolac Action Pathway,drug_action,DB00465
SMP00706,Tenoxicam Action Pathway,drug_action,DB00469
SMP00426,Fluoxetine Action Pathway,drug_action,DB00472
SMP00646,Fluoxetine Metabolism Pathway,drug_metabolism,DB00472
SMP00253,Amikacin Action Pathway,drug_action,DB00479
SMP00644,Celecoxib Metabolism Pathway,drug_metabolism,DB00482
SMP00096,Celecoxib Action Pathway,drug_action,DB00482
SMP00660,Sotalol Action Pathway,drug_action,DB00489
SMP00149,Fosinopril Action Pathway,drug_action,DB00492
SMP00594,Fosinopril Metabolism Pathway,drug_metabolism,DB00492
SMP00747,Zidovudine Action Pathway,drug_action,DB00495
SMP00409,Oxycodone Action Pathway,drug_action,DB00497
SMP00655,Phenindione Action Pathway,drug_action,DB00498
SMP00704,Tolmetin Action Pathway,drug_action,DB00500
SMP00232,Cimetidine Action Pathway,drug_action,DB00501
SMP00617,Cimetidine Metabolism Pathway,drug_metabolism,DB00501
SMP00683,Levallorphan Action Pathway,drug_action,DB00504
SMP00286,Aminocaproic Acid Action Pathway,drug_action,DB00513
SMP00599,Trandolapril Metabolism Pathway,drug_metabolism,DB00519
SMP00157,Trandolapril Action Pathway,drug_action,DB00519
SMP00658,Carteolol Action Pathway,drug_action,DB00521
SMP63662,Retinol Metabolism,metabolic,DB00523
SMP00074,Retinol Metabolism,metabolic,DB00523
SMP00336,Vitamin A Deficiency,disease,DB00523
SMP00105,Metolazone Action Pathway,drug_action,DB00524
SMP00396,Dibucaine Action Pathway,drug_action,DB00527
SMP00472,Erlotinib Action Pathway,drug_action,DB00530
SMP00447,Cyclophosphamide Action Pathway,drug_action,DB00531
SMP00604,Cyclophosphamide Metabolism Pathway,drug_metabolism,DB00531
SMP00087,Rofecoxib Action Pathway,drug_action,DB00533
SMP00437,Vincristine Action Pathway,drug_action,DB00541
SMP00145,Benazepril Action Pathway,drug_action,DB00542
SMP00591,Benazepril Metabolism Pathway,drug_metabolism,DB00542
SMP00607,Capecitabine Metabolism Pathway,drug_metabolism,DB00544
SMP00608,Fluorouracil Metabolism Pathway,drug_metabolism,DB00544
SMP00469,Capecitabine Action Pathway,drug_action,DB00544
SMP00470,Fluorouracil Action Pathway,drug_action,DB00544
SMP00077,Piroxicam Action Pathway,drug_action,DB00554
SMP58936,Hydroxyzine H1-Antihistamine Action,drug_action,DB00557
SMP00712,Tigecycline Action Pathway,drug_action,DB00560
SMP00432,Methotrexate Action Pathway,drug_action,DB00563
SMP00634,Carbamazepine Metabolism Pathway,drug_metabolism,DB00564
SMP59110,Cinnarizine H1-Antihistamine Action,drug_action,DB00568
SMP00273,Fondaparinux Action Pathway,drug_action,DB00569
SMP00436,Vinblastine Action Pathway,drug_action,DB00570
SMP00307,Propranolol Action Pathway,drug_action,DB00571
SMP00696,Fenoprofen Action Pathway,drug_action,DB00573
SMP00116,Valdecoxib Action Pathway,drug_action,DB00580
SMP00545,Trifunctional protein deficiency,disease,DB00583
SMP02051,L-carnitine degradation I,metabolic,DB00583
SMP00185,Glutaric Aciduria Type I,disease,DB00583
SMP00540,Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),disease,DB00583
SMP63589,Fatty Acid Metabolism,metabolic,DB00583
SMP63605,Carnitine Synthesis,metabolic,DB00583
SMP00030,Oxidation of Branched Chain Fatty Acids,metabolic,DB00583
SMP00051,Fatty Acid Metabolism,metabolic,DB00583
SMP00052,Beta Oxidation of Very Long Chain Fatty Acids,metabolic,DB00583
SMP00181,Ethylmalonic Encephalopathy,disease,DB00583
SMP00541,Carnitine palmitoyl transferase deficiency (II),disease,DB00583
SMP00235,Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB00583
SMP00482,Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,metabolic,DB00583
SMP00516,"Adrenoleukodystrophy, X-linked",disease,DB00583
SMP00538,Carnitine palmitoyl transferase deficiency (I),disease,DB00583
SMP00542,Medium chain acyl-coa dehydrogenase deficiency (MCAD),disease,DB00583
SMP00465,Carnitine Synthesis,metabolic,DB00583
SMP00517,Carnitine-acylcarnitine translocase deficiency,disease,DB00583
SMP00539,Long chain acyl-CoA dehydrogenase deficiency (LCAD),disease,DB00583
SMP02361,Fatty acid Metabolism ,metabolic,DB00583
SMP63598,Beta Oxidation of Very Long Chain Fatty Acids,metabolic,DB00583
SMP63639,Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,metabolic,DB00583
SMP63646,Oxidation of Branched Chain Fatty Acids,metabolic,DB00583
SMP00148,Enalapril Action Pathway,drug_action,DB00584
SMP00593,Enalapril Metabolism Pathway,drug_metabolism,DB00584
SMP00233,Nizatidine Action Pathway,drug_action,DB00585
SMP00093,Diclofenac Action Pathway,drug_action,DB00586
SMP00133,Amiloride Action Pathway,drug_action,DB00594
SMP00293,Oxytetracycline Action Pathway,drug_action,DB00595
SMP00368,Labetalol Action Pathway,drug_action,DB00598
SMP00094,Sulindac Action Pathway,drug_action,DB00605
SMP00103,Cyclothiazide Action Pathway,drug_action,DB00606
SMP00300,Bisoprolol Action Pathway,drug_action,DB00612
SMP00290,Demeclocycline Action Pathway,drug_action,DB00618
SMP31694,Imatinib Inhibition of BCR-ABL,drug_action,DB00619
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB00624
SMP00565,Aromatase deficiency,disease,DB00624
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB00624
SMP30406,Androstenedione Metabolism,metabolic,DB00624
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB00624
SMP63688,Androstenedione Metabolism,metabolic,DB00624
SMP00740,Efavirenz Action Pathway,drug_action,DB00625
SMP02338,NAD metabolism,metabolic,DB00627
SMP01898,adenosylcobalamin salvage from cobinamide,metabolic,DB00627
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB00627
SMP00850,NAD salvage,metabolic,DB00627
SMP63643,Nicotinate and Nicotinamide Metabolism,metabolic,DB00627
SMP00095,Alendronate Action Pathway,drug_action,DB00630
SMP00440,Prednisone Action Pathway,drug_action,DB00635
SMP00631,Prednisone Metabolism Pathway,drug_metabolism,DB00635
SMP59897,Astemizole H1-Antihistamine Action,drug_action,DB00637
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00640
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB00640
SMP00537,Myoadenylate deaminase deficiency,disease,DB00640
SMP02088,purine ribonucleosides degradation,metabolic,DB00640
SMP63587,Selenoamino Acid Metabolism,metabolic,DB00640
SMP00168,AICA-Ribosiduria,disease,DB00640
SMP00428,Mercaptopurine Action Pathway,drug_action,DB00640
SMP00430,Thioguanine Action Pathway,drug_action,DB00640
SMP00512,Xanthinuria type I,disease,DB00640
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB00640
SMP02081,adenine and adenosine salvage I,metabolic,DB00640
SMP00029,Selenoamino Acid Metabolism,metabolic,DB00640
SMP00033,Methionine Metabolism,metabolic,DB00640
SMP00050,Purine Metabolism,metabolic,DB00640
SMP00144,Adenosine Deaminase Deficiency,disease,DB00640
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB00640
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB00640
SMP00341,Hypermethioninemia,disease,DB00640
SMP12058,Cytokinins Degradation,metabolic,DB00640
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB00640
SMP00203,Molybdenum Cofactor Deficiency,disease,DB00640
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB00640
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB00640
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB00640
SMP00321,Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,signaling,DB00640
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB00640
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB00640
SMP63600,Betaine Metabolism,metabolic,DB00640
SMP63668,Purine Metabolism,metabolic,DB00640
SMP00123,Betaine Metabolism,metabolic,DB00640
SMP00082,Simvastatin Action Pathway,drug_action,DB00641
SMP00672,Propoxyphene Action Pathway,drug_action,DB00647
SMP00745,Stavudine Action Pathway,drug_action,DB00649
SMP02369,One Carbon Pool by Folate I ,metabolic,DB00650
SMP00432,Methotrexate Action Pathway,drug_action,DB00650
SMP00543,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB00650
SMP01750,One Carbon Pool by Folate I,metabolic,DB00650
SMP00053,Folate Metabolism,metabolic,DB00650
SMP00724,"Folate malabsorption, hereditary",disease,DB00650
SMP00801,Folate Metabolism,metabolic,DB00650
SMP00686,Pentazocine Action Pathway,drug_action,DB00652
SMP63690,Sulfate/Sulfite Metabolism,metabolic,DB00655
SMP30880,Estrone Metabolism,metabolic,DB00655
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB00655
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB00655
SMP63688,Androstenedione Metabolism,metabolic,DB00655
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB00655
SMP30406,Androstenedione Metabolism,metabolic,DB00655
SMP63696,Estrone Metabolism,metabolic,DB00655
SMP00041,Sulfate/Sulfite Metabolism,metabolic,DB00655
SMP00532,Sulfite oxidase deficiency,disease,DB00655
SMP00565,Aromatase deficiency,disease,DB00655
SMP00375,Verapamil Action Pathway,drug_action,DB00661
SMP00012,Catecholamine Biosynthesis,metabolic,DB00668
SMP00006,Tyrosine Metabolism,metabolic,DB00668
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00668
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00668
SMP63606,Catecholamine Biosynthesis,metabolic,DB00668
SMP63684,Tyrosine Metabolism,metabolic,DB00668
SMP00218,Tyrosinemia Type I,disease,DB00668
SMP00429,Disulfiram Action Pathway,drug_action,DB00668
SMP00497,Tyrosine hydroxylase deficiency,disease,DB00668
SMP00661,Epinephrine Action Pathway,drug_action,DB00668
SMP00169,Alkaptonuria,disease,DB00668
SMP00190,Hawkinsinuria,disease,DB00668
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB00668
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB00668
SMP00246,Pirenzepine Action Pathway,drug_action,DB00670
SMP00606,Tamoxifen Metabolism Pathway,drug_metabolism,DB00675
SMP00471,Tamoxifen Action Pathway,drug_action,DB00675
SMP00162,Losartan Action Pathway,drug_action,DB00678
SMP00268,Warfarin Action Pathway,drug_action,DB00682
SMP00711,Tobramycin Action Pathway,drug_action,DB00684
SMP00652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB00688
SMP00595,Moexipril Metabolism Pathway,drug_metabolism,DB00691
SMP00151,Moexipril Action Pathway,drug_action,DB00691
SMP00115,Furosemide Action Pathway,drug_action,DB00695
SMP00135,Eplerenone Action Pathway,drug_action,DB00700
SMP00687,Naltrexone Action Pathway,drug_action,DB00704
SMP00738,Delavirdine Action Pathway,drug_action,DB00705
SMP00417,Sufentanil Action Pathway,drug_action,DB00708
SMP00649,Lamivudine Metabolism Pathway,drug_metabolism,DB00709
SMP00742,Lamivudine  Action Pathway,drug_action,DB00709
SMP00079,Ibandronate Action Pathway,drug_action,DB00710
SMP00697,Flurbiprofen Action Pathway,drug_action,DB00712
SMP00629,Adefovir Dipivoxil Metabolism Pathway,drug_metabolism,DB00718
SMP59865,Azatadine H1-Antihistamine Action,drug_action,DB00719
SMP00402,Procaine Action Pathway,drug_action,DB00721
SMP00150,Lisinopril Action Pathway,drug_action,DB00722
SMP00453,Nateglinide Action Pathway,drug_action,DB00731
SMP00225,Esomeprazole Action Pathway,drug_action,DB00736
SMP00612,Esomeprazole Metabolism Pathway,drug_metabolism,DB00736
SMP58956,Meclizine H1-Antihistamine Action,drug_action,DB00737
SMP00566,17-alpha-hydroxylase deficiency (CYP17),disease,DB00741
SMP63672,Steroidogenesis,metabolic,DB00741
SMP00310,Corticotropin Activation of Cortisol Production,signaling,DB00741
SMP00577,Corticosterone methyl oxidase I deficiency (CMO I),disease,DB00741
SMP00130,Steroidogenesis,metabolic,DB00741
SMP00373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,disease,DB00741
SMP00576,21-hydroxylase deficiency (CYP21),disease,DB00741
SMP00717,Apparent mineralocorticoid excess syndrome,disease,DB00741
SMP00718,3-Beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB00741
SMP00371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB00741
SMP00372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,disease,DB00741
SMP00575,11-beta-hydroxylase deficiency (CYP11B1),disease,DB00741
SMP00578,Corticosterone methyl oxidase II deficiency - CMO II,disease,DB00741
SMP00807,glycolysis and pyruvate dehydrogenase,metabolic,DB00742
SMP58797,Carbinoxamine H1-Antihistamine Action,drug_action,DB00748
SMP00084,Etodolac Action Pathway,drug_action,DB00749
SMP00401,Prilocaine Action Pathway,drug_action,DB00750
SMP61191,Epinastine H1-Antihistamine Action,drug_action,DB00751
SMP63662,Retinol Metabolism,metabolic,DB00755
SMP00074,Retinol Metabolism,metabolic,DB00755
SMP00336,Vitamin A Deficiency,disease,DB00755
SMP00260,Clopidogrel Action Pathway,drug_action,DB00758
SMP00610,Clopidogrel Metabolism Pathway,drug_metabolism,DB00758
SMP00294,Tetracycline Action Pathway,drug_action,DB00759
SMP00600,Irinotecan Metabolism Pathway,drug_metabolism,DB00762
SMP00433,Irinotecan Action Pathway,drug_action,DB00762
SMP60740,Olopatadine H1-Antihistamine Action,drug_action,DB00768
SMP00601,Etoposide Metabolism Pathway,drug_metabolism,DB00773
SMP00442,Etoposide Action Pathway,drug_action,DB00773
SMP00108,Hydroflumethiazide Action Pathway,drug_action,DB00774
SMP00267,Tirofiban Action Pathway,drug_action,DB00775
SMP00634,Carbamazepine Metabolism Pathway,drug_metabolism,DB00776
SMP62625,Propiomazine H1-Antihistamine Action,drug_action,DB00777
SMP00251,Roxithromycin Action Pathway,drug_action,DB00778
SMP00565,Aromatase deficiency,disease,DB00783
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB00783
SMP30880,Estrone Metabolism,metabolic,DB00783
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB00783
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB00783
SMP63696,Estrone Metabolism,metabolic,DB00783
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB00784
SMP00120,Naproxen Action Pathway,drug_action,DB00788
SMP00152,Perindopril Action Pathway,drug_action,DB00790
SMP57587,Tripelennamine H1-Antihistamine Action,drug_action,DB00792
SMP00158,Candesartan Action Pathway,drug_action,DB00796
SMP00254,Gentamicin Action Pathway,drug_action,DB00798
SMP00413,Alfentanil Action Pathway,drug_action,DB00802
SMP00403,Proparacaine Action Pathway,drug_action,DB00807
SMP00110,Indapamide Action Pathway,drug_action,DB00808
SMP00701,Phenylbutazone Action Pathway,drug_action,DB00812
SMP00415,Fentanyl Action Pathway,drug_action,DB00813
SMP00106,Meloxicam Action Pathway,drug_action,DB00814
SMP00694,Carprofen Action Pathway,drug_action,DB00821
SMP00429,Disulfiram Action Pathway,drug_action,DB00822
SMP57579,Brompheniramine H1-Antihistamine Action,drug_action,DB00835
SMP00662,Dobutamine Action Pathway,drug_action,DB00841
SMP00691,Nalbuphine Action Pathway,drug_action,DB00844
SMP00027,Pantothenate and CoA Biosynthesis,metabolic,DB00847
SMP00021,Taurine and Hypotaurine Metabolism,metabolic,DB00847
SMP63647,Pantothenate and CoA Biosynthesis,metabolic,DB00847
SMP63675,Taurine and Hypotaurine Metabolism,metabolic,DB00847
SMP00673,Levorphanol Action Pathway,drug_action,DB00854
SMP00223,Non Ketotic Hyperglycinemia,disease,DB00855
SMP00342,Hereditary Coproporphyria (HCP),disease,DB00855
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB00855
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB00855
SMP00346,Porphyria Variegata (PV),disease,DB00855
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB00855
SMP02363,Porphyrin Metabolism ,metabolic,DB00855
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB00855
SMP00953,Porphyrin metabolism,metabolic,DB00855
SMP63626,Glycine and Serine Metabolism,metabolic,DB00855
SMP63655,Porphyrin Metabolism,metabolic,DB00855
SMP00004,Glycine and Serine Metabolism,metabolic,DB00855
SMP00024,Porphyrin Metabolism,metabolic,DB00855
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB00855
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB00855
SMP00244,Sarcosinemia,disease,DB00855
SMP00344,Acute Intermittent Porphyria,disease,DB00855
SMP00440,Prednisone Action Pathway,drug_action,DB00860
SMP00441,Prednisolone Action Pathway,drug_action,DB00860
SMP00631,Prednisone Metabolism Pathway,drug_metabolism,DB00860
SMP00632,Prednisolone Metabolism Pathway,drug_metabolism,DB00860
SMP00289,Diflunisal Action Pathway,drug_action,DB00861
SMP00230,Ranitidine Action Pathway,drug_action,DB00863
SMP00297,Alprenolol Action Pathway,drug_action,DB00866
SMP00101,Suprofen Action Pathway,drug_action,DB00870
SMP00159,Eprosartan Action Pathway,drug_action,DB00876
SMP02409,TOR signalling pathway:  Rapamycin based repression,signaling,DB00877
SMP00741,Emtricitabine Action Pathway,drug_action,DB00879
SMP00078,Chlorothiazide Action Pathway,drug_action,DB00880
SMP00153,Quinapril Action Pathway,drug_action,DB00881
SMP00596,Quinapril Metabolism Pathway,drug_metabolism,DB00881
SMP00112,Risedronate Action Pathway,drug_action,DB00884
SMP00088,Bumetanide Action Pathway,drug_action,DB00887
SMP00400,Oxybuprocaine Action Pathway,drug_action,DB00892
SMP02356,Ethanol fermentation,metabolic,DB00898
SMP00429,Disulfiram Action Pathway,drug_action,DB00898
SMP00449,Ethanol Degradation,metabolic,DB00898
SMP02355,Pyruvate metabolism,metabolic,DB00898
SMP63611,Ethanol Degradation,metabolic,DB00898
SMP00416,Remifentanil Action Pathway,drug_action,DB00899
SMP00739,Didanosine Action Pathway,drug_action,DB00900
SMP59730,Methdilazine H1-Antihistamine Action,drug_action,DB00902
SMP00097,Ethacrynic Acid Action Pathway,drug_action,DB00903
SMP00395,Cocaine Action Pathway,drug_action,DB00907
SMP00323,Quinidine Action Pathway,drug_action,DB00908
SMP00454,Repaglinide Action Pathway,drug_action,DB00912
SMP00674,Anileridine Action Pathway,drug_action,DB00913
SMP00700,Lornoxicam Action Pathway,drug_action,DB00917
SMP00701,Phenylbutazone Action Pathway,drug_action,DB00917
SMP00707,Salsalate Action Pathway,drug_action,DB00917
SMP00710,Acetaminophen  Action Pathway,drug_action,DB00917
SMP00075,Arachidonic Acid Metabolism,metabolic,DB00917
SMP00106,Meloxicam Action Pathway,drug_action,DB00917
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB00917
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB00917
SMP00702,Nepafenac Action Pathway,drug_action,DB00917
SMP00708,Salicylate-sodium Action Pathway,drug_action,DB00917
SMP00098,Ketorolac Action Pathway,drug_action,DB00917
SMP00101,Suprofen Action Pathway,drug_action,DB00917
SMP00116,Valdecoxib Action Pathway,drug_action,DB00917
SMP00289,Diflunisal Action Pathway,drug_action,DB00917
SMP00353,Leukotriene C4 Synthesis Deficiency,disease,DB00917
SMP00703,Trisalicylate-choline Action Pathway,drug_action,DB00917
SMP00084,Etodolac Action Pathway,drug_action,DB00917
SMP00086,Ibuprofen Action Pathway,drug_action,DB00917
SMP00093,Diclofenac Action Pathway,drug_action,DB00917
SMP00102,Bromfenac Action Pathway,drug_action,DB00917
SMP00692,Antipyrine Action Pathway,drug_action,DB00917
SMP00693,Antrafenine Action Pathway,drug_action,DB00917
SMP00696,Fenoprofen Action Pathway,drug_action,DB00917
SMP00697,Flurbiprofen Action Pathway,drug_action,DB00917
SMP00699,Lumiracoxib Action Pathway,drug_action,DB00917
SMP00706,Tenoxicam Action Pathway,drug_action,DB00917
SMP00709,Salicylic Acid Action Pathway,drug_action,DB00917
SMP63595,Arachidonic Acid Metabolism,metabolic,DB00917
SMP00077,Piroxicam Action Pathway,drug_action,DB00917
SMP00083,Acetylsalicylic Acid Action Pathway,drug_action,DB00917
SMP00258,Spectinomycin Action Pathway,drug_action,DB00919
SMP59868,Ketotifen H1-Antihistamine Action,drug_action,DB00920
SMP00684,Buprenorphine Action Pathway,drug_action,DB00921
SMP00231,Famotidine Action Pathway,drug_action,DB00927
SMP00727,Methacycline Action Pathway,drug_action,DB00931
SMP00709,Salicylic Acid Action Pathway,drug_action,DB00936
SMP00746,Zalcitabine Action Pathway,drug_action,DB00943
SMP00083,Acetylsalicylic Acid Action Pathway,drug_action,DB00945
SMP00271,Phenprocoumon Action Pathway,drug_action,DB00946
SMP00633,Felbamate Metabolism Pathway,drug_metabolism,DB00949
SMP60218,Fexofenadine H1-Antihistamine Action,drug_action,DB00950
SMP00257,Netilmicin Action Pathway,drug_action,DB00955
SMP00411,Hydrocodone Action Pathway,drug_action,DB00956
SMP00306,Pindolol Action Pathway,drug_action,DB00960
SMP00399,Mepivacaine Action Pathway,drug_action,DB00961
SMP00102,Bromfenac Action Pathway,drug_action,DB00963
SMP00164,Telmisartan Action Pathway,drug_action,DB00966
SMP60201,Desloratadine H1-Antihistamine Action,drug_action,DB00967
SMP60741,Azelastine H1-Antihistamine Action,drug_action,DB00972
SMP00264,Dipyridamole (Antiplatelet) Action Pathway,drug_action,DB00975
SMP00252,Telithromycin Action Pathway,drug_action,DB00976
SMP00012,Catecholamine Biosynthesis,metabolic,DB00988
SMP00401,Prilocaine Action Pathway,drug_action,DB00988
SMP00407,Heroin Action Pathway,drug_action,DB00988
SMP00408,Methadone Action Pathway,drug_action,DB00988
SMP00413,Alfentanil Action Pathway,drug_action,DB00988
SMP00414,Carfentanil Action Pathway,drug_action,DB00988
SMP00671,Tramadol Action Action Pathway,drug_action,DB00988
SMP00683,Levallorphan Action Pathway,drug_action,DB00988
SMP00006,Tyrosine Metabolism,metabolic,DB00988
SMP00396,Dibucaine Action Pathway,drug_action,DB00988
SMP00402,Procaine Action Pathway,drug_action,DB00988
SMP00405,Codeine Action Pathway,drug_action,DB00988
SMP00410,Hydromorphone Action Pathway,drug_action,DB00988
SMP00416,Remifentanil Action Pathway,drug_action,DB00988
SMP00422,Imipramine Action Pathway,drug_action,DB00988
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB00988
SMP00672,Propoxyphene Action Pathway,drug_action,DB00988
SMP00675,Diphenoxylate Action Pathway,drug_action,DB00988
SMP00679,3-Methylthiofentanyl Action Pathway,drug_action,DB00988
SMP00681,Ethylmorphine Action Pathway,drug_action,DB00988
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB00988
SMP00308,Dopamine Activation of Neurological Reward System,signaling,DB00988
SMP00397,Levobupivacaine Action Pathway,drug_action,DB00988
SMP00412,Oxymorphone Action Pathway,drug_action,DB00988
SMP00415,Fentanyl Action Pathway,drug_action,DB00988
SMP00426,Fluoxetine Action Pathway,drug_action,DB00988
SMP00431,Nicotine Action Pathway,drug_action,DB00988
SMP00673,Levorphanol Action Pathway,drug_action,DB00988
SMP00674,Anileridine Action Pathway,drug_action,DB00988
SMP00678,Methadyl Acetate Action Pathway,drug_action,DB00988
SMP00113,Oxaprozin Action Pathway,drug_action,DB00991
SMP00645,Azathioprine Metabolism Pathway,drug_metabolism,DB00993
SMP00427,Azathioprine Action Pathway,drug_action,DB00993
SMP00650,Doxorubicin Metabolism Pathway,drug_metabolism,DB00997
SMP00100,Hydrochlorothiazide Action Pathway,drug_action,DB00999
SMP00397,Levobupivacaine Action Pathway,drug_action,DB01002
SMP00085,Ketoprofen Action Pathway,drug_action,DB01009
SMP00460,Glibenclamide Action Pathway,drug_action,DB01016
SMP00292,Minocycline Action Pathway,drug_action,DB01017
SMP00121,Trichlormethiazide Action Pathway,drug_action,DB01021
SMP00287,Tranexamic Acid Action Pathway,drug_action,DB01022
SMP00464,Vitamin K Metabolism,metabolic,DB01022
SMP00270,Dicumarol Action Pathway,drug_action,DB01022
SMP00275,Ardeparin Action Pathway,drug_action,DB01022
SMP00282,Streptokinase Action Pathway,drug_action,DB01022
SMP63591,Vitamin K Metabolism,metabolic,DB01022
SMP00284,Urokinase Action Pathway,drug_action,DB01022
SMP00288,Aprotinin Action Pathway,drug_action,DB01022
SMP00586,Coagulation ,physiological,DB01022
SMP00656,Dicoumarol Action Pathway,drug_action,DB01022
SMP00276,Argatroban Action Pathway,drug_action,DB01022
SMP00278,Lepirudin Action Pathway,drug_action,DB01022
SMP00280,Alteplase Action Pathway,drug_action,DB01022
SMP00281,Anistreplase Action Pathway,drug_action,DB01022
SMP00283,Tenecteplase Action Pathway,drug_action,DB01022
SMP00655,Phenindione Action Pathway,drug_action,DB01022
SMP00268,Warfarin Action Pathway,drug_action,DB01022
SMP00269,Acenocoumarol Action Pathway,drug_action,DB01022
SMP00271,Phenprocoumon Action Pathway,drug_action,DB01022
SMP00272,Enoxaparin Action Pathway,drug_action,DB01022
SMP00273,Fondaparinux Action Pathway,drug_action,DB01022
SMP00274,Heparin Action Pathway,drug_action,DB01022
SMP00277,Bivalirudin Action Pathway,drug_action,DB01022
SMP00279,Ximelagatran Action Pathway,drug_action,DB01022
SMP00285,Reteplase Action Pathway,drug_action,DB01022
SMP00286,Aminocaproic Acid Action Pathway,drug_action,DB01022
SMP00619,Felodipine Metabolism Pathway,drug_metabolism,DB01023
SMP00377,Felodipine Action Pathway,drug_action,DB01023
SMP00652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB01024
SMP00161,Irbesartan Action Pathway,drug_action,DB01029
SMP00645,Azathioprine Metabolism Pathway,drug_metabolism,DB01033
SMP00427,Azathioprine Action Pathway,drug_action,DB01033
SMP00609,Mercaptopurine Metabolism Pathway,drug_metabolism,DB01033
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01033
SMP00430,Thioguanine Action Pathway,drug_action,DB01033
SMP00324,Procainamide (Antiarrhythmic) Action Pathway,drug_action,DB01035
SMP00737,Abacavir Action Pathway,drug_action,DB01048
SMP00086,Ibuprofen Action Pathway,drug_action,DB01050
SMP00590,Ibuprofen Metabolism Pathway,drug_metabolism,DB01050
SMP00382,Nitrendipine Action Pathway,drug_action,DB01054
SMP00330,Tocainide Action Pathway,drug_action,DB01056
SMP00663,Isoprenaline Action Pathway,drug_action,DB01064
SMP63693,Tryptophan Metabolism,metabolic,DB01065
SMP00063,Tryptophan Metabolism,metabolic,DB01065
SMP59211,Promethazine H1-Antihistamine Action,drug_action,DB01069
SMP59720,Mequitazine H1-Antihistamine Action,drug_action,DB01071
SMP58785,Diphenhydramine H1-Antihistamine Action,drug_action,DB01075
SMP00675,Diphenoxylate Action Pathway,drug_action,DB01081
SMP00259,Streptomycin Action Pathway,drug_action,DB01082
SMP61040,Emedastine H1-Antihistamine Action,drug_action,DB01084
SMP00392,Benzocaine Action Pathway,drug_action,DB01086
SMP01906,dimethyl sulfoxide electron transfer ,metabolic,DB01093
SMP00119,Fluvastatin Action Pathway,drug_action,DB01095
SMP00092,Rosuvastatin Action Pathway,drug_action,DB01098
SMP00607,Capecitabine Metabolism Pathway,drug_metabolism,DB01101
SMP00469,Capecitabine Action Pathway,drug_action,DB01101
SMP00664,Arbutamine Action Pathway,drug_action,DB01102
SMP60224,Levocabastine H1-Antihistamine Action,drug_action,DB01106
SMP00274,Heparin Action Pathway,drug_action,DB01109
SMP00358,Fc Epsilon Receptor I Signaling in Mast Cells,signaling,DB01109
SMP56661,Chlorphenamine H1-Antihistamine Action,drug_action,DB01114
SMP00379,Nifedipine Action Pathway,drug_action,DB01115
SMP00665,Amiodarone Action Pathway,drug_action,DB01118
SMP00461,Gliclazide Action Pathway,drug_action,DB01120
SMP00229,Rabeprazole Action Pathway,drug_action,DB01129
SMP00616,Rabeprazole Metabolism Pathway,drug_metabolism,DB01129
SMP00367,Carvedilol Action Pathway,drug_action,DB01136
SMP00641,Doxepin Metabolism Pathway,drug_metabolism,DB01142
SMP59872,Doxepin H1-Antihistamine Action,drug_action,DB01142
SMP58908,Diphenylpyraline H1-Antihistamine Action,drug_action,DB01146
SMP00423,Desipramine Action Pathway,drug_action,DB01151
SMP00422,Imipramine Action Pathway,drug_action,DB01151
SMP00625,Imipramine Metabolism Pathway,drug_metabolism,DB01151
SMP00626,Desipramine Metabolism Pathway,drug_metabolism,DB01151
SMP00394,Chloroprocaine Action Pathway,drug_action,DB01161
SMP00263,Cilostazol Action Pathway,drug_action,DB01166
SMP00255,Kanamycin Action Pathway,drug_action,DB01172
SMP58808,Orphenadrine H1-Antihistamine Action,drug_action,DB01173
SMP00425,Escitalopram Action Pathway,drug_action,DB01175
SMP58923,Cyclizine H1-Antihistamine Action,drug_action,DB01176
SMP00155,Rescinnamine Action Pathway,drug_action,DB01180
SMP00448,Ifosfamide Action Pathway,drug_action,DB01181
SMP00605,Ifosfamide Metabolism Pathway,drug_metabolism,DB01181
SMP00688,Naloxone Action Pathway,drug_action,DB01183
SMP00249,Clindamycin Action Pathway,drug_action,DB01190
SMP00412,Oxymorphone Action Pathway,drug_action,DB01192
SMP00296,Acebutolol Action Pathway,drug_action,DB01193
SMP00331,Flecainide Action Pathway,drug_action,DB01195
SMP00146,Captopril Action Pathway,drug_action,DB01197
SMP00303,Nadolol Action Pathway,drug_action,DB01203
SMP00676,Dezocine Action Pathway,drug_action,DB01209
SMP00666,Levobunolol Action Pathway,drug_action,DB01210
SMP00248,Clarithromycin Action Pathway,drug_action,DB01211
SMP00667,Metipranolol Action Pathway,drug_action,DB01214
SMP62884,Quetiapine H1-Antihistamine Action,drug_action,DB01224
SMP00638,Levomethadyl Acetate Metabolism Pathway,drug_metabolism,DB01227
SMP00677,Levomethadyl Acetate Action Action Pathway,drug_action,DB01227
SMP00434,Paclitaxel Action Pathway,drug_action,DB01229
SMP00012,Catecholamine Biosynthesis,metabolic,DB01235
SMP00006,Tyrosine Metabolism,metabolic,DB01235
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB01235
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB01235
SMP63606,Catecholamine Biosynthesis,metabolic,DB01235
SMP63684,Tyrosine Metabolism,metabolic,DB01235
SMP00218,Tyrosinemia Type I,disease,DB01235
SMP00429,Disulfiram Action Pathway,drug_action,DB01235
SMP00497,Tyrosine hydroxylase deficiency,disease,DB01235
SMP63471,Isoquinoline Alkaloid Biosynthesis,metabolic,DB01235
SMP00169,Alkaptonuria,disease,DB01235
SMP00190,Hawkinsinuria,disease,DB01235
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB01235
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB01235
SMP58813,Bromodiphenhydramine H1-Antihistamine Action,drug_action,DB01237
SMP00639,Clomipramine Metabolism Pathway,drug_metabolism,DB01242
SMP59689,Alimemazine H1-Antihistamine Action,drug_action,DB01246
SMP00435,Docetaxel Action Pathway,drug_action,DB01248
SMP31696,Dasatinib Inhibition of BCR-ABL,drug_action,DB01254
SMP00475,Panitumumab Action Pathway,drug_action,DB01269
SMP00699,Lumiracoxib Action Pathway,drug_action,DB01283
SMP00668,Bevantolol Action Pathway,drug_action,DB01295
SMP00240,Salla Disease/Infantile Sialic Acid Storage Disease,disease,DB01296
SMP00217,Sialuria or French Type Sialuria,disease,DB01296
SMP02056,Chitobiose Degradation,metabolic,DB01296
SMP00045,Amino Sugar Metabolism,metabolic,DB01296
SMP00390,Tay-Sachs Disease,disease,DB01296
SMP00216,Sialuria or French Type Sialuria,disease,DB01296
SMP00534,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",disease,DB01296
SMP63580,Amino Sugar Metabolism,metabolic,DB01296
SMP00669,Practolol Action Pathway,drug_action,DB01297
SMP00726,Rolitetracycline Action Pathway,drug_action,DB01301
SMP00618,Fosphenytoin (Antiarrhythmic) Metabolism Pathway,drug_metabolism,DB01320
SMP00326,Fosphenytoin (Antiarrhythmic) Action Pathway,drug_action,DB01320
SMP00731,Josamycin Action Pathway,drug_action,DB01321
SMP00080,Polythiazide Action Pathway,drug_action,DB01324
SMP00091,Quinethazone Action Pathway,drug_action,DB01325
SMP00592,Cilazapril Metabolism Pathway,drug_metabolism,DB01340
SMP00147,Cilazapril Action Pathway,drug_action,DB01340
SMP00160,Forasartan Action Pathway,drug_action,DB01342
SMP00040,Glycolysis,metabolic,DB01345
SMP00100,Hydrochlorothiazide Action Pathway,drug_action,DB01345
SMP00118,Torsemide Action Pathway,drug_action,DB01345
SMP00122,Chlorthalidone Action Pathway,drug_action,DB01345
SMP00132,Triamterene Action Pathway,drug_action,DB01345
SMP00134,Spironolactone Action Pathway,drug_action,DB01345
SMP00168,AICA-Ribosiduria,disease,DB01345
SMP00196,Leigh Syndrome,disease,DB01345
SMP00231,Famotidine Action Pathway,drug_action,DB01345
SMP00301,Esmolol Action Pathway,drug_action,DB01345
SMP00302,Metoprolol Action Pathway,drug_action,DB01345
SMP00307,Propranolol Action Pathway,drug_action,DB01345
SMP00325,Disopyramide Action Pathway,drug_action,DB01345
SMP00327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB01345
SMP00331,Flecainide Action Pathway,drug_action,DB01345
SMP00379,Nifedipine Action Pathway,drug_action,DB01345
SMP00396,Dibucaine Action Pathway,drug_action,DB01345
SMP00402,Procaine Action Pathway,drug_action,DB01345
SMP00405,Codeine Action Pathway,drug_action,DB01345
SMP00410,Hydromorphone Action Pathway,drug_action,DB01345
SMP00416,Remifentanil Action Pathway,drug_action,DB01345
SMP00422,Imipramine Action Pathway,drug_action,DB01345
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01345
SMP00430,Thioguanine Action Pathway,drug_action,DB01345
SMP00461,Gliclazide Action Pathway,drug_action,DB01345
SMP00512,Xanthinuria type I,disease,DB01345
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB01345
SMP00585,Lysinuric protein intolerance (LPI),disease,DB01345
SMP00668,Bevantolol Action Pathway,drug_action,DB01345
SMP00672,Propoxyphene Action Pathway,drug_action,DB01345
SMP00156,Spirapril Action Pathway,drug_action,DB01348
SMP00598,Spirapril Metabolism Pathway,drug_metabolism,DB01348
SMP00841,galactose metabolism,metabolic,DB01356
SMP00808,inner membrane transport,metabolic,DB01356
SMP00305,Penbutolol Action Pathway,drug_action,DB01359
SMP00003,Argininosuccinic Aciduria,disease,DB01373
SMP00006,Tyrosine Metabolism,metabolic,DB01373
SMP00011,Inositol Metabolism,metabolic,DB01373
SMP00044,Histidine Metabolism,metabolic,DB01373
SMP00053,Folate Metabolism,metabolic,DB01373
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB01373
SMP00168,AICA-Ribosiduria,disease,DB01373
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01373
SMP00284,Urokinase Action Pathway,drug_action,DB01373
SMP00288,Aprotinin Action Pathway,drug_action,DB01373
SMP00301,Esmolol Action Pathway,drug_action,DB01373
SMP00302,Metoprolol Action Pathway,drug_action,DB01373
SMP00307,Propranolol Action Pathway,drug_action,DB01373
SMP00325,Disopyramide Action Pathway,drug_action,DB01373
SMP00327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB01373
SMP00331,Flecainide Action Pathway,drug_action,DB01373
SMP00347,Metachromatic Leukodystrophy (MLD),disease,DB01373
SMP00351,GABA-Transaminase Deficiency,disease,DB01373
SMP00379,Nifedipine Action Pathway,drug_action,DB01373
SMP00396,Dibucaine Action Pathway,drug_action,DB01373
SMP00402,Procaine Action Pathway,drug_action,DB01373
SMP00405,Codeine Action Pathway,drug_action,DB01373
SMP00410,Hydromorphone Action Pathway,drug_action,DB01373
SMP00416,Remifentanil Action Pathway,drug_action,DB01373
SMP00422,Imipramine Action Pathway,drug_action,DB01373
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01373
SMP00430,Thioguanine Action Pathway,drug_action,DB01373
SMP00461,Gliclazide Action Pathway,drug_action,DB01373
SMP00492,Ureidopropionase Deficiency,disease,DB01373
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB01373
SMP00006,Tyrosine Metabolism,metabolic,DB01378
SMP00011,Inositol Metabolism,metabolic,DB01378
SMP00040,Glycolysis,metabolic,DB01378
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB01378
SMP00053,Folate Metabolism,metabolic,DB01378
SMP00057,Citric Acid Cycle,metabolic,DB01378
SMP00089,Pravastatin Action Pathway,drug_action,DB01378
SMP00112,Risedronate Action Pathway,drug_action,DB01378
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB01378
SMP00168,AICA-Ribosiduria,disease,DB01378
SMP00185,Glutaric Aciduria Type I,disease,DB01378
SMP00196,Leigh Syndrome,disease,DB01378
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01378
SMP00209,Hypercholesterolemia,disease,DB01378
SMP00216,Sialuria or French Type Sialuria,disease,DB01378
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB01378
SMP00301,Esmolol Action Pathway,drug_action,DB01378
SMP00302,Metoprolol Action Pathway,drug_action,DB01378
SMP00307,Propranolol Action Pathway,drug_action,DB01378
SMP00325,Disopyramide Action Pathway,drug_action,DB01378
SMP00327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB01378
SMP00331,Flecainide Action Pathway,drug_action,DB01378
SMP00338,Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,signaling,DB01378
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB01378
SMP00347,Metachromatic Leukodystrophy (MLD),disease,DB01378
SMP00379,Nifedipine Action Pathway,drug_action,DB01378
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01378
SMP00430,Thioguanine Action Pathway,drug_action,DB01378
SMP00451,Refsum Disease,disease,DB01378
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB01378
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB01397
SMP00707,Salsalate Action Pathway,drug_action,DB01399
SMP00703,Trisalicylate-choline Action Pathway,drug_action,DB01401
SMP63604,Caffeine Metabolism,metabolic,DB01412
SMP00028,Caffeine Metabolism,metabolic,DB01412
SMP63475,Caffeine Metabolism,metabolic,DB01412
SMP00269,Acenocoumarol Action Pathway,drug_action,DB01418
SMP00693,Antrafenine Action Pathway,drug_action,DB01419
SMP00714,Paromomycin Action Pathway,drug_action,DB01421
SMP00678,Methadyl Acetate Action Pathway,drug_action,DB01433
SMP00692,Antipyrine Action Pathway,drug_action,DB01435
SMP00679,3-Methylthiofentanyl Action Pathway,drug_action,DB01439
SMP02427,Glutamic acid metabolism,metabolic,DB01440
SMP12467,Butanoate Metabolism,metabolic,DB01440
SMP00680,Dimethylthiambutene Action Pathway,drug_action,DB01444
SMP00407,Heroin Action Pathway,drug_action,DB01452
SMP00623,Heroin Metabolism Pathway,drug_metabolism,DB01452
SMP00681,Ethylmorphine Action Pathway,drug_action,DB01466
SMP00414,Carfentanil Action Pathway,drug_action,DB01535
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB01536
SMP00565,Aromatase deficiency,disease,DB01536
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB01536
SMP30406,Androstenedione Metabolism,metabolic,DB01536
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB01536
SMP63688,Androstenedione Metabolism,metabolic,DB01536
SMP30406,Androstenedione Metabolism,metabolic,DB01561
SMP63688,Androstenedione Metabolism,metabolic,DB01561
SMP00689,Dihydromorphine Action Pathway,drug_action,DB01565
SMP00304,Oxprenolol Action Pathway,drug_action,DB01580
SMP00012,Catecholamine Biosynthesis,metabolic,DB01592
SMP00013,Cysteine Metabolism,metabolic,DB01592
SMP00031,Pentose Phosphate Pathway,metabolic,DB01592
SMP00092,Rosuvastatin Action Pathway,drug_action,DB01592
SMP00119,Fluvastatin Action Pathway,drug_action,DB01592
SMP00182,Galactosemia,disease,DB01592
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB01592
SMP00346,Porphyria Variegata (PV),disease,DB01592
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB01592
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB01592
SMP00387,CHILD Syndrome,disease,DB01592
SMP00495,Galactosemia II (GALK),disease,DB01592
SMP00509,Hyper-IgD syndrome,disease,DB01592
SMP00520,Transaldolase deficiency,disease,DB01592
SMP00720,27-Hydroxylase Deficiency,disease,DB01592
SMP00722,"Cystinosis, ocular nonnephropathic",disease,DB01592
SMP00837,threonine biosynthesis,metabolic,DB01592
SMP00959,pyrimidine metabolism,metabolic,DB01592
SMP02295,The Oncogenic Action of Fumarate,disease,DB01592
SMP02363,Porphyrin Metabolism ,metabolic,DB01592
SMP63601,Bile Acid Biosynthesis,metabolic,DB01592
SMP63653,Phytanic Acid Peroxisomal Oxidation,metabolic,DB01592
SMP63658,Pyrimidine Metabolism,metabolic,DB01592
SMP63693,Tryptophan Metabolism,metabolic,DB01592
SMP00006,Tyrosine Metabolism,metabolic,DB01592
SMP00011,Inositol Metabolism,metabolic,DB01592
SMP00021,Taurine and Hypotaurine Metabolism,metabolic,DB01592
SMP00089,Pravastatin Action Pathway,drug_action,DB01592
SMP00112,Risedronate Action Pathway,drug_action,DB01592
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01592
SMP00005,Pterine Biosynthesis,metabolic,DB01593
SMP00006,Tyrosine Metabolism,metabolic,DB01593
SMP00044,Histidine Metabolism,metabolic,DB01593
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB01593
SMP00147,Cilazapril Action Pathway,drug_action,DB01593
SMP00149,Fosinopril Action Pathway,drug_action,DB01593
SMP00151,Moexipril Action Pathway,drug_action,DB01593
SMP00168,AICA-Ribosiduria,disease,DB01593
SMP00196,Leigh Syndrome,disease,DB01593
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01593
SMP00231,Famotidine Action Pathway,drug_action,DB01593
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB01593
SMP00264,Dipyridamole (Antiplatelet) Action Pathway,drug_action,DB01593
SMP00337,Glutathione Synthetase Deficiency,disease,DB01593
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB01593
SMP00347,Metachromatic Leukodystrophy (MLD),disease,DB01593
SMP00351,GABA-Transaminase Deficiency,disease,DB01593
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01593
SMP00430,Thioguanine Action Pathway,drug_action,DB01593
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB01593
SMP00490,Segawa syndrome,disease,DB01593
SMP00492,Ureidopropionase Deficiency,disease,DB01593
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB01593
SMP00500,5-oxoprolinase deficiency,disease,DB01593
SMP00512,Xanthinuria type I,disease,DB01593
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB01593
SMP00594,Fosinopril Metabolism Pathway,drug_metabolism,DB01593
SMP00700,Lornoxicam Action Pathway,drug_action,DB01593
SMP00701,Phenylbutazone Action Pathway,drug_action,DB01593
SMP00707,Salsalate Action Pathway,drug_action,DB01593
SMP00705,Tiaprofenic Acid Action Pathway,drug_action,DB01600
SMP61190,Phenindamine H1-Antihistamine Action,drug_action,DB01619
SMP56662,Pheniramine H1-Antihistamine Action,drug_action,DB01620
SMP00728,Lincomycin Action Pathway,drug_action,DB01627
SMP00695,Etoricoxib Action Pathway,drug_action,DB01628
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB01632
SMP00537,Myoadenylate deaminase deficiency,disease,DB01632
SMP00647,Thioguanine Metabolism Pathway,drug_metabolism,DB01632
SMP02086,guanine and guanosine salvage,metabolic,DB01632
SMP02088,purine ribonucleosides degradation,metabolic,DB01632
SMP02370,pyrimidine metabolism ,metabolic,DB01632
SMP63590,Glutamate Metabolism,metabolic,DB01632
SMP00046,Pyrimidine Metabolism,metabolic,DB01632
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB01632
SMP00203,Molybdenum Cofactor Deficiency,disease,DB01632
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB01632
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB01632
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB01632
SMP00926,PRPP Biosynthesis,metabolic,DB01632
SMP02338,NAD metabolism,metabolic,DB01632
SMP02445,Tryptophan metabolism,metabolic,DB01632
SMP63668,Purine Metabolism,metabolic,DB01632
SMP00050,Purine Metabolism,metabolic,DB01632
SMP00072,Glutamate Metabolism,metabolic,DB01632
SMP00144,Adenosine Deaminase Deficiency,disease,DB01632
SMP00172,Beta Ureidopropionase Deficiency,disease,DB01632
SMP00178,Dihydropyrimidinase Deficiency,disease,DB01632
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB01632
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01632
SMP00385,Homocarnosinosis,disease,DB01632
SMP02353,Tryptophan metabolism,metabolic,DB01632
SMP02377,purine nucleotides de novo biosynthesis ,metabolic,DB01632
SMP00031,Pentose Phosphate Pathway,metabolic,DB01632
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB01632
SMP00427,Azathioprine Action Pathway,drug_action,DB01632
SMP02314,Fructose Metabolism,metabolic,DB01638
SMP00561,Fructosuria,disease,DB01638
SMP00725,"Fructose intolerance, hereditary",disease,DB01638
SMP63614,Fructose and Mannose Degradation,metabolic,DB01638
SMP00182,Galactosemia,disease,DB01638
SMP12445,Fructose Metabolism,metabolic,DB01638
SMP00043,Galactose Metabolism,metabolic,DB01638
SMP00064,Fructose and Mannose Degradation,metabolic,DB01638
SMP63625,Galactose Metabolism,metabolic,DB01638
SMP00046,Pyrimidine Metabolism,metabolic,DB01643
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01643
SMP12077,Pyrimidine Deoxyribonucleosides Salvage,metabolic,DB01643
SMP01750,One Carbon Pool by Folate I,metabolic,DB01643
SMP02073,salvage pathways of pyrimidine deoxyribonucleotides,metabolic,DB01643
SMP02370,pyrimidine metabolism ,metabolic,DB01643
SMP00959,pyrimidine metabolism,metabolic,DB01643
SMP02369,One Carbon Pool by Folate I ,metabolic,DB01643
SMP63658,Pyrimidine Metabolism,metabolic,DB01643
SMP00172,Beta Ureidopropionase Deficiency,disease,DB01643
SMP00178,Dihydropyrimidinase Deficiency,disease,DB01643
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB01643
SMP00774,"2,3-dihydroxybenzoate biosynthesis",metabolic,DB01672
SMP00826,tyrosine biosynthesis,metabolic,DB01688
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB01700
SMP00537,Myoadenylate deaminase deficiency,disease,DB01700
SMP00050,Purine Metabolism,metabolic,DB01700
SMP00144,Adenosine Deaminase Deficiency,disease,DB01700
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01700
SMP02377,purine nucleotides de novo biosynthesis ,metabolic,DB01700
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB01700
SMP00427,Azathioprine Action Pathway,drug_action,DB01700
SMP00513,Xanthinuria type II,disease,DB01700
SMP00927,purine nucleotides de novo biosynthesis,metabolic,DB01700
SMP02335,Histidine Biosynthesis,metabolic,DB01700
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB01700
SMP00203,Molybdenum Cofactor Deficiency,disease,DB01700
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB01700
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB01700
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB01700
SMP63668,Purine Metabolism,metabolic,DB01700
SMP00168,AICA-Ribosiduria,disease,DB01700
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01700
SMP00430,Thioguanine Action Pathway,drug_action,DB01700
SMP00512,Xanthinuria type I,disease,DB01700
SMP02047,purine nucleotides de novo biosynthesis 2,metabolic,DB01700
SMP02429,Histidine Metabolism,metabolic,DB01700
SMP63684,Tyrosine Metabolism,metabolic,DB01702
SMP00218,Tyrosinemia Type I,disease,DB01702
SMP00429,Disulfiram Action Pathway,drug_action,DB01702
SMP00006,Tyrosine Metabolism,metabolic,DB01702
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB01702
SMP00169,Alkaptonuria,disease,DB01702
SMP00190,Hawkinsinuria,disease,DB01702
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB01702
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB01702
SMP00562,"Fructose-1,6-diphosphatase deficiency",disease,DB01709
SMP00572,Fanconi-bickel syndrome,disease,DB01709
SMP00654,Warburg Effect,metabolic,DB01709
SMP00931,glycerol metabolism,metabolic,DB01709
SMP00934,glycerol metabolism IV (glycerophosphoglycerol),metabolic,DB01709
SMP00040,Glycolysis,metabolic,DB01709
SMP00581,"Glycogenosis, Type IA. Von gierke disease",disease,DB01709
SMP00807,glycolysis and pyruvate dehydrogenase,metabolic,DB01709
SMP00932,glycerol metabolism II,metabolic,DB01709
SMP00935,glycerol metabolism V (glycerophosphoserine),metabolic,DB01709
SMP00374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB01709
SMP00560,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),disease,DB01709
SMP00563,Triosephosphate isomerase,disease,DB01709
SMP00933,glycerol metabolism III (sn-glycero-3-phosphoethanolamine),metabolic,DB01709
SMP02312,Glycolysis I,metabolic,DB01709
SMP02356,Ethanol fermentation,metabolic,DB01709
SMP00128,Gluconeogenesis,metabolic,DB01709
SMP00531,"Glycogenosis, Type VII. Tarui disease",disease,DB01709
SMP00573,"Glycogenosis, Type IB",disease,DB01709
SMP00574,"Glycogenosis, Type IC",disease,DB01709
SMP00859,Glycolysis,metabolic,DB01709
SMP00930,fructose metabolism,metabolic,DB01709
SMP02108,2-O-alpha-mannosyl-D-glycerate degradation,metabolic,DB01709
SMP63478,Glycolysis,metabolic,DB01709
SMP63617,Gluconeogenesis,metabolic,DB01709
SMP00462,Inositol Phosphate Metabolism,metabolic,DB01729
SMP02397,Inositol Metabolism ,metabolic,DB01729
SMP00011,Inositol Metabolism,metabolic,DB01729
SMP63630,Inositol Phosphate Metabolism,metabolic,DB01729
SMP12028,Phytate Biosynthesis,metabolic,DB01729
SMP63629,Inositol Metabolism,metabolic,DB01729
SMP00716,Thyroid hormone synthesis,metabolic,DB01758
SMP63679,Thyroid hormone synthesis,metabolic,DB01758
SMP00006,Tyrosine Metabolism,metabolic,DB01762
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB01762
SMP00173,Beta-Ketothiolase Deficiency,disease,DB01762
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB01762
SMP00071,Ketone Body Metabolism,metabolic,DB01762
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB01762
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB01762
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB01762
SMP00569,Succinyl CoA: 3-ketoacid CoA transferase deficiency,disease,DB01762
SMP12467,Butanoate Metabolism,metabolic,DB01762
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB01762
SMP00206,Phenylketonuria,disease,DB01762
SMP00521,3-hydroxyisobutyric acid dehydrogenase deficiency,disease,DB01762
SMP00522,3-hydroxyisobutyric aciduria,disease,DB01762
SMP02433,Leucine Degradation,metabolic,DB01762
SMP02457,Tyrosine metabolism,metabolic,DB01762
SMP63631,Ketone Body Metabolism,metabolic,DB01762
SMP63684,Tyrosine Metabolism,metabolic,DB01762
SMP63689,"Valine, Leucine and Isoleucine Degradation",metabolic,DB01762
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB01762
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB01762
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB01762
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB01762
SMP00169,Alkaptonuria,disease,DB01762
SMP00190,Hawkinsinuria,disease,DB01762
SMP00199,Maple Syrup Urine Disease,disease,DB01762
SMP00236,Propionic Acidemia,disease,DB01762
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB01762
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB01762
SMP00073,Butyrate Metabolism,metabolic,DB01762
SMP00984,Secondary metabolites: Trehalose Biosynthesis and Metabolism,metabolic,DB01774
SMP00906,Amino sugar and nucleotide sugar metabolism II,metabolic,DB01774
SMP00914,Amino sugar and nucleotide sugar metabolism III,metabolic,DB01774
SMP00958,starch and sucrose metabolism,metabolic,DB01774
SMP02328,Glycerol metabolism,metabolic,DB01775
SMP02307,Beta-Alanine metabolism,metabolic,DB01783
SMP00493,"Carnosinuria, carnosinemia",disease,DB01783
SMP00848,Pantothenate and CoA Biosynthesis,metabolic,DB01783
SMP00007,Beta-Alanine Metabolism,metabolic,DB01783
SMP00027,Pantothenate and CoA Biosynthesis,metabolic,DB01783
SMP00915,Beta-Alanine Metabolism,metabolic,DB01783
SMP02364,Pantothenate and CoA Biosynthesis ,metabolic,DB01783
SMP00351,GABA-Transaminase Deficiency,disease,DB01783
SMP00492,Ureidopropionase Deficiency,disease,DB01783
SMP63599,Beta-Alanine Metabolism,metabolic,DB01783
SMP63647,Pantothenate and CoA Biosynthesis,metabolic,DB01783
SMP00095,Alendronate Action Pathway,drug_action,DB01785
SMP00107,Zoledronate Action Pathway,drug_action,DB01785
SMP00511,Wolman disease,disease,DB01785
SMP02384,Terpenoid backbone biosynthesis,metabolic,DB01785
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB01785
SMP00089,Pravastatin Action Pathway,drug_action,DB01785
SMP00112,Risedronate Action Pathway,drug_action,DB01785
SMP00209,Hypercholesterolemia,disease,DB01785
SMP00974,Secondary metabolites: methylerythritol phosphate and polyisoprenoid biosynthesis,metabolic,DB01785
SMP02381,Steroid Biosynthesis ,metabolic,DB01785
SMP00092,Rosuvastatin Action Pathway,drug_action,DB01785
SMP00119,Fluvastatin Action Pathway,drug_action,DB01785
SMP00387,CHILD Syndrome,disease,DB01785
SMP00509,Hyper-IgD syndrome,disease,DB01785
SMP00991,Secondary metabolites: isoprenoid biosynthesis (nonmevalonate pathway),metabolic,DB01785
SMP12042,Epoxysqualene Biosynthesis,metabolic,DB01785
SMP12049,Farnesene Biosynthesis,metabolic,DB01785
SMP00111,Cerivastatin Action Pathway,drug_action,DB01785
SMP00117,Pamidronate Action Pathway,drug_action,DB01785
SMP00131,Atorvastatin Action Pathway,drug_action,DB01785
SMP00508,Cholesteryl ester storage disease,disease,DB01785
SMP00510,Mevalonic aciduria,disease,DB01785
SMP02440,Cholesterol biosynthesis and metabolism CE(16:0),metabolic,DB01785
SMP63670,Steroid Biosynthesis,metabolic,DB01785
SMP00023,Steroid Biosynthesis,metabolic,DB01785
SMP00079,Ibandronate Action Pathway,drug_action,DB01785
SMP00082,Simvastatin Action Pathway,drug_action,DB01785
SMP00099,Lovastatin Action Pathway,drug_action,DB01785
SMP00319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB01785
SMP00386,Desmosterolosis,disease,DB01785
SMP00849,NAD biosynthesis,metabolic,DB01796
SMP63693,Tryptophan Metabolism,metabolic,DB01796
SMP00063,Tryptophan Metabolism,metabolic,DB01796
SMP02338,NAD metabolism,metabolic,DB01796
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB01796
SMP63643,Nicotinate and Nicotinamide Metabolism,metabolic,DB01796
SMP00217,Sialuria or French Type Sialuria,disease,DB01819
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB01819
SMP00562,"Fructose-1,6-diphosphatase deficiency",disease,DB01819
SMP00572,Fanconi-bickel syndrome,disease,DB01819
SMP00816, D-glucarate and D-galactarate degradation,metabolic,DB01819
SMP00851,lipopolysaccharide biosynthesis,metabolic,DB01819
SMP01001,Secondary Metabolites: Shikimate Pathway,metabolic,DB01819
SMP12057,CMP-3-Deoxy-D-Manno-Octulosonate (CMP-Kdo) Biosynthesis,metabolic,DB01819
SMP00060,Pyruvate Metabolism,metabolic,DB01819
SMP00374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB01819
SMP00559,Pyruvate kinase deficiency,disease,DB01819
SMP00560,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),disease,DB01819
SMP00563,Triosephosphate isomerase,disease,DB01819
SMP00933,glycerol metabolism III (sn-glycero-3-phosphoethanolamine),metabolic,DB01819
SMP02312,Glycolysis I,metabolic,DB01819
SMP02356,Ethanol fermentation,metabolic,DB01819
SMP63661,Pyruvate Metabolism,metabolic,DB01819
SMP00045,Amino Sugar Metabolism,metabolic,DB01819
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB01819
SMP00390,Tay-Sachs Disease,disease,DB01819
SMP00654,Warburg Effect,metabolic,DB01819
SMP00839,Gluconeogenesis from L-malic acid,metabolic,DB01819
SMP00905,Amino sugar and nucleotide sugar metabolism I,metabolic,DB01819
SMP00931,glycerol metabolism,metabolic,DB01819
SMP00934,glycerol metabolism IV (glycerophosphoglycerol),metabolic,DB01819
SMP02413,Gluconeogenesis from L-malic acid ,metabolic,DB01819
SMP00040,Glycolysis,metabolic,DB01819
SMP00196,Leigh Syndrome,disease,DB01819
SMP00216,Sialuria or French Type Sialuria,disease,DB01819
SMP00534,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",disease,DB01819
SMP63591,Vitamin K Metabolism,metabolic,DB01822
SMP00464,Vitamin K Metabolism,metabolic,DB01822
SMP63684,Tyrosine Metabolism,metabolic,DB01828
SMP00006,Tyrosine Metabolism,metabolic,DB01828
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB01828
SMP00218,Tyrosinemia Type I,disease,DB01828
SMP00424,Citalopram Action Pathway,drug_action,DB01828
SMP00429,Disulfiram Action Pathway,drug_action,DB01828
SMP00627,Citalopram Metabolism Pathway,drug_metabolism,DB01828
SMP00169,Alkaptonuria,disease,DB01828
SMP00190,Hawkinsinuria,disease,DB01828
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB01828
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB01828
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB01839
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB01839
SMP00196,Leigh Syndrome,disease,DB01839
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB01839
SMP00060,Pyruvate Metabolism,metabolic,DB01839
SMP00559,Pyruvate kinase deficiency,disease,DB01839
SMP63661,Pyruvate Metabolism,metabolic,DB01839
SMP00493,"Carnosinuria, carnosinemia",disease,DB01849
SMP00046,Pyrimidine Metabolism,metabolic,DB01849
SMP00007,Beta-Alanine Metabolism,metabolic,DB01849
SMP63658,Pyrimidine Metabolism,metabolic,DB01849
SMP00172,Beta Ureidopropionase Deficiency,disease,DB01849
SMP00178,Dihydropyrimidinase Deficiency,disease,DB01849
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB01849
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB01849
SMP00351,GABA-Transaminase Deficiency,disease,DB01849
SMP00492,Ureidopropionase Deficiency,disease,DB01849
SMP63599,Beta-Alanine Metabolism,metabolic,DB01849
SMP12025,Flavonol Biosynthesis,metabolic,DB01852
SMP00182,Galactosemia,disease,DB01861
SMP00349,Gaucher Disease,disease,DB01861
SMP00495,Galactosemia II (GALK),disease,DB01861
SMP00557,Sucrase-isomaltase deficiency,disease,DB01861
SMP00851,lipopolysaccharide biosynthesis,metabolic,DB01861
SMP00347,Metachromatic Leukodystrophy (MLD),disease,DB01861
SMP00553,"Glycogenosis, Type III. Cori disease, Debrancher glycogenosis",disease,DB01861
SMP00556,Mucopolysaccharidosis VI. Sly syndrome,disease,DB01861
SMP00906,Amino sugar and nucleotide sugar metabolism II,metabolic,DB01861
SMP01919,lipopolysaccharide biosynthesis II,metabolic,DB01861
SMP12076,Phenolic Malonylglucosides Biosynthesis,metabolic,DB01861
SMP63673,Starch and Sucrose Metabolism,metabolic,DB01861
SMP00034,Sphingolipid Metabolism,metabolic,DB01861
SMP00058,Starch and Sucrose Metabolism,metabolic,DB01861
SMP00444,Lactose Synthesis,metabolic,DB01861
SMP00554,"Glycogenosis, Type IV. Amylopectinosis, Anderson disease",disease,DB01861
SMP00579,Congenital disorder of glycosylation CDG-IId,disease,DB01861
SMP00903,galactose degradation/Leloir Pathway,metabolic,DB01861
SMP12033,Abscisic Acid Glucose Ester Metabolism,metabolic,DB01861
SMP63667,Sphingolipid Metabolism,metabolic,DB01861
SMP00525,Fabry disease,disease,DB01861
SMP00555,"Glycogenosis, Type VI. Hers disease",disease,DB01861
SMP00580,GLUT-1 deficiency syndrome,disease,DB01861
SMP02100,trehalose biosynthesis I,metabolic,DB01861
SMP02331,Amino sugar and nucleotide sugar metabolism,metabolic,DB01861
SMP02380,Starch and Sucrose Metabolism ,metabolic,DB01861
SMP12055,Cis-Zeatin-O-Glucoside Biosynthesis,metabolic,DB01861
SMP12067,Cis-Zeatin-N-Glucoside Biosynthesis,metabolic,DB01861
SMP63634,Lactose Synthesis,metabolic,DB01861
SMP63645,Nucleotide Sugars Metabolism,metabolic,DB01861
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB01917
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB01917
SMP00445,Spermidine and Spermine Biosynthesis,metabolic,DB01917
SMP00813,ornithine metabolism,metabolic,DB01917
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB01917
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB01917
SMP02307,Beta-Alanine metabolism,metabolic,DB01917
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB01917
SMP00812,arginine metabolism,metabolic,DB01917
SMP00857,S-adenosyl-L-methionine biosynthesis,metabolic,DB01917
SMP63637,Methionine Metabolism,metabolic,DB01917
SMP00033,Methionine Metabolism,metabolic,DB01917
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB01917
SMP00341,Hypermethioninemia,disease,DB01917
SMP02054,Spermidine Biosynthesis I,metabolic,DB01917
SMP02067,Putrescine Degradation II,metabolic,DB01917
SMP02097,Spermidine biosynthesis and metabolism ,metabolic,DB01917
SMP63671,Spermidine and Spermine Biosynthesis,metabolic,DB01917
SMP00111,Cerivastatin Action Pathway,drug_action,DB01942
SMP00117,Pamidronate Action Pathway,drug_action,DB01942
SMP00131,Atorvastatin Action Pathway,drug_action,DB01942
SMP00432,Methotrexate Action Pathway,drug_action,DB01942
SMP00489,Hyperphenylalaninemia due to dhpr-deficiency,disease,DB01942
SMP00508,Cholesteryl ester storage disease,disease,DB01942
SMP00510,Mevalonic aciduria,disease,DB01942
SMP02353,Tryptophan metabolism,metabolic,DB01942
SMP02377,purine nucleotides de novo biosynthesis ,metabolic,DB01942
SMP02440,Cholesterol biosynthesis and metabolism CE(16:0),metabolic,DB01942
SMP63462,Riboflavin Metabolism,metabolic,DB01942
SMP63670,Steroid Biosynthesis,metabolic,DB01942
SMP00063,Tryptophan Metabolism,metabolic,DB01942
SMP00095,Alendronate Action Pathway,drug_action,DB01942
SMP00107,Zoledronate Action Pathway,drug_action,DB01942
SMP00511,Wolman disease,disease,DB01942
SMP00565,Aromatase deficiency,disease,DB01942
SMP01903,N-oxide electron transfer,metabolic,DB01942
SMP01907,preQ0 metabolism,metabolic,DB01942
SMP02065,polymyxin resistance,metabolic,DB01942
SMP02323,serine metabolism,metabolic,DB01942
SMP02338,NAD metabolism,metabolic,DB01942
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB01942
SMP02443,Serine Metabolism,metabolic,DB01942
SMP12013,Pterin Biosynthesis (Folate Precursor),metabolic,DB01942
SMP00005,Pterine Biosynthesis,metabolic,DB01942
SMP00053,Folate Metabolism,metabolic,DB01942
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB01942
SMP00089,Pravastatin Action Pathway,drug_action,DB01942
SMP00112,Risedronate Action Pathway,drug_action,DB01942
SMP00808,inner membrane transport,metabolic,DB01956
SMP00939,sulfur metabolism,metabolic,DB01956
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB01956
SMP00941,sulfur metabolism (propanesulfonate),metabolic,DB01956
SMP00942,sulfur metabolism (ethanesulfonate),metabolic,DB01956
SMP00720,27-Hydroxylase Deficiency,disease,DB01956
SMP01044,Taurine Metabolism I,metabolic,DB01956
SMP02379,Taurine and hypotaurine biosynthesis,metabolic,DB01956
SMP63601,Bile Acid Biosynthesis,metabolic,DB01956
SMP00035,Bile Acid Biosynthesis,metabolic,DB01956
SMP00317,Familial Hypercholanemia (FHCA),disease,DB01956
SMP00797,Taurine Metabolism,metabolic,DB01956
SMP00943,sulfur metabolism (isethionate),metabolic,DB01956
SMP00944,sulfur metabolism (methanesulfonate),metabolic,DB01956
SMP00021,Taurine and Hypotaurine Metabolism,metabolic,DB01956
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB01956
SMP00316,Zellweger Syndrome,disease,DB01956
SMP00318,Congenital Bile Acid Synthesis Defect Type III,disease,DB01956
SMP00940,sulfur metabolism (butanesulfonate),metabolic,DB01956
SMP02382,Sulfur metabolism,metabolic,DB01956
SMP63675,Taurine and Hypotaurine Metabolism,metabolic,DB01956
SMP00826,tyrosine biosynthesis,metabolic,DB01962
SMP00044,Histidine Metabolism,metabolic,DB01971
SMP00009,Ammonia Recycling,metabolic,DB01971
SMP63632,Histidine Metabolism,metabolic,DB01971
SMP00191,Histidinemia,disease,DB01971
SMP63579,Ammonia Recycling,metabolic,DB01971
SMP00050,Purine Metabolism,metabolic,DB01972
SMP00072,Glutamate Metabolism,metabolic,DB01972
SMP00144,Adenosine Deaminase Deficiency,disease,DB01972
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB01972
SMP00385,Homocarnosinosis,disease,DB01972
SMP00711,Tobramycin Action Pathway,drug_action,DB01972
SMP00713,Arbekacin Action Pathway,drug_action,DB01972
SMP00727,Methacycline Action Pathway,drug_action,DB01972
SMP02377,purine nucleotides de novo biosynthesis ,metabolic,DB01972
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB01972
SMP00168,AICA-Ribosiduria,disease,DB01972
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB01972
SMP00253,Amikacin Action Pathway,drug_action,DB01972
SMP00258,Spectinomycin Action Pathway,drug_action,DB01972
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB01972
SMP00428,Mercaptopurine Action Pathway,drug_action,DB01972
SMP00430,Thioguanine Action Pathway,drug_action,DB01972
SMP00512,Xanthinuria type I,disease,DB01972
SMP02047,purine nucleotides de novo biosynthesis 2,metabolic,DB01972
SMP00249,Clindamycin Action Pathway,drug_action,DB01972
SMP00254,Gentamicin Action Pathway,drug_action,DB01972
SMP00257,Netilmicin Action Pathway,drug_action,DB01972
SMP00291,Doxycycline Action Pathway,drug_action,DB01972
SMP00292,Minocycline Action Pathway,drug_action,DB01972
SMP00295,Lymecycline Action Pathway,drug_action,DB01972
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB01972
SMP00427,Azathioprine Action Pathway,drug_action,DB01972
SMP00513,Xanthinuria type II,disease,DB01972
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB01972
SMP00712,Tigecycline Action Pathway,drug_action,DB01972
SMP00700,Lornoxicam Action Pathway,drug_action,DB02056
SMP00701,Phenylbutazone Action Pathway,drug_action,DB02056
SMP00707,Salsalate Action Pathway,drug_action,DB02056
SMP00710,Acetaminophen  Action Pathway,drug_action,DB02056
SMP00098,Ketorolac Action Pathway,drug_action,DB02056
SMP00101,Suprofen Action Pathway,drug_action,DB02056
SMP00116,Valdecoxib Action Pathway,drug_action,DB02056
SMP00289,Diflunisal Action Pathway,drug_action,DB02056
SMP00353,Leukotriene C4 Synthesis Deficiency,disease,DB02056
SMP00703,Trisalicylate-choline Action Pathway,drug_action,DB02056
SMP00075,Arachidonic Acid Metabolism,metabolic,DB02056
SMP00106,Meloxicam Action Pathway,drug_action,DB02056
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB02056
SMP00358,Fc Epsilon Receptor I Signaling in Mast Cells,signaling,DB02056
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB02056
SMP00702,Nepafenac Action Pathway,drug_action,DB02056
SMP00708,Salicylate-sodium Action Pathway,drug_action,DB02056
SMP00084,Etodolac Action Pathway,drug_action,DB02056
SMP00086,Ibuprofen Action Pathway,drug_action,DB02056
SMP00093,Diclofenac Action Pathway,drug_action,DB02056
SMP00102,Bromfenac Action Pathway,drug_action,DB02056
SMP00343,Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,signaling,DB02056
SMP00692,Antipyrine Action Pathway,drug_action,DB02056
SMP00693,Antrafenine Action Pathway,drug_action,DB02056
SMP00696,Fenoprofen Action Pathway,drug_action,DB02056
SMP00697,Flurbiprofen Action Pathway,drug_action,DB02056
SMP00699,Lumiracoxib Action Pathway,drug_action,DB02056
SMP00706,Tenoxicam Action Pathway,drug_action,DB02056
SMP00709,Salicylic Acid Action Pathway,drug_action,DB02056
SMP63595,Arachidonic Acid Metabolism,metabolic,DB02056
SMP63693,Tryptophan Metabolism,metabolic,DB02070
SMP02353,Tryptophan metabolism,metabolic,DB02070
SMP00063,Tryptophan Metabolism,metabolic,DB02070
SMP02338,NAD metabolism,metabolic,DB02070
SMP00456,Fatty Acid Biosynthesis,metabolic,DB02074
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB02074
SMP63613,Fatty Acid Biosynthesis,metabolic,DB02074
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB02083
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB02083
SMP63626,Glycine and Serine Metabolism,metabolic,DB02083
SMP00123,Betaine Metabolism,metabolic,DB02083
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB02083
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB02083
SMP63637,Methionine Metabolism,metabolic,DB02083
SMP00033,Methionine Metabolism,metabolic,DB02083
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB02083
SMP00341,Hypermethioninemia,disease,DB02083
SMP02092,S-adenosyl-L-methionine cycle,metabolic,DB02083
SMP00004,Glycine and Serine Metabolism,metabolic,DB02083
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02083
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02083
SMP00244,Sarcosinemia,disease,DB02083
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB02083
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB02083
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB02083
SMP00223,Non Ketotic Hyperglycinemia,disease,DB02083
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02083
SMP00856,Quorum Sensing,signaling,DB02083
SMP02313,Sarcosine Oncometabolite Pathway ,disease,DB02083
SMP63600,Betaine Metabolism,metabolic,DB02083
SMP63658,Pyrimidine Metabolism,metabolic,DB02129
SMP00046,Pyrimidine Metabolism,metabolic,DB02129
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02129
SMP00172,Beta Ureidopropionase Deficiency,disease,DB02129
SMP00178,Dihydropyrimidinase Deficiency,disease,DB02129
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02129
SMP12038,Chlorophyll a Biosynthesis II,metabolic,DB02133
SMP12044,Chlorophyll a Degradation II,metabolic,DB02133
SMP12050,Chlorophyll a Biosynthesis I,metabolic,DB02133
SMP12051,Chlorophyll a Degradation I,metabolic,DB02133
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB02134
SMP00537,Myoadenylate deaminase deficiency,disease,DB02134
SMP02088,purine ribonucleosides degradation,metabolic,DB02134
SMP00050,Purine Metabolism,metabolic,DB02134
SMP00144,Adenosine Deaminase Deficiency,disease,DB02134
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02134
SMP00168,AICA-Ribosiduria,disease,DB02134
SMP00428,Mercaptopurine Action Pathway,drug_action,DB02134
SMP00430,Thioguanine Action Pathway,drug_action,DB02134
SMP00512,Xanthinuria type I,disease,DB02134
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB02134
SMP00427,Azathioprine Action Pathway,drug_action,DB02134
SMP00513,Xanthinuria type II,disease,DB02134
SMP02103,adenosine nucleotides degradation ,metabolic,DB02134
SMP12052,AMP Degradation (Hypoxanthine Route),metabolic,DB02134
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB02134
SMP00203,Molybdenum Cofactor Deficiency,disease,DB02134
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02134
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB02134
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB02134
SMP63668,Purine Metabolism,metabolic,DB02134
SMP00503,Hypophosphatasia,disease,DB02142
SMP02387,Vitamin B6,metabolic,DB02142
SMP00017,Vitamin B6 Metabolism,metabolic,DB02142
SMP63472,Vitamin B6 Metabolism ,metabolic,DB02142
SMP63592,Vitamin B6 Metabolism,metabolic,DB02142
SMP00456,Fatty Acid Biosynthesis,metabolic,DB02175
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB02175
SMP63613,Fatty Acid Biosynthesis,metabolic,DB02175
SMP02442,Phenylalanine metabolism,metabolic,DB02178
SMP02041,Phenylethylamine metabolism,metabolic,DB02178
SMP02349,Phenylalanine metabolism,metabolic,DB02178
SMP00739,Didanosine Action Pathway,drug_action,DB02189
SMP02442,Phenylalanine metabolism,metabolic,DB02192
SMP02349,Phenylalanine metabolism,metabolic,DB02192
SMP00503,Hypophosphatasia,disease,DB02209
SMP02387,Vitamin B6,metabolic,DB02209
SMP00017,Vitamin B6 Metabolism,metabolic,DB02209
SMP63472,Vitamin B6 Metabolism ,metabolic,DB02209
SMP63592,Vitamin B6 Metabolism,metabolic,DB02209
SMP63684,Tyrosine Metabolism,metabolic,DB02232
SMP00218,Tyrosinemia Type I,disease,DB02232
SMP00429,Disulfiram Action Pathway,drug_action,DB02232
SMP00006,Tyrosine Metabolism,metabolic,DB02232
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB02232
SMP00169,Alkaptonuria,disease,DB02232
SMP00190,Hawkinsinuria,disease,DB02232
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB02232
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB02232
SMP00958,starch and sucrose metabolism,metabolic,DB02237
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB02238
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB02238
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB02238
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB02238
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB02238
SMP02310,Methionine metabolism and salvage,metabolic,DB02238
SMP63637,Methionine Metabolism,metabolic,DB02238
SMP00033,Methionine Metabolism,metabolic,DB02238
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB02238
SMP00341,Hypermethioninemia,disease,DB02238
SMP02370,pyrimidine metabolism ,metabolic,DB02262
SMP00046,Pyrimidine Metabolism,metabolic,DB02262
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02262
SMP00959,pyrimidine metabolism,metabolic,DB02262
SMP63658,Pyrimidine Metabolism,metabolic,DB02262
SMP00172,Beta Ureidopropionase Deficiency,disease,DB02262
SMP00178,Dihydropyrimidinase Deficiency,disease,DB02262
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02262
SMP00374,Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,disease,DB02263
SMP00560,Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),disease,DB02263
SMP00563,Triosephosphate isomerase,disease,DB02263
SMP00725,"Fructose intolerance, hereditary",disease,DB02263
SMP00933,glycerol metabolism III (sn-glycero-3-phosphoethanolamine),metabolic,DB02263
SMP02312,Glycolysis I,metabolic,DB02263
SMP02356,Ethanol fermentation,metabolic,DB02263
SMP12089,Photosynthesis,metabolic,DB02263
SMP63472,Vitamin B6 Metabolism ,metabolic,DB02263
SMP63614,Fructose and Mannose Degradation,metabolic,DB02263
SMP00031,Pentose Phosphate Pathway,metabolic,DB02263
SMP00520,Transaldolase deficiency,disease,DB02263
SMP00562,"Fructose-1,6-diphosphatase deficiency",disease,DB02263
SMP00572,Fanconi-bickel syndrome,disease,DB02263
SMP00835,tryptophan metabolism,metabolic,DB02263
SMP00991,Secondary metabolites: isoprenoid biosynthesis (nonmevalonate pathway),metabolic,DB02263
SMP01930,tryptophan metabolism II,metabolic,DB02263
SMP02017,ketogluconate metabolism,metabolic,DB02263
SMP02345,xylitol degradation,metabolic,DB02263
SMP02406,Riboneogenesis,metabolic,DB02263
SMP12445,Fructose Metabolism,metabolic,DB02263
SMP00040,Glycolysis,metabolic,DB02263
SMP00518,Glucose-6-phosphate dehydrogenase deficiency,disease,DB02263
SMP00519,Ribose-5-phosphate isomerase deficiency,disease,DB02263
SMP00581,"Glycogenosis, Type IA. Von gierke disease",disease,DB02263
SMP00807,glycolysis and pyruvate dehydrogenase,metabolic,DB02263
SMP00854, hexuronide and hexuronate degradation,metabolic,DB02263
SMP00932,glycerol metabolism II,metabolic,DB02263
SMP00935,glycerol metabolism V (glycerophosphoserine),metabolic,DB02263
SMP00974,Secondary metabolites: methylerythritol phosphate and polyisoprenoid biosynthesis,metabolic,DB02263
SMP00342,Hereditary Coproporphyria (HCP),disease,DB02285
SMP00024,Porphyrin Metabolism,metabolic,DB02285
SMP00344,Acute Intermittent Porphyria,disease,DB02285
SMP00953,Porphyrin metabolism,metabolic,DB02285
SMP63655,Porphyrin Metabolism,metabolic,DB02285
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB02285
SMP00346,Porphyria Variegata (PV),disease,DB02285
SMP02363,Porphyrin Metabolism ,metabolic,DB02285
SMP00837,threonine biosynthesis,metabolic,DB02289
SMP02389,Leucine Degradation,metabolic,DB02296
SMP00906,Amino sugar and nucleotide sugar metabolism II,metabolic,DB02317
SMP00182,Galactosemia,disease,DB02317
SMP00495,Galactosemia II (GALK),disease,DB02317
SMP00444,Lactose Synthesis,metabolic,DB02317
SMP00579,Congenital disorder of glycosylation CDG-IId,disease,DB02317
SMP00903,galactose degradation/Leloir Pathway,metabolic,DB02317
SMP00580,GLUT-1 deficiency syndrome,disease,DB02317
SMP02331,Amino sugar and nucleotide sugar metabolism,metabolic,DB02317
SMP63634,Lactose Synthesis,metabolic,DB02317
SMP63645,Nucleotide Sugars Metabolism,metabolic,DB02317
SMP00010,Nucleotide Sugars Metabolism,metabolic,DB02317
SMP00043,Galactose Metabolism,metabolic,DB02317
SMP00496,Galactosemia III,disease,DB02317
SMP00840,Galactitol and galactonate degradation,metabolic,DB02317
SMP00841,galactose metabolism,metabolic,DB02317
SMP00914,Amino sugar and nucleotide sugar metabolism III,metabolic,DB02317
SMP00958,starch and sucrose metabolism,metabolic,DB02317
SMP02319,Leloir Pathway ,metabolic,DB02317
SMP12059,D-Galactose Degradation (Leloir pathway),metabolic,DB02317
SMP63625,Galactose Metabolism,metabolic,DB02317
SMP00029,Selenoamino Acid Metabolism,metabolic,DB02345
SMP02371,Selenocompound Metabolism,metabolic,DB02345
SMP63587,Selenoamino Acid Metabolism,metabolic,DB02345
SMP12014,Folate Biosynthesis,metabolic,DB02362
SMP12013,Pterin Biosynthesis (Folate Precursor),metabolic,DB02362
SMP00925,Folate Biosynthesis,metabolic,DB02362
SMP02334,tetrahydrofolate biosynthesis,metabolic,DB02362
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB02377
SMP00427,Azathioprine Action Pathway,drug_action,DB02377
SMP00513,Xanthinuria type II,disease,DB02377
SMP00050,Purine Metabolism,metabolic,DB02377
SMP00144,Adenosine Deaminase Deficiency,disease,DB02377
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02377
SMP00168,AICA-Ribosiduria,disease,DB02377
SMP00428,Mercaptopurine Action Pathway,drug_action,DB02377
SMP00430,Thioguanine Action Pathway,drug_action,DB02377
SMP00512,Xanthinuria type I,disease,DB02377
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB02377
SMP00537,Myoadenylate deaminase deficiency,disease,DB02377
SMP02086,guanine and guanosine salvage,metabolic,DB02377
SMP02088,purine ribonucleosides degradation,metabolic,DB02377
SMP02138,Operon: cytosine transport inactivation I,signaling,DB02377
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB02377
SMP00203,Molybdenum Cofactor Deficiency,disease,DB02377
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02377
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB02377
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB02377
SMP01907,preQ0 metabolism,metabolic,DB02377
SMP02089,purine deoxyribonucleosides degradation,metabolic,DB02377
SMP63668,Purine Metabolism,metabolic,DB02377
SMP00491,Sepiapterin reductase deficiency,disease,DB02385
SMP00489,Hyperphenylalaninemia due to dhpr-deficiency,disease,DB02385
SMP00005,Pterine Biosynthesis,metabolic,DB02385
SMP00490,Segawa syndrome,disease,DB02385
SMP00486,Dopa-responsive dystonia,disease,DB02385
SMP00487,Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,disease,DB02385
SMP00488,Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),disease,DB02385
SMP63657,Pterine Biosynthesis,metabolic,DB02385
SMP00045,Amino Sugar Metabolism,metabolic,DB02431
SMP00172,Beta Ureidopropionase Deficiency,disease,DB02431
SMP00178,Dihydropyrimidinase Deficiency,disease,DB02431
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02431
SMP00390,Tay-Sachs Disease,disease,DB02431
SMP00711,Tobramycin Action Pathway,drug_action,DB02431
SMP00713,Arbekacin Action Pathway,drug_action,DB02431
SMP00727,Methacycline Action Pathway,drug_action,DB02431
SMP01045,phospholipid biosynthesis CL(14:0/15:0cyclo/14:0/17:0cycw7c),metabolic,DB02431
SMP01050,phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/19:0cycv8c)) 1440195714,metabolic,DB02431
SMP01054,phospholipid biosynthesis CL(14:0/16:0/19:0cycv8c/14:0),metabolic,DB02431
SMP01070,phospholipid biosynthesis CL(15:0cyclo/14:0/16:1(9Z)/16:1(9Z)),metabolic,DB02431
SMP01078,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/19:0cycv8c),metabolic,DB02431
SMP01079,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/16:1(9Z)),metabolic,DB02431
SMP01082,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/14:0),metabolic,DB02431
SMP01083,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/17:0cycw7c),metabolic,DB02431
SMP01092,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/16:0),metabolic,DB02431
SMP01099,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/16:1(9Z)),metabolic,DB02431
SMP01109,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/19:0cycv8c),metabolic,DB02431
SMP01113,phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/17:0cycw7c),metabolic,DB02431
SMP01118,phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/16:1(9Z)),metabolic,DB02431
SMP01124,phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/16:1(9Z)),metabolic,DB02431
SMP01128,phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/16:0),metabolic,DB02431
SMP01129,phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/18:1(9Z)),metabolic,DB02431
SMP01133,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/14:0/15:0cyclo),metabolic,DB02431
SMP01136,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/16:1(9Z)),metabolic,DB02431
SMP01138,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/18:1(9Z)),metabolic,DB02431
SMP01142,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/14:0),metabolic,DB02431
SMP01143,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/15:0cyclo),metabolic,DB02431
SMP01152,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/18:1(9Z)/15:0cyclo),metabolic,DB02431
SMP00991,Secondary metabolites: isoprenoid biosynthesis (nonmevalonate pathway),metabolic,DB02496
SMP02055,Thiazole Biosynthesis I ,metabolic,DB02496
SMP00974,Secondary metabolites: methylerythritol phosphate and polyisoprenoid biosynthesis,metabolic,DB02496
SMP02387,Vitamin B6,metabolic,DB02496
SMP00039,Glycerolipid Metabolism,metabolic,DB02515
SMP01041,"phospholipid biosynthesis I (CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) )",metabolic,DB02515
SMP01042,phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/19:0cycv8c)),metabolic,DB02515
SMP01046,phospholipid biosynthesis (CL(14:0/15:0cyclo/17:0cycw7c/14:0),metabolic,DB02515
SMP01048,phospholipid biosynthesis CL(14:0/16:0/14:0/16:0),metabolic,DB02515
SMP01051,phospholipid biosynthesis CL(14:0/16:0/14:0/19:0cycv8c),metabolic,DB02515
SMP01053,phospholipid biosynthesis CL(14:0/16:0/18:1(9Z)/14:0),metabolic,DB02515
SMP01057,phospholipid biosynthesis CL(14:0/16:1(9Z)/14:0/19:0cycv8c),metabolic,DB02515
SMP01058,phospholipid biosynthesis CL(14:0/16:1(9Z)/18:1(9Z)/14:0),metabolic,DB02515
SMP01065,phospholipid biosynthesis CL(14:0/18:1(9Z)/19:0cycv8c/14:0),metabolic,DB02515
SMP01066,phospholipid biosynthesis CL(14:0/19:0cycv8c/14:0/17:0cycw7c),metabolic,DB02515
SMP01071,phospholipid biosynthesis CL(15:0cyclo/14:0/17:0cycw7c/14:0),metabolic,DB02515
SMP01072,phospholipid biosynthesis CL(15:0cyclo/14:0/17:0cycw7c/17:0cycw7c),metabolic,DB02515
SMP01076,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/16:1(9Z)),metabolic,DB02515
SMP01085,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/18:1(9Z)),metabolic,DB02515
SMP01091,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/19:0cycv8c),metabolic,DB02515
SMP01098,phospholipid biosynthesis  CL(15:0cyclo/15:0cyclo/18:1(9Z)/15:0cyclo),metabolic,DB02515
SMP01102,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/19:0cycv8c),metabolic,DB02515
SMP01103,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/14:0),metabolic,DB02515
SMP01105,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/16:0),metabolic,DB02515
SMP01120,phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/18:1(9Z)),metabolic,DB02515
SMP01130,phospholipid biosynthesis (CL(15:0cyclo/16:0/19:0cycv8c/15:0cyclo)),metabolic,DB02515
SMP01131,phospholipid biosynthesis CL(15:0cyclo/16:0/19:0cycv8c/16:0),metabolic,DB02515
SMP01132,phospholipid biosynthesis CL(15:0cyclo/16:0/19:0cycv8c/19:0cycv8c),metabolic,DB02515
SMP01137,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/17:0cycw7c),metabolic,DB02515
SMP01140,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:0/16:0),metabolic,DB02515
SMP01141,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:0/16:1(9Z)),metabolic,DB02515
SMP01151,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/17:0cycw7c/17:0cycw7c),metabolic,DB02515
SMP01155,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/19:0cycv8c/15:0cyclo),metabolic,DB02515
SMP01169,phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/17:0cycw7c),metabolic,DB02515
SMP00168,AICA-Ribosiduria,disease,DB02527
SMP00338,Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,signaling,DB02527
SMP00428,Mercaptopurine Action Pathway,drug_action,DB02527
SMP00430,Thioguanine Action Pathway,drug_action,DB02527
SMP00512,Xanthinuria type I,disease,DB02527
SMP02249,Operon: maltodextrins and maltose transport II,signaling,DB02527
SMP02274,Operon: glucuronate pathway,signaling,DB02527
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB02527
SMP00203,Molybdenum Cofactor Deficiency,disease,DB02527
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02527
SMP00309,Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,signaling,DB02527
SMP00321,Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,signaling,DB02527
SMP00333,Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,signaling,DB02527
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB02527
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB02527
SMP02193,Operon: mannose uptake II,signaling,DB02527
SMP63668,Purine Metabolism,metabolic,DB02527
SMP63759,Lysophosphatidic Acid LPA6 Signalling,signaling,DB02527
SMP00310,Corticotropin Activation of Cortisol Production,signaling,DB02527
SMP00311,Excitatory Neural Signalling Through 5-HTR 7 and Serotonin,signaling,DB02527
SMP00320,Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,signaling,DB02527
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB02527
SMP00427,Azathioprine Action Pathway,drug_action,DB02527
SMP00513,Xanthinuria type II,disease,DB02527
SMP00971,Lac Operon ,signaling,DB02527
SMP00972,Lac Operon Inactivation 2,signaling,DB02527
SMP02214,Operon: glycine cleavage system,signaling,DB02527
SMP02251,Operon: maltodextrins and maltose transport IV,signaling,DB02527
SMP02283,Operon: nucleotide and deoxyribonucleotide catabolism III,signaling,DB02527
SMP63753,Lysophosphatidic Acid LPA2 Signalling,signaling,DB02527
SMP00813,ornithine metabolism,metabolic,DB02530
SMP02080,4-aminobutanoate degradation I,metabolic,DB02530
SMP63590,Glutamate Metabolism,metabolic,DB02530
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB02530
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB02530
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB02530
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB02530
SMP00812,arginine metabolism,metabolic,DB02530
SMP02427,Glutamic acid metabolism,metabolic,DB02530
SMP12467,Butanoate Metabolism,metabolic,DB02530
SMP00072,Glutamate Metabolism,metabolic,DB02530
SMP00385,Homocarnosinosis,disease,DB02530
SMP02067,Putrescine Degradation II,metabolic,DB02530
SMP02308,4-aminobutanoate degradation ,metabolic,DB02530
SMP00095,Alendronate Action Pathway,drug_action,DB02552
SMP00107,Zoledronate Action Pathway,drug_action,DB02552
SMP00511,Wolman disease,disease,DB02552
SMP02384,Terpenoid backbone biosynthesis,metabolic,DB02552
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB02552
SMP00092,Rosuvastatin Action Pathway,drug_action,DB02552
SMP00119,Fluvastatin Action Pathway,drug_action,DB02552
SMP00387,CHILD Syndrome,disease,DB02552
SMP00509,Hyper-IgD syndrome,disease,DB02552
SMP12042,Epoxysqualene Biosynthesis,metabolic,DB02552
SMP12049,Farnesene Biosynthesis,metabolic,DB02552
SMP00089,Pravastatin Action Pathway,drug_action,DB02552
SMP00112,Risedronate Action Pathway,drug_action,DB02552
SMP00209,Hypercholesterolemia,disease,DB02552
SMP00974,Secondary metabolites: methylerythritol phosphate and polyisoprenoid biosynthesis,metabolic,DB02552
SMP02381,Steroid Biosynthesis ,metabolic,DB02552
SMP14204,Monoterpenoid Biosynthesis,metabolic,DB02552
SMP00111,Cerivastatin Action Pathway,drug_action,DB02552
SMP00117,Pamidronate Action Pathway,drug_action,DB02552
SMP00131,Atorvastatin Action Pathway,drug_action,DB02552
SMP00508,Cholesteryl ester storage disease,disease,DB02552
SMP00510,Mevalonic aciduria,disease,DB02552
SMP02440,Cholesterol biosynthesis and metabolism CE(16:0),metabolic,DB02552
SMP63670,Steroid Biosynthesis,metabolic,DB02552
SMP00023,Steroid Biosynthesis,metabolic,DB02552
SMP00079,Ibandronate Action Pathway,drug_action,DB02552
SMP00082,Simvastatin Action Pathway,drug_action,DB02552
SMP00099,Lovastatin Action Pathway,drug_action,DB02552
SMP00319,Lysosomal Acid Lipase Deficiency (Wolman Disease),disease,DB02552
SMP00386,Desmosterolosis,disease,DB02552
SMP02434,Lysine Metabolism,metabolic,DB02571
SMP02032,glutathione metabolism III,metabolic,DB02576
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB02577
SMP00089,Pravastatin Action Pathway,drug_action,DB02577
SMP00112,Risedronate Action Pathway,drug_action,DB02577
SMP00168,AICA-Ribosiduria,disease,DB02577
SMP00207,Prolidase Deficiency (PD),disease,DB02577
SMP00209,Hypercholesterolemia,disease,DB02577
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB02577
SMP00316,Zellweger Syndrome,disease,DB02577
SMP00318,Congenital Bile Acid Synthesis Defect Type III,disease,DB02577
SMP00327,Phenytoin (Antiarrhythmic) Action Pathway,drug_action,DB02577
SMP00405,Codeine Action Pathway,drug_action,DB02577
SMP00422,Imipramine Action Pathway,drug_action,DB02577
SMP00428,Mercaptopurine Action Pathway,drug_action,DB02577
SMP00430,Thioguanine Action Pathway,drug_action,DB02577
SMP00471,Tamoxifen Action Pathway,drug_action,DB02577
SMP00512,Xanthinuria type I,disease,DB02577
SMP00576,21-hydroxylase deficiency (CYP21),disease,DB02577
SMP00605,Ifosfamide Metabolism Pathway,drug_metabolism,DB02577
SMP00635,Valproic Acid Metabolism Pathway,drug_metabolism,DB02577
SMP00638,Levomethadyl Acetate Metabolism Pathway,drug_metabolism,DB02577
SMP00640,Acetaminophen Metabolism Pathway,drug_metabolism,DB02577
SMP00648,Sorafenib Metabolism Pathway,drug_metabolism,DB02577
SMP00651,Artemether Metabolism Pathway,drug_metabolism,DB02577
SMP00700,Lornoxicam Action Pathway,drug_action,DB02577
SMP00701,Phenylbutazone Action Pathway,drug_action,DB02577
SMP00707,Salsalate Action Pathway,drug_action,DB02577
SMP00710,Acetaminophen  Action Pathway,drug_action,DB02577
SMP00717,Apparent mineralocorticoid excess syndrome,disease,DB02577
SMP00718,3-Beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB02577
SMP02381,Steroid Biosynthesis ,metabolic,DB02577
SMP00448,Ifosfamide Action Pathway,drug_action,DB02579
SMP00447,Cyclophosphamide Action Pathway,drug_action,DB02579
SMP00605,Ifosfamide Metabolism Pathway,drug_metabolism,DB02579
SMP00604,Cyclophosphamide Metabolism Pathway,drug_metabolism,DB02579
SMP00192,Hypoacetylaspartia,disease,DB02655
SMP00067,Aspartate Metabolism,metabolic,DB02655
SMP00175,Canavan Disease,disease,DB02655
SMP63597,Aspartate Metabolism,metabolic,DB02655
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB02659
SMP00035,Bile Acid Biosynthesis,metabolic,DB02659
SMP00317,Familial Hypercholanemia (FHCA),disease,DB02659
SMP00720,27-Hydroxylase Deficiency,disease,DB02659
SMP63601,Bile Acid Biosynthesis,metabolic,DB02659
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB02659
SMP00316,Zellweger Syndrome,disease,DB02659
SMP00318,Congenital Bile Acid Synthesis Defect Type III,disease,DB02659
SMP00943,sulfur metabolism (isethionate),metabolic,DB02688
SMP00944,sulfur metabolism (methanesulfonate),metabolic,DB02688
SMP00835,tryptophan metabolism,metabolic,DB02688
SMP01930,tryptophan metabolism II,metabolic,DB02688
SMP00940,sulfur metabolism (butanesulfonate),metabolic,DB02688
SMP02113,D-serine degradation,metabolic,DB02688
SMP02382,Sulfur metabolism,metabolic,DB02688
SMP00829,serine biosynthesis and metabolism,metabolic,DB02688
SMP00939,sulfur metabolism,metabolic,DB02688
SMP02040,Uracil degradation III,metabolic,DB02688
SMP00716,Thyroid hormone synthesis,metabolic,DB02688
SMP00941,sulfur metabolism (propanesulfonate),metabolic,DB02688
SMP00942,sulfur metabolism (ethanesulfonate),metabolic,DB02688
SMP63679,Thyroid hormone synthesis,metabolic,DB02688
SMP63662,Retinol Metabolism,metabolic,DB02699
SMP00074,Retinol Metabolism,metabolic,DB02699
SMP00336,Vitamin A Deficiency,disease,DB02699
SMP02338,NAD metabolism,metabolic,DB02701
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB02701
SMP00850,NAD salvage,metabolic,DB02701
SMP63643,Nicotinate and Nicotinamide Metabolism,metabolic,DB02701
SMP02038,Pyrimidine Ribonucleosides Degradation,metabolic,DB02745
SMP63658,Pyrimidine Metabolism,metabolic,DB02745
SMP00046,Pyrimidine Metabolism,metabolic,DB02745
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02745
SMP02116,pyrimidine ribonucleosides degradation,metabolic,DB02745
SMP00172,Beta Ureidopropionase Deficiency,disease,DB02745
SMP00178,Dihydropyrimidinase Deficiency,disease,DB02745
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02745
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB02751
SMP00223,Non Ketotic Hyperglycinemia,disease,DB02751
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02751
SMP12004,Arginine and Proline Metabolism,metabolic,DB02751
SMP00207,Prolidase Deficiency (PD),disease,DB02751
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB02751
SMP63626,Glycine and Serine Metabolism,metabolic,DB02751
SMP00004,Glycine and Serine Metabolism,metabolic,DB02751
SMP00020,Arginine and Proline Metabolism,metabolic,DB02751
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02751
SMP00208,Prolinemia Type II,disease,DB02751
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02751
SMP00244,Sarcosinemia,disease,DB02751
SMP00361,Hyperprolinemia Type I,disease,DB02751
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB02751
SMP00360,Hyperprolinemia Type II,disease,DB02751
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB02751
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB02751
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB02751
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB02751
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB02751
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB02751
SMP63596,Arginine and Proline Metabolism,metabolic,DB02751
SMP00456,Fatty Acid Biosynthesis,metabolic,DB02767
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB02767
SMP63613,Fatty Acid Biosynthesis,metabolic,DB02767
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB02838
SMP00036,D-Arginine and D-Ornithine Metabolism,metabolic,DB02838
SMP12004,Arginine and Proline Metabolism,metabolic,DB02838
SMP00207,Prolidase Deficiency (PD),disease,DB02838
SMP63608,D-Arginine and D-Ornithine Metabolism,metabolic,DB02838
SMP00020,Arginine and Proline Metabolism,metabolic,DB02838
SMP00208,Prolinemia Type II,disease,DB02838
SMP00361,Hyperprolinemia Type I,disease,DB02838
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB02838
SMP00360,Hyperprolinemia Type II,disease,DB02838
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB02838
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB02838
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB02838
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB02838
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB02838
SMP63596,Arginine and Proline Metabolism,metabolic,DB02838
SMP30406,Androstenedione Metabolism,metabolic,DB02854
SMP63688,Androstenedione Metabolism,metabolic,DB02854
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB02857
SMP00427,Azathioprine Action Pathway,drug_action,DB02857
SMP00513,Xanthinuria type II,disease,DB02857
SMP00050,Purine Metabolism,metabolic,DB02857
SMP00144,Adenosine Deaminase Deficiency,disease,DB02857
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB02857
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB02857
SMP00537,Myoadenylate deaminase deficiency,disease,DB02857
SMP02086,guanine and guanosine salvage,metabolic,DB02857
SMP02088,purine ribonucleosides degradation,metabolic,DB02857
SMP00168,AICA-Ribosiduria,disease,DB02857
SMP00428,Mercaptopurine Action Pathway,drug_action,DB02857
SMP00430,Thioguanine Action Pathway,drug_action,DB02857
SMP00512,Xanthinuria type I,disease,DB02857
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB02857
SMP00203,Molybdenum Cofactor Deficiency,disease,DB02857
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB02857
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB02857
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB02857
SMP63668,Purine Metabolism,metabolic,DB02857
SMP00064,Fructose and Mannose Degradation,metabolic,DB02867
SMP02315,Mannose Metabolism,metabolic,DB02867
SMP00561,Fructosuria,disease,DB02867
SMP00725,"Fructose intolerance, hereditary",disease,DB02867
SMP00842,Mannose Metabolism,metabolic,DB02867
SMP02331,Amino sugar and nucleotide sugar metabolism,metabolic,DB02867
SMP12444,Mannose Metabolism,metabolic,DB02867
SMP63614,Fructose and Mannose Degradation,metabolic,DB02867
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB02897
SMP00196,Leigh Syndrome,disease,DB02897
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB02897
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB02897
SMP02102,Acetate metabolism,metabolic,DB02897
SMP00060,Pyruvate Metabolism,metabolic,DB02897
SMP00559,Pyruvate kinase deficiency,disease,DB02897
SMP63661,Pyruvate Metabolism,metabolic,DB02897
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB02951
SMP00223,Non Ketotic Hyperglycinemia,disease,DB02951
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02951
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB02951
SMP63626,Glycine and Serine Metabolism,metabolic,DB02951
SMP00004,Glycine and Serine Metabolism,metabolic,DB02951
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02951
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02951
SMP00244,Sarcosinemia,disease,DB02951
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB02957
SMP00959,pyrimidine metabolism,metabolic,DB02957
SMP63658,Pyrimidine Metabolism,metabolic,DB02957
SMP00046,Pyrimidine Metabolism,metabolic,DB02957
SMP00223,Non Ketotic Hyperglycinemia,disease,DB02957
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB02957
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB02957
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB02957
SMP63626,Glycine and Serine Metabolism,metabolic,DB02957
SMP00172,Beta Ureidopropionase Deficiency,disease,DB02957
SMP00178,Dihydropyrimidinase Deficiency,disease,DB02957
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB02957
SMP00004,Glycine and Serine Metabolism,metabolic,DB02957
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB02957
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB02957
SMP00244,Sarcosinemia,disease,DB02957
SMP02370,pyrimidine metabolism ,metabolic,DB02957
SMP63693,Tryptophan Metabolism,metabolic,DB02959
SMP00063,Tryptophan Metabolism,metabolic,DB02959
SMP00818,Palmitate Biosynthesis ,metabolic,DB03017
SMP00481,Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,metabolic,DB03017
SMP00516,"Adrenoleukodystrophy, X-linked",disease,DB03017
SMP01036,fatty acid oxidation (laurate),metabolic,DB03017
SMP00052,Beta Oxidation of Very Long Chain Fatty Acids,metabolic,DB03017
SMP02438,Cholesterol biosynthesis and metabolism CE(12:0),metabolic,DB03017
SMP63640,Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,metabolic,DB03017
SMP00456,Fatty Acid Biosynthesis,metabolic,DB03017
SMP00517,Carnitine-acylcarnitine translocase deficiency,disease,DB03017
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB03017
SMP63598,Beta Oxidation of Very Long Chain Fatty Acids,metabolic,DB03017
SMP63613,Fatty Acid Biosynthesis,metabolic,DB03017
SMP00196,Leigh Syndrome,disease,DB03066
SMP00906,Amino sugar and nucleotide sugar metabolism II,metabolic,DB03066
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03066
SMP00905,Amino sugar and nucleotide sugar metabolism I,metabolic,DB03066
SMP00060,Pyruvate Metabolism,metabolic,DB03066
SMP00559,Pyruvate kinase deficiency,disease,DB03066
SMP63661,Pyruvate Metabolism,metabolic,DB03066
SMP00459,Pyruvaldehyde Degradation,metabolic,DB03066
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB03066
SMP02076,"1,6-anhydro-<i>N</i>-acetylmuramic acid recycling",metabolic,DB03066
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03066
SMP00914,Amino sugar and nucleotide sugar metabolism III,metabolic,DB03066
SMP02096,methylglyoxal degradation II,metabolic,DB03066
SMP02355,Pyruvate metabolism,metabolic,DB03066
SMP63660,Pyruvaldehyde Degradation,metabolic,DB03066
SMP00847,glycolate and glyoxylate degradation,metabolic,DB03085
SMP02105,Ethylene Glycol Degradation,metabolic,DB03085
SMP00808,inner membrane transport,metabolic,DB03085
SMP02052,D-arabinose degradation I,metabolic,DB03085
SMP63622,Glutathione Metabolism,metabolic,DB03088
SMP00143,5-Oxoprolinuria,disease,DB03088
SMP00337,Glutathione Synthetase Deficiency,disease,DB03088
SMP00500,5-oxoprolinase deficiency,disease,DB03088
SMP00015,Glutathione Metabolism,metabolic,DB03088
SMP00183,Gamma-Glutamyltransferase Deficiency,disease,DB03088
SMP00501,Gamma-glutamyl-transpeptidase deficiency,disease,DB03088
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB03101
SMP00537,Myoadenylate deaminase deficiency,disease,DB03101
SMP02038,Pyrimidine Ribonucleosides Degradation,metabolic,DB03101
SMP02086,guanine and guanosine salvage,metabolic,DB03101
SMP02088,purine ribonucleosides degradation,metabolic,DB03101
SMP00050,Purine Metabolism,metabolic,DB03101
SMP00144,Adenosine Deaminase Deficiency,disease,DB03101
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03101
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03101
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03101
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB03101
SMP00031,Pentose Phosphate Pathway,metabolic,DB03101
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB03101
SMP00427,Azathioprine Action Pathway,drug_action,DB03101
SMP00513,Xanthinuria type II,disease,DB03101
SMP00520,Transaldolase deficiency,disease,DB03101
SMP02083,adenine and adenosine salvage II,metabolic,DB03101
SMP02103,adenosine nucleotides degradation ,metabolic,DB03101
SMP63658,Pyrimidine Metabolism,metabolic,DB03101
SMP00046,Pyrimidine Metabolism,metabolic,DB03101
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB03101
SMP00203,Molybdenum Cofactor Deficiency,disease,DB03101
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB03101
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB03101
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB03101
SMP00926,PRPP Biosynthesis,metabolic,DB03101
SMP63668,Purine Metabolism,metabolic,DB03101
SMP00048,Nicotinate and Nicotinamide Metabolism,metabolic,DB03101
SMP00168,AICA-Ribosiduria,disease,DB03101
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03101
SMP00007,Beta-Alanine Metabolism,metabolic,DB03107
SMP63658,Pyrimidine Metabolism,metabolic,DB03107
SMP00175,Canavan Disease,disease,DB03107
SMP00493,"Carnosinuria, carnosinemia",disease,DB03107
SMP00848,Pantothenate and CoA Biosynthesis,metabolic,DB03107
SMP63597,Aspartate Metabolism,metabolic,DB03107
SMP63632,Histidine Metabolism,metabolic,DB03107
SMP00046,Pyrimidine Metabolism,metabolic,DB03107
SMP00191,Histidinemia,disease,DB03107
SMP00192,Hypoacetylaspartia,disease,DB03107
SMP00502,Malonyl-coa decarboxylase deficiency,disease,DB03107
SMP02307,Beta-Alanine metabolism,metabolic,DB03107
SMP63656,Propanoate Metabolism,metabolic,DB03107
SMP00016,Propanoate Metabolism,metabolic,DB03107
SMP00044,Histidine Metabolism,metabolic,DB03107
SMP00198,Malonic Aciduria,disease,DB03107
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03107
SMP00351,GABA-Transaminase Deficiency,disease,DB03107
SMP00492,Ureidopropionase Deficiency,disease,DB03107
SMP63599,Beta-Alanine Metabolism,metabolic,DB03107
SMP00067,Aspartate Metabolism,metabolic,DB03107
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03107
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03107
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03107
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03107
SMP00915,Beta-Alanine Metabolism,metabolic,DB03107
SMP02364,Pantothenate and CoA Biosynthesis ,metabolic,DB03107
SMP00229,Rabeprazole Action Pathway,drug_action,DB03128
SMP00735,Metiamide Action Pathway,drug_action,DB03128
SMP00231,Famotidine Action Pathway,drug_action,DB03128
SMP63652,Phospholipid Biosynthesis,metabolic,DB03128
SMP00228,Pantoprazole Action Pathway,drug_action,DB03128
SMP00734,Roxatidine acetate Action Pathway,drug_action,DB03128
SMP51038,Lafutidine H2-Antihistamine Action,drug_action,DB03128
SMP00025,Phospholipid Biosynthesis,metabolic,DB03128
SMP00225,Esomeprazole Action Pathway,drug_action,DB03128
SMP00227,Lansoprazole Action Pathway,drug_action,DB03128
SMP00589,Gastric Acid Production,physiological,DB03128
SMP00226,Omeprazole Action Pathway,drug_action,DB03128
SMP00230,Ranitidine Action Pathway,drug_action,DB03128
SMP00232,Cimetidine Action Pathway,drug_action,DB03128
SMP00233,Nizatidine Action Pathway,drug_action,DB03128
SMP00246,Pirenzepine Action Pathway,drug_action,DB03128
SMP00736,Betazole Action Pathway,drug_action,DB03128
SMP12004,Arginine and Proline Metabolism,metabolic,DB03144
SMP00207,Prolidase Deficiency (PD),disease,DB03144
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB03144
SMP00020,Arginine and Proline Metabolism,metabolic,DB03144
SMP00208,Prolinemia Type II,disease,DB03144
SMP00361,Hyperprolinemia Type I,disease,DB03144
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB03144
SMP00360,Hyperprolinemia Type II,disease,DB03144
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB03144
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB03144
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB03144
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB03144
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB03144
SMP63596,Arginine and Proline Metabolism,metabolic,DB03144
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB03147
SMP00017,Vitamin B6 Metabolism,metabolic,DB03147
SMP00033,Methionine Metabolism,metabolic,DB03147
SMP00050,Purine Metabolism,metabolic,DB03147
SMP00067,Aspartate Metabolism,metabolic,DB03147
SMP00072,Glutamate Metabolism,metabolic,DB03147
SMP00111,Cerivastatin Action Pathway,drug_action,DB03147
SMP00117,Pamidronate Action Pathway,drug_action,DB03147
SMP00124,Glycerol Phosphate Shuttle,metabolic,DB03147
SMP00131,Atorvastatin Action Pathway,drug_action,DB03147
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB03147
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB03147
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB03147
SMP00143,5-Oxoprolinuria,disease,DB03147
SMP00144,Adenosine Deaminase Deficiency,disease,DB03147
SMP00169,Alkaptonuria,disease,DB03147
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03147
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03147
SMP00186,Glutaric Aciduria Type I,disease,DB03147
SMP00190,Hawkinsinuria,disease,DB03147
SMP00199,Maple Syrup Urine Disease,disease,DB03147
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03147
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03147
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB03147
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB03147
SMP00236,Propionic Acidemia,disease,DB03147
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03147
SMP00341,Hypermethioninemia,disease,DB03147
SMP00355,Mitochondrial Electron Transport Chain,metabolic,DB03147
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB03147
SMP00045,Amino Sugar Metabolism,metabolic,DB03166
SMP00067,Aspartate Metabolism,metabolic,DB03166
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03166
SMP00390,Tay-Sachs Disease,disease,DB03166
SMP00821,cysteine biosynthesis ,metabolic,DB03166
SMP00905,Amino sugar and nucleotide sugar metabolism I,metabolic,DB03166
SMP00939,sulfur metabolism,metabolic,DB03166
SMP02309,Cysteine Metabolism,metabolic,DB03166
SMP00196,Leigh Syndrome,disease,DB03166
SMP00216,Sialuria or French Type Sialuria,disease,DB03166
SMP00534,"G(M2)-Gangliosidosis: Variant B, Tay-sachs disease",disease,DB03166
SMP00906,Amino sugar and nucleotide sugar metabolism II,metabolic,DB03166
SMP00940,sulfur metabolism (butanesulfonate),metabolic,DB03166
SMP01919,lipopolysaccharide biosynthesis II,metabolic,DB03166
SMP02382,Sulfur metabolism,metabolic,DB03166
SMP02420,Proline Metabolism,metabolic,DB03166
SMP63580,Amino Sugar Metabolism,metabolic,DB03166
SMP00060,Pyruvate Metabolism,metabolic,DB03166
SMP00175,Canavan Disease,disease,DB03166
SMP00559,Pyruvate kinase deficiency,disease,DB03166
SMP00813,ornithine metabolism,metabolic,DB03166
SMP00943,sulfur metabolism (isethionate),metabolic,DB03166
SMP00944,sulfur metabolism (methanesulfonate),metabolic,DB03166
SMP00993,Secondary Metabolites: cysteine biosynthesis from serine,metabolic,DB03166
SMP02371,Selenocompound Metabolism,metabolic,DB03166
SMP02391,Ether lipid metabolism,metabolic,DB03166
SMP63597,Aspartate Metabolism,metabolic,DB03166
SMP63661,Pyruvate Metabolism,metabolic,DB03166
SMP00217,Sialuria or French Type Sialuria,disease,DB03166
SMP00407,Heroin Action Pathway,drug_action,DB03166
SMP63690,Sulfate/Sulfite Metabolism,metabolic,DB03175
SMP00041,Sulfate/Sulfite Metabolism,metabolic,DB03175
SMP00532,Sulfite oxidase deficiency,disease,DB03175
SMP02325,Biosynthesis of unsaturated fatty acids (tetracosanoyl-CoA),metabolic,DB03193
SMP02329,Biosynthesis of unsaturated fatty acids (docosanoyl),metabolic,DB03193
SMP12485,"Triacylglycerol Degradation TG(16:0/18:0/18:3(6Z,9Z,12Z))",metabolic,DB03193
SMP12487,Triacylglycerol Degradation TG(16:0/18:0/20:0),metabolic,DB03193
SMP12616,"Triacylglycerol Degradation TG(18:0/16:0/18:2(9Z,12Z))",metabolic,DB03193
SMP12619,Triacylglycerol Degradation TG(18:0/16:0/20:0),metabolic,DB03193
SMP12623,Triacylglycerol Degradation TG(18:0/16:0/22:1(13Z)),metabolic,DB03193
SMP12629,"Triacylglycerol Degradation TG(18:0/18:0/18:3(6Z,9Z,12Z))",metabolic,DB03193
SMP12635,Triacylglycerol Degradation TG(18:0/18:0/22:1(13Z)),metabolic,DB03193
SMP12637,Triacylglycerol Degradation TG(18:0/18:1(9Z)/18:0),metabolic,DB03193
SMP12650,Triacylglycerol Degradation TG(18:0/18:1(11Z)/18:1(9Z)),metabolic,DB03193
SMP12663,"Triacylglycerol Degradation TG(18:0/18:2(9Z,12Z)/18:1(11Z))",metabolic,DB03193
SMP12666,"Triacylglycerol Degradation TG(18:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))",metabolic,DB03193
SMP12667,"Triacylglycerol Degradation TG(18:0/18:2(9Z,12Z)/20:0)",metabolic,DB03193
SMP12671,"Triacylglycerol Degradation TG(18:0/18:2(9Z,12Z)/22:1(13Z))",metabolic,DB03193
SMP12691,"Triacylglycerol Degradation TG(18:0/18:3(9Z,12Z,15Z)/20:0)",metabolic,DB03193
SMP12693,"Triacylglycerol Degradation TG(18:0/18:3(9Z,12Z,15Z)/20:1(13Z))",metabolic,DB03193
SMP12696,Triacylglycerol Degradation TG(18:0/20:0/16:0),metabolic,DB03193
SMP12698,Triacylglycerol Degradation TG(18:0/20:0/18:1(9Z)),metabolic,DB03193
SMP12706,Triacylglycerol Degradation TG(18:0/20:0/22:0),metabolic,DB03193
SMP12707,Triacylglycerol Degradation TG(18:0/20:0/22:1(13Z)),metabolic,DB03193
SMP12710,Triacylglycerol Degradation TG(18:0/20:1(11Z)/18:1(9Z)),metabolic,DB03193
SMP12716,Triacylglycerol Degradation TG(18:0/20:1(11Z)/20:1(11Z)),metabolic,DB03193
SMP12728,Triacylglycerol Degradation TG(18:0/20:1(13Z)/20:1(11Z)),metabolic,DB03193
SMP12730,Triacylglycerol Degradation TG(18:0/20:1(13Z)/22:0),metabolic,DB03193
SMP12736,"Triacylglycerol Degradation TG(18:0/22:0/18:2(9Z,12Z))",metabolic,DB03193
SMP12738,"Triacylglycerol Degradation TG(18:0/22:0/18:3(9Z,12Z,15Z))",metabolic,DB03193
SMP12742,Triacylglycerol Degradation TG(18:0/22:0/22:0),metabolic,DB03193
SMP12743,Triacylglycerol Degradation TG(18:0/22:0/22:1(13Z)),metabolic,DB03193
SMP12744,Triacylglycerol Degradation TG(18:0/22:1(13Z)/16:0),metabolic,DB03193
SMP00012,Catecholamine Biosynthesis,metabolic,DB03205
SMP00006,Tyrosine Metabolism,metabolic,DB03205
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB03205
SMP00170,Aromatic L-Aminoacid Decarboxylase Deficiency,disease,DB03205
SMP63606,Catecholamine Biosynthesis,metabolic,DB03205
SMP63684,Tyrosine Metabolism,metabolic,DB03205
SMP00218,Tyrosinemia Type I,disease,DB03205
SMP00429,Disulfiram Action Pathway,drug_action,DB03205
SMP00497,Tyrosine hydroxylase deficiency,disease,DB03205
SMP00169,Alkaptonuria,disease,DB03205
SMP00190,Hawkinsinuria,disease,DB03205
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB03205
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB03205
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB03229
SMP02374,Leucine Biosynthesis ,metabolic,DB03229
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB03229
SMP00173,Beta-Ketothiolase Deficiency,disease,DB03229
SMP00140,3-Methylglutaconic Aciduria Type III,disease,DB03229
SMP00200,Methylmalonic Aciduria,disease,DB03229
SMP00238,Isovaleric Aciduria,disease,DB03229
SMP00384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB03229
SMP00523,Isobutyryl-coa dehydrogenase deficiency,disease,DB03229
SMP00524,Isovaleric acidemia,disease,DB03229
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB03229
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB03229
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB03229
SMP00199,Maple Syrup Urine Disease,disease,DB03229
SMP00236,Propionic Acidemia,disease,DB03229
SMP00996,Secondary Metabolite: Leucine biosynthesis,metabolic,DB03229
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB03229
SMP00521,3-hydroxyisobutyric acid dehydrogenase deficiency,disease,DB03229
SMP00522,3-hydroxyisobutyric aciduria,disease,DB03229
SMP00831,Leucine Biosynthesis,metabolic,DB03229
SMP00994,Secondary Metabolites: Valine and I-leucine biosynthesis from pyruvate,metabolic,DB03229
SMP02389,Leucine Degradation,metabolic,DB03229
SMP02432,Leucine Biosynthesis ,metabolic,DB03229
SMP02433,Leucine Degradation,metabolic,DB03229
SMP63689,"Valine, Leucine and Isoleucine Degradation",metabolic,DB03229
SMP02115,L-arabinose Degradation I,metabolic,DB03246
SMP00046,Pyrimidine Metabolism,metabolic,DB03247
SMP00941,sulfur metabolism (propanesulfonate),metabolic,DB03247
SMP00942,sulfur metabolism (ethanesulfonate),metabolic,DB03247
SMP12004,Arginine and Proline Metabolism,metabolic,DB03247
SMP63777,Nitric Oxide Signaling Pathway,signaling,DB03247
SMP00017,Vitamin B6 Metabolism,metabolic,DB03247
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03247
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03247
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03247
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB03247
SMP00939,sulfur metabolism,metabolic,DB03247
SMP02040,Uracil degradation III,metabolic,DB03247
SMP63462,Riboflavin Metabolism,metabolic,DB03247
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03247
SMP00207,Prolidase Deficiency (PD),disease,DB03247
SMP00351,GABA-Transaminase Deficiency,disease,DB03247
SMP00492,Ureidopropionase Deficiency,disease,DB03247
SMP00940,sulfur metabolism (butanesulfonate),metabolic,DB03247
SMP00953,Porphyrin metabolism,metabolic,DB03247
SMP02382,Sulfur metabolism,metabolic,DB03247
SMP63599,Beta-Alanine Metabolism,metabolic,DB03247
SMP63647,Pantothenate and CoA Biosynthesis,metabolic,DB03247
SMP00020,Arginine and Proline Metabolism,metabolic,DB03247
SMP00208,Prolinemia Type II,disease,DB03247
SMP00361,Hyperprolinemia Type I,disease,DB03247
SMP00493,"Carnosinuria, carnosinemia",disease,DB03247
SMP00943,sulfur metabolism (isethionate),metabolic,DB03247
SMP00944,sulfur metabolism (methanesulfonate),metabolic,DB03247
SMP01985,Flavin biosynthesis,metabolic,DB03247
SMP02370,pyrimidine metabolism ,metabolic,DB03247
SMP63690,Sulfate/Sulfite Metabolism,metabolic,DB03255
SMP00041,Sulfate/Sulfite Metabolism,metabolic,DB03255
SMP00532,Sulfite oxidase deficiency,disease,DB03255
SMP02255,Operon: malto dextrins uptake,signaling,DB03277
SMP02252,Operon: maltodextrins and maltose transport V,signaling,DB03277
SMP00958,starch and sucrose metabolism,metabolic,DB03277
SMP02253,Operon: maltodextrins and maltose transport VI,signaling,DB03277
SMP02259,Operon: malto dextrins uptake IV,signaling,DB03277
SMP00064,Fructose and Mannose Degradation,metabolic,DB03283
SMP00561,Fructosuria,disease,DB03283
SMP00725,"Fructose intolerance, hereditary",disease,DB03283
SMP63614,Fructose and Mannose Degradation,metabolic,DB03283
SMP00557,Sucrase-isomaltase deficiency,disease,DB03323
SMP00555,"Glycogenosis, Type VI. Hers disease",disease,DB03323
SMP02380,Starch and Sucrose Metabolism ,metabolic,DB03323
SMP00552,Glycogen synthetase deficiency,disease,DB03323
SMP00958,starch and sucrose metabolism,metabolic,DB03323
SMP00058,Starch and Sucrose Metabolism,metabolic,DB03323
SMP00554,"Glycogenosis, Type IV. Amylopectinosis, Anderson disease",disease,DB03323
SMP00553,"Glycogenosis, Type III. Cori disease, Debrancher glycogenosis",disease,DB03323
SMP00556,Mucopolysaccharidosis VI. Sly syndrome,disease,DB03323
SMP63673,Starch and Sucrose Metabolism,metabolic,DB03323
SMP00716,Thyroid hormone synthesis,metabolic,DB03374
SMP63679,Thyroid hormone synthesis,metabolic,DB03374
SMP00525,Fabry disease,disease,DB03381
SMP00347,Metachromatic Leukodystrophy (MLD),disease,DB03381
SMP00349,Gaucher Disease,disease,DB03381
SMP02378,Sphingolipid Metabolism ,metabolic,DB03381
SMP00348,Globoid Cell Leukodystrophy,disease,DB03381
SMP00526,Krabbe disease,disease,DB03381
SMP00034,Sphingolipid Metabolism,metabolic,DB03381
SMP63667,Sphingolipid Metabolism,metabolic,DB03381
SMP01941,glutathione metabolism II,metabolic,DB03408
SMP63622,Glutathione Metabolism,metabolic,DB03408
SMP00499,Beta-mercaptolactate-cysteine disulfiduria,disease,DB03408
SMP02032,glutathione metabolism III,metabolic,DB03408
SMP02317,Glutathione Metabolism,metabolic,DB03408
SMP63590,Glutamate Metabolism,metabolic,DB03408
SMP00136,2-Hydroxyglutric Aciduria (D And L Form),disease,DB03408
SMP00243,4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,disease,DB03408
SMP00337,Glutathione Synthetase Deficiency,disease,DB03408
SMP00339,Hyperinsulinism-Hyperammonemia Syndrome,disease,DB03408
SMP00500,5-oxoprolinase deficiency,disease,DB03408
SMP00072,Glutamate Metabolism,metabolic,DB03408
SMP00143,5-Oxoprolinuria,disease,DB03408
SMP00385,Homocarnosinosis,disease,DB03408
SMP00853,glutathione metabolism,metabolic,DB03408
SMP63607,Cysteine Metabolism,metabolic,DB03408
SMP00013,Cysteine Metabolism,metabolic,DB03408
SMP00015,Glutathione Metabolism,metabolic,DB03408
SMP00183,Gamma-Glutamyltransferase Deficiency,disease,DB03408
SMP00501,Gamma-glutamyl-transpeptidase deficiency,disease,DB03408
SMP00567,Succinic semialdehyde dehydrogenase deficiency,disease,DB03408
SMP00722,"Cystinosis, ocular nonnephropathic",disease,DB03408
SMP00076,Thiamine Metabolism,metabolic,DB03416
SMP02385,Vitamin B1/Thiamine metabolism,metabolic,DB03416
SMP02042,Thiamin diphosphate biosynthesis,metabolic,DB03416
SMP63677,Thiamine Metabolism,metabolic,DB03416
SMP00046,Pyrimidine Metabolism,metabolic,DB03419
SMP00493,"Carnosinuria, carnosinemia",disease,DB03419
SMP02038,Pyrimidine Ribonucleosides Degradation,metabolic,DB03419
SMP02073,salvage pathways of pyrimidine deoxyribonucleotides,metabolic,DB03419
SMP00007,Beta-Alanine Metabolism,metabolic,DB03419
SMP02075,pyrimidine deoxyribonucleosides degradation,metabolic,DB03419
SMP63658,Pyrimidine Metabolism,metabolic,DB03419
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03419
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03419
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03419
SMP02040,Uracil degradation III,metabolic,DB03419
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03419
SMP00351,GABA-Transaminase Deficiency,disease,DB03419
SMP00492,Ureidopropionase Deficiency,disease,DB03419
SMP01901,Purine degradation,metabolic,DB03419
SMP02116,pyrimidine ribonucleosides degradation,metabolic,DB03419
SMP63599,Beta-Alanine Metabolism,metabolic,DB03419
SMP28021,Cardiolipin Biosynthesis CL(18:0/18:0/18:0/18:0),metabolic,DB03429
SMP00182,Galactosemia,disease,DB03435
SMP00217,Sialuria or French Type Sialuria,disease,DB03435
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB03435
SMP00346,Porphyria Variegata (PV),disease,DB03435
SMP00349,Gaucher Disease,disease,DB03435
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB03435
SMP00557,Sucrase-isomaltase deficiency,disease,DB03435
SMP00644,Celecoxib Metabolism Pathway,drug_metabolism,DB03435
SMP00652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB03435
SMP00959,pyrimidine metabolism,metabolic,DB03435
SMP02363,Porphyrin Metabolism ,metabolic,DB03435
SMP30406,Androstenedione Metabolism,metabolic,DB03435
SMP63658,Pyrimidine Metabolism,metabolic,DB03435
SMP63696,Estrone Metabolism,metabolic,DB03435
SMP00034,Sphingolipid Metabolism,metabolic,DB03435
SMP00045,Amino Sugar Metabolism,metabolic,DB03435
SMP00058,Starch and Sucrose Metabolism,metabolic,DB03435
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03435
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03435
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03435
SMP00390,Tay-Sachs Disease,disease,DB03435
SMP00444,Lactose Synthesis,metabolic,DB03435
SMP00554,"Glycogenosis, Type IV. Amylopectinosis, Anderson disease",disease,DB03435
SMP00579,Congenital disorder of glycosylation CDG-IId,disease,DB03435
SMP00590,Ibuprofen Metabolism Pathway,drug_metabolism,DB03435
SMP00628,Nicotine Metabolism Pathway,drug_metabolism,DB03435
SMP00642,Nevirapine Metabolism Pathway,drug_metabolism,DB03435
SMP12033,Abscisic Acid Glucose Ester Metabolism,metabolic,DB03435
SMP63667,Sphingolipid Metabolism,metabolic,DB03435
SMP00024,Porphyrin Metabolism,metabolic,DB03435
SMP02073,salvage pathways of pyrimidine deoxyribonucleotides,metabolic,DB03462
SMP00046,Pyrimidine Metabolism,metabolic,DB03462
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03462
SMP02075,pyrimidine deoxyribonucleosides degradation,metabolic,DB03462
SMP63658,Pyrimidine Metabolism,metabolic,DB03462
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03462
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03462
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03462
SMP12022,Leucopelargonidin and Leucocyanidin Biosynthesis,metabolic,DB03467
SMP12021,Flavonoid Biosynthesis (Dihydroflavonol Biosynthesis),metabolic,DB03467
SMP12024,Flavanone Biosynthesis,metabolic,DB03467
SMP02488,Beer Reactions ,metabolic,DB03514
SMP02434,Lysine Metabolism,metabolic,DB03553
SMP00811,L-glutamate metabolism,metabolic,DB03553
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB03566
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB03566
SMP00445,Spermidine and Spermine Biosynthesis,metabolic,DB03566
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB03566
SMP00857,S-adenosyl-L-methionine biosynthesis,metabolic,DB03566
SMP63637,Methionine Metabolism,metabolic,DB03566
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB03566
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB03566
SMP02307,Beta-Alanine metabolism,metabolic,DB03566
SMP00033,Methionine Metabolism,metabolic,DB03566
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB03566
SMP00341,Hypermethioninemia,disease,DB03566
SMP02054,Spermidine Biosynthesis I,metabolic,DB03566
SMP02097,Spermidine biosynthesis and metabolism ,metabolic,DB03566
SMP63671,Spermidine and Spermine Biosynthesis,metabolic,DB03566
SMP01033,fatty acid oxidation (Butanoate),metabolic,DB03568
SMP00073,Butyrate Metabolism,metabolic,DB03568
SMP00456,Fatty Acid Biosynthesis,metabolic,DB03568
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB03568
SMP63603,Butyrate Metabolism,metabolic,DB03568
SMP63613,Fatty Acid Biosynthesis,metabolic,DB03568
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03587
SMP00459,Pyruvaldehyde Degradation,metabolic,DB03587
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB03587
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB03587
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03587
SMP00223,Non Ketotic Hyperglycinemia,disease,DB03587
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03587
SMP02096,methylglyoxal degradation II,metabolic,DB03587
SMP02355,Pyruvate metabolism,metabolic,DB03587
SMP63660,Pyruvaldehyde Degradation,metabolic,DB03587
SMP00196,Leigh Syndrome,disease,DB03587
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB03587
SMP02091,methylglyoxal degradation III,metabolic,DB03587
SMP02118,L-threonine degradation to methylglyoxal,metabolic,DB03587
SMP02125,methylglyoxal degradation I,metabolic,DB03587
SMP63626,Glycine and Serine Metabolism,metabolic,DB03587
SMP00004,Glycine and Serine Metabolism,metabolic,DB03587
SMP00060,Pyruvate Metabolism,metabolic,DB03587
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03587
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03587
SMP00244,Sarcosinemia,disease,DB03587
SMP00445,Spermidine and Spermine Biosynthesis,metabolic,DB03587
SMP00559,Pyruvate kinase deficiency,disease,DB03587
SMP02090,methylglyoxal degradation IV,metabolic,DB03587
SMP63661,Pyruvate Metabolism,metabolic,DB03587
SMP02434,Lysine Metabolism,metabolic,DB03590
SMP01034,fatty acid oxidation (Decanoate),metabolic,DB03600
SMP00456,Fatty Acid Biosynthesis,metabolic,DB03600
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB03600
SMP63613,Fatty Acid Biosynthesis,metabolic,DB03600
SMP00816, D-glucarate and D-galactarate degradation,metabolic,DB03603
SMP63693,Tryptophan Metabolism,metabolic,DB03644
SMP02353,Tryptophan metabolism,metabolic,DB03644
SMP00063,Tryptophan Metabolism,metabolic,DB03644
SMP02338,NAD metabolism,metabolic,DB03644
SMP00983,Secondary Metabolites: Glyoxylate cycle,metabolic,DB03680
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03685
SMP00253,Amikacin Action Pathway,drug_action,DB03685
SMP00258,Spectinomycin Action Pathway,drug_action,DB03685
SMP00975,Secondary Metabolites: enterobacterial common antigen biosynthesis,metabolic,DB03685
SMP01919,lipopolysaccharide biosynthesis II,metabolic,DB03685
SMP02059,Secondary Metabolites: enterobacterial common antigen biosynthesis 2,metabolic,DB03685
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03685
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03685
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03685
SMP00444,Lactose Synthesis,metabolic,DB03685
SMP00579,Congenital disorder of glycosylation CDG-IId,disease,DB03685
SMP00711,Tobramycin Action Pathway,drug_action,DB03685
SMP00713,Arbekacin Action Pathway,drug_action,DB03685
SMP00727,Methacycline Action Pathway,drug_action,DB03685
SMP00249,Clindamycin Action Pathway,drug_action,DB03685
SMP00254,Gentamicin Action Pathway,drug_action,DB03685
SMP00257,Netilmicin Action Pathway,drug_action,DB03685
SMP00291,Doxycycline Action Pathway,drug_action,DB03685
SMP00292,Minocycline Action Pathway,drug_action,DB03685
SMP00295,Lymecycline Action Pathway,drug_action,DB03685
SMP00712,Tigecycline Action Pathway,drug_action,DB03685
SMP00851,lipopolysaccharide biosynthesis,metabolic,DB03685
SMP00959,pyrimidine metabolism,metabolic,DB03685
SMP63658,Pyrimidine Metabolism,metabolic,DB03685
SMP00247,Azithromycin Action Pathway,drug_action,DB03685
SMP00252,Telithromycin Action Pathway,drug_action,DB03685
SMP00259,Streptomycin Action Pathway,drug_action,DB03685
SMP00290,Demeclocycline Action Pathway,drug_action,DB03685
SMP00293,Oxytetracycline Action Pathway,drug_action,DB03685
SMP00294,Tetracycline Action Pathway,drug_action,DB03685
SMP00502,Malonyl-coa decarboxylase deficiency,disease,DB03688
SMP63656,Propanoate Metabolism,metabolic,DB03688
SMP00016,Propanoate Metabolism,metabolic,DB03688
SMP00198,Malonic Aciduria,disease,DB03688
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03688
SMP02040,Uracil degradation III,metabolic,DB03688
SMP02373,Valine Biosynthesis ,metabolic,DB03750
SMP00832,Valine Biosynthesis,metabolic,DB03750
SMP02070,Conversion of Succinate to Propanoate,metabolic,DB03766
SMP00957,propanoate metabolism,metabolic,DB03766
SMP63591,Vitamin K Metabolism,metabolic,DB03766
SMP00502,Malonyl-coa decarboxylase deficiency,disease,DB03766
SMP63656,Propanoate Metabolism,metabolic,DB03766
SMP00016,Propanoate Metabolism,metabolic,DB03766
SMP00198,Malonic Aciduria,disease,DB03766
SMP02069,propanoyl CoA degradation,metabolic,DB03766
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB03766
SMP00464,Vitamin K Metabolism,metabolic,DB03766
SMP00808,inner membrane transport,metabolic,DB03766
SMP00785,Biotin metabolism,metabolic,DB03775
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB03776
SMP00196,Leigh Syndrome,disease,DB03776
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB03776
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB03776
SMP02355,Pyruvate metabolism,metabolic,DB03776
SMP00060,Pyruvate Metabolism,metabolic,DB03776
SMP00559,Pyruvate kinase deficiency,disease,DB03776
SMP63661,Pyruvate Metabolism,metabolic,DB03776
SMP00092,Rosuvastatin Action Pathway,drug_action,DB03796
SMP00119,Fluvastatin Action Pathway,drug_action,DB03796
SMP00235,Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),disease,DB03796
SMP00387,CHILD Syndrome,disease,DB03796
SMP00509,Hyper-IgD syndrome,disease,DB03796
SMP00538,Carnitine palmitoyl transferase deficiency (I),disease,DB03796
SMP00542,Medium chain acyl-coa dehydrogenase deficiency (MCAD),disease,DB03796
SMP00720,27-Hydroxylase Deficiency,disease,DB03796
SMP02324,Biosynthesis of unsaturated fatty acids,metabolic,DB03796
SMP02346,Biosynthesis of unsaturated fatty acids (icosanoyl),metabolic,DB03796
SMP02347,Biosynthesis of unsaturated fatty acids (stearoyl),metabolic,DB03796
SMP02392,Glycerophospholipid metabolism,metabolic,DB03796
SMP06731,Triacylglycerol metabolism TG(10:0/12:0/16:1(9Z)),metabolic,DB03796
SMP06732,Triacylglycerol metabolism TG(10:0/14:0/14:1(9Z)),metabolic,DB03796
SMP06735,Triacylglycerol metabolism TG(10:0/12:0/18:0),metabolic,DB03796
SMP06736,Triacylglycerol metabolism TG(10:0/14:0/16:0),metabolic,DB03796
SMP06737,Triacylglycerol metabolism TG(10:0/15:0/15:0),metabolic,DB03796
SMP06739,Triacylglycerol metabolism TG(12:0/14:0/14:0),metabolic,DB03796
SMP06741,Triacylglycerol metabolism TG(10:0/12:0/18:1(9Z)),metabolic,DB03796
SMP06746,Triacylglycerol metabolism TG(12:0/14:0/14:1(9Z)),metabolic,DB03796
SMP06759,Triacylglycerol metabolism TG(10:0/12:0/20:1(13Z)),metabolic,DB03796
SMP06761,Triacylglycerol metabolism TG(10:0/14:1(9Z)/18:0),metabolic,DB03796
SMP06764,Triacylglycerol metabolism TG(12:0/14:0/16:1(9Z)),metabolic,DB03796
SMP06776,Triacylglycerol metabolism TG(14:0/14:0/15:0),metabolic,DB03796
SMP06779,Triacylglycerol metabolism TG(10:0/15:1(9Z)/18:0),metabolic,DB03796
SMP06785,Triacylglycerol metabolism TG(12:0/15:1(9Z)/16:1(9Z)),metabolic,DB03796
SMP06786,Triacylglycerol metabolism TG(14:0/14:1(9Z)/15:1(9Z)),metabolic,DB03796
SMP06787,Triacylglycerol metabolism TG(14:1(9Z)/14:1(9Z)/15:0),metabolic,DB03796
SMP06788,Triacylglycerol metabolism TG(10:0/10:0/24:0),metabolic,DB03796
SMP06789,Triacylglycerol metabolism TG(10:0/12:0/22:0),metabolic,DB03796
SMP00046,Pyrimidine Metabolism,metabolic,DB03800
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB03800
SMP12077,Pyrimidine Deoxyribonucleosides Salvage,metabolic,DB03800
SMP01750,One Carbon Pool by Folate I,metabolic,DB03800
SMP02073,salvage pathways of pyrimidine deoxyribonucleotides,metabolic,DB03800
SMP02370,pyrimidine metabolism ,metabolic,DB03800
SMP00959,pyrimidine metabolism,metabolic,DB03800
SMP02369,One Carbon Pool by Folate I ,metabolic,DB03800
SMP63658,Pyrimidine Metabolism,metabolic,DB03800
SMP00172,Beta Ureidopropionase Deficiency,disease,DB03800
SMP00178,Dihydropyrimidinase Deficiency,disease,DB03800
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB03800
SMP00398,Lidocaine (Local Anaesthetic) Action Pathway,drug_action,DB03843
SMP00443,Teniposide Action Pathway,drug_action,DB03843
SMP00625,Imipramine Metabolism Pathway,drug_metabolism,DB03843
SMP00628,Nicotine Metabolism Pathway,drug_metabolism,DB03843
SMP00028,Caffeine Metabolism,metabolic,DB03843
SMP00408,Methadone Action Pathway,drug_action,DB03843
SMP00636,Venlafaxine Metabolism Pathway,drug_metabolism,DB03843
SMP00641,Doxepin Metabolism Pathway,drug_metabolism,DB03843
SMP00652,Mycophenolic Acid Metabolism Pathway,drug_metabolism,DB03843
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB03843
SMP00405,Codeine Action Pathway,drug_action,DB03843
SMP00422,Imipramine Action Pathway,drug_action,DB03843
SMP00471,Tamoxifen Action Pathway,drug_action,DB03843
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB03843
SMP00638,Levomethadyl Acetate Metabolism Pathway,drug_metabolism,DB03843
SMP00651,Artemether Metabolism Pathway,drug_metabolism,DB03843
SMP63626,Glycine and Serine Metabolism,metabolic,DB03843
SMP00223,Non Ketotic Hyperglycinemia,disease,DB03843
SMP00424,Citalopram Action Pathway,drug_action,DB03843
SMP00442,Etoposide Action Pathway,drug_action,DB03843
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03843
SMP00602,Teniposide Metabolism Pathway,drug_metabolism,DB03843
SMP00606,Tamoxifen Metabolism Pathway,drug_metabolism,DB03843
SMP00621,Codeine Metabolism Pathway,drug_metabolism,DB03843
SMP00624,Methadone Metabolism Pathway,drug_metabolism,DB03843
SMP00627,Citalopram Metabolism Pathway,drug_metabolism,DB03843
SMP00639,Clomipramine Metabolism Pathway,drug_metabolism,DB03843
SMP00653,Rosiglitazone Metabolism Pathway,drug_metabolism,DB03843
SMP00004,Glycine and Serine Metabolism,metabolic,DB03843
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03843
SMP14204,Monoterpenoid Biosynthesis,metabolic,DB03852
SMP02434,Lysine Metabolism,metabolic,DB03854
SMP00795,Lysine Degradation I,metabolic,DB03854
SMP00808,inner membrane transport,metabolic,DB03854
SMP02053,aminopropylcadaverine biosynthesis,metabolic,DB03854
SMP63474,"Tropane, Piperidine and Pyridine Alkaloid Biosynthesis",metabolic,DB03854
SMP00700,Lornoxicam Action Pathway,drug_action,DB03866
SMP00701,Phenylbutazone Action Pathway,drug_action,DB03866
SMP00707,Salsalate Action Pathway,drug_action,DB03866
SMP00710,Acetaminophen  Action Pathway,drug_action,DB03866
SMP00075,Arachidonic Acid Metabolism,metabolic,DB03866
SMP00106,Meloxicam Action Pathway,drug_action,DB03866
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB03866
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB03866
SMP00702,Nepafenac Action Pathway,drug_action,DB03866
SMP00708,Salicylate-sodium Action Pathway,drug_action,DB03866
SMP00098,Ketorolac Action Pathway,drug_action,DB03866
SMP00101,Suprofen Action Pathway,drug_action,DB03866
SMP00116,Valdecoxib Action Pathway,drug_action,DB03866
SMP00289,Diflunisal Action Pathway,drug_action,DB03866
SMP00353,Leukotriene C4 Synthesis Deficiency,disease,DB03866
SMP00703,Trisalicylate-choline Action Pathway,drug_action,DB03866
SMP00084,Etodolac Action Pathway,drug_action,DB03866
SMP00086,Ibuprofen Action Pathway,drug_action,DB03866
SMP00093,Diclofenac Action Pathway,drug_action,DB03866
SMP00102,Bromfenac Action Pathway,drug_action,DB03866
SMP00692,Antipyrine Action Pathway,drug_action,DB03866
SMP00693,Antrafenine Action Pathway,drug_action,DB03866
SMP00696,Fenoprofen Action Pathway,drug_action,DB03866
SMP00697,Flurbiprofen Action Pathway,drug_action,DB03866
SMP00699,Lumiracoxib Action Pathway,drug_action,DB03866
SMP00706,Tenoxicam Action Pathway,drug_action,DB03866
SMP00709,Salicylic Acid Action Pathway,drug_action,DB03866
SMP63595,Arachidonic Acid Metabolism,metabolic,DB03866
SMP00077,Piroxicam Action Pathway,drug_action,DB03866
SMP00083,Acetylsalicylic Acid Action Pathway,drug_action,DB03866
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB03884
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB03884
SMP63474,"Tropane, Piperidine and Pyridine Alkaloid Biosynthesis",metabolic,DB03884
SMP63649,Phenylalanine and Tyrosine Metabolism,metabolic,DB03884
SMP00206,Phenylketonuria,disease,DB03884
SMP00827,phenylalanine biosynthesis,metabolic,DB03884
SMP02442,Phenylalanine metabolism,metabolic,DB03884
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB03884
SMP00938,Phenylalanine metabolism,metabolic,DB03884
SMP02349,Phenylalanine metabolism,metabolic,DB03884
SMP02353,Tryptophan metabolism,metabolic,DB03884
SMP00491,Sepiapterin reductase deficiency,disease,DB03896
SMP00005,Pterine Biosynthesis,metabolic,DB03896
SMP00490,Segawa syndrome,disease,DB03896
SMP00489,Hyperphenylalaninemia due to dhpr-deficiency,disease,DB03896
SMP01898,adenosylcobalamin salvage from cobinamide,metabolic,DB03896
SMP00486,Dopa-responsive dystonia,disease,DB03896
SMP00487,Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,disease,DB03896
SMP00488,Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),disease,DB03896
SMP63657,Pterine Biosynthesis,metabolic,DB03896
SMP00020,Arginine and Proline Metabolism,metabolic,DB03904
SMP00059,Urea Cycle,metabolic,DB03904
SMP00110,Indapamide Action Pathway,drug_action,DB03904
SMP00121,Trichlormethiazide Action Pathway,drug_action,DB03904
SMP00133,Amiloride Action Pathway,drug_action,DB03904
SMP00205,Ornithine Transcarbamylase Deficiency (OTC Deficiency),disease,DB03904
SMP00208,Prolinemia Type II,disease,DB03904
SMP00361,Hyperprolinemia Type I,disease,DB03904
SMP00001,Citrullinemia Type I,disease,DB03904
SMP00002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB03904
SMP00078,Chlorothiazide Action Pathway,drug_action,DB03904
SMP00097,Ethacrynic Acid Action Pathway,drug_action,DB03904
SMP00108,Hydroflumethiazide Action Pathway,drug_action,DB03904
SMP00115,Furosemide Action Pathway,drug_action,DB03904
SMP00184,Glucose Transporter Defect (SGLT2),disease,DB03904
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB03904
SMP00036,D-Arginine and D-Ornithine Metabolism,metabolic,DB03904
SMP00091,Quinethazone Action Pathway,drug_action,DB03904
SMP00105,Metolazone Action Pathway,drug_action,DB03904
SMP00189,Hartnup Disorder,disease,DB03904
SMP00193,Iminoglycinuria,disease,DB03904
SMP00357,Argininemia,disease,DB03904
SMP00583,Blue diaper syndrome,disease,DB03904
SMP00723,Cystinuria,disease,DB03904
SMP12004,Arginine and Proline Metabolism,metabolic,DB03904
SMP63686,Urea Cycle,metabolic,DB03904
SMP00003,Argininosuccinic Aciduria,disease,DB03904
SMP00100,Hydrochlorothiazide Action Pathway,drug_action,DB03904
SMP00118,Torsemide Action Pathway,drug_action,DB03904
SMP00122,Chlorthalidone Action Pathway,drug_action,DB03904
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB03915
SMP00837,threonine biosynthesis,metabolic,DB03915
SMP00223,Non Ketotic Hyperglycinemia,disease,DB03915
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03915
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB03915
SMP02118,L-threonine degradation to methylglyoxal,metabolic,DB03915
SMP63626,Glycine and Serine Metabolism,metabolic,DB03915
SMP00004,Glycine and Serine Metabolism,metabolic,DB03915
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03915
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB03915
SMP00244,Sarcosinemia,disease,DB03915
SMP00711,Tobramycin Action Pathway,drug_action,DB03929
SMP00713,Arbekacin Action Pathway,drug_action,DB03929
SMP00727,Methacycline Action Pathway,drug_action,DB03929
SMP00253,Amikacin Action Pathway,drug_action,DB03929
SMP00258,Spectinomycin Action Pathway,drug_action,DB03929
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB03929
SMP02113,D-serine degradation,metabolic,DB03929
SMP63626,Glycine and Serine Metabolism,metabolic,DB03929
SMP00249,Clindamycin Action Pathway,drug_action,DB03929
SMP00254,Gentamicin Action Pathway,drug_action,DB03929
SMP00257,Netilmicin Action Pathway,drug_action,DB03929
SMP00291,Doxycycline Action Pathway,drug_action,DB03929
SMP00292,Minocycline Action Pathway,drug_action,DB03929
SMP00295,Lymecycline Action Pathway,drug_action,DB03929
SMP00712,Tigecycline Action Pathway,drug_action,DB03929
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB03929
SMP00223,Non Ketotic Hyperglycinemia,disease,DB03929
SMP00248,Clarithromycin Action Pathway,drug_action,DB03929
SMP00250,Erythromycin Action Pathway,drug_action,DB03929
SMP00251,Roxithromycin Action Pathway,drug_action,DB03929
SMP00255,Kanamycin Action Pathway,drug_action,DB03929
SMP00256,Neomycin Action Pathway,drug_action,DB03929
SMP00262,Clomocycline Action Pathway,drug_action,DB03929
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB03929
SMP00714,Paromomycin Action Pathway,drug_action,DB03929
SMP00726,Rolitetracycline Action Pathway,drug_action,DB03929
SMP00729,Chloramphenicol Action Pathway,drug_action,DB03929
SMP02443,Serine Metabolism,metabolic,DB03929
SMP00004,Glycine and Serine Metabolism,metabolic,DB03929
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB03929
SMP00347,Metachromatic Leukodystrophy (MLD),disease,DB03945
SMP02512,Lysolipid incorporation into ER PC(10:0/10:0),metabolic,DB03945
SMP02514,Lysolipid incorporation into ER PC(16:0/16:0),metabolic,DB03945
SMP02516,Lysolipid incorporation into ER PC(16:1(11Z)/16:1(11Z)),metabolic,DB03945
SMP02517,Lysolipid incorporation into ER PC(18:0/18:0),metabolic,DB03945
SMP14237,Phosphatidylcholine Biosynthesis PC(14:0/22:1(13Z)),metabolic,DB03945
SMP14249,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)),metabolic,DB03945
SMP14252,Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:1(9Z)),metabolic,DB03945
SMP14264,"Phosphatidylcholine Biosynthesis PC(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB03945
SMP14276,Phosphatidylcholine Biosynthesis PC(15:0/15:0),metabolic,DB03945
SMP14292,"Phosphatidylcholine Biosynthesis PC(15:0/20:4(8Z,11Z,14Z,17Z))",metabolic,DB03945
SMP14293,"Phosphatidylcholine Biosynthesis PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB03945
SMP14301,Phosphatidylcholine Biosynthesis PC(15:0/24:0),metabolic,DB03945
SMP14304,Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)),metabolic,DB03945
SMP14307,Phosphatidylcholine Biosynthesis PC(16:0/16:1(9Z)),metabolic,DB03945
SMP14310,Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)),metabolic,DB03945
SMP14316,Phosphatidylcholine Biosynthesis PC(16:0/20:1(11Z)),metabolic,DB03945
SMP14321,"Phosphatidylcholine Biosynthesis PC(16:0/20:4(8Z,11Z,14Z,17Z))",metabolic,DB03945
SMP14322,"Phosphatidylcholine Biosynthesis PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z))",metabolic,DB03945
SMP14332,Phosphatidylcholine Biosynthesis PC(16:1(9Z)/14:0),metabolic,DB03945
SMP14347,"Phosphatidylcholine Biosynthesis PC(16:1(9Z)/20:3(5Z,8Z,11Z))",metabolic,DB03945
SMP14348,"Phosphatidylcholine Biosynthesis PC(16:1(9Z)/20:3(8Z,11Z,14Z))",metabolic,DB03945
SMP14353,Phosphatidylcholine Biosynthesis PC(16:1(9Z)/22:1(13Z)),metabolic,DB03945
SMP14355,"Phosphatidylcholine Biosynthesis PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))",metabolic,DB03945
SMP14365,Phosphatidylcholine Biosynthesis PC(18:0/16:1(9Z)),metabolic,DB03945
SMP14366,Phosphatidylcholine Biosynthesis PC(18:0/18:0),metabolic,DB03945
SMP14374,Phosphatidylcholine Biosynthesis PC(18:0/20:1(11Z)),metabolic,DB03945
SMP14388,Phosphatidylcholine Biosynthesis PC(18:0/24:0),metabolic,DB03945
SMP14393,Phosphatidylcholine Biosynthesis PC(18:1(11Z)/16:0),metabolic,DB03945
SMP14398,"Phosphatidylcholine Biosynthesis PC(18:1(11Z)/18:2(9Z,12Z))",metabolic,DB03945
SMP02345,xylitol degradation,metabolic,DB03947
SMP02117,Xylose Degradation I,metabolic,DB03947
SMP01052,phospholipid biosynthesis CL(14:0/16:0/16:1(9Z)/14:0),metabolic,DB03994
SMP01060,phospholipid biosynthesis CL(14:0/18:1(9Z)/14:0/14:0),metabolic,DB03994
SMP01077,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/18:1(9Z)),metabolic,DB03994
SMP01088,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/16:0),metabolic,DB03994
SMP01090,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/18:1(9Z)),metabolic,DB03994
SMP01106,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/16:1(9Z)),metabolic,DB03994
SMP01108,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/18:1(9Z)),metabolic,DB03994
SMP01111,phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/14:0),metabolic,DB03994
SMP01114,phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/18:1(9Z)),metabolic,DB03994
SMP01115,phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/19:0cycv8c),metabolic,DB03994
SMP01121,phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/19:0cycv8c),metabolic,DB03994
SMP01122,phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/16:0),metabolic,DB03994
SMP01125,phospholipid biosynthesis CL(15:0cyclo/16:0/17:0cycw7c/16:0),metabolic,DB03994
SMP01135,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/14:0),metabolic,DB03994
SMP01139,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/19:0cycv8c),metabolic,DB03994
SMP01145,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/16:1(9Z)),metabolic,DB03994
SMP01148,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/19:0cycv8c),metabolic,DB03994
SMP01150,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/17:0cycw7c/16:1(9Z)),metabolic,DB03994
SMP01153,phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/18:1(9Z)/16:1(9Z)),metabolic,DB03994
SMP01158,phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/14:0/14:0),metabolic,DB03994
SMP01164,phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/16:1(9Z)/17:0cycw7c),metabolic,DB03994
SMP01165,phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/14:0),metabolic,DB03994
SMP01167,phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c)/16:0),metabolic,DB03994
SMP01188,phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/14:0),metabolic,DB03994
SMP01194,phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/19:0cycv8c),metabolic,DB03994
SMP01196,phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/19:0cycv8c/18:1(9Z)),metabolic,DB03994
SMP01208,phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:1(9Z)/19:0cycv8c),metabolic,DB03994
SMP01212,phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/18:1(9Z)/18:1(9Z)),metabolic,DB03994
SMP01221,phospholipid biosynthesis CL(16:0/14:0/14:0/16:0),metabolic,DB03994
SMP01228,phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/19:0cycv8c/16:1(9Z)) ,metabolic,DB03994
SMP12089,Photosynthesis,metabolic,DB04034
SMP00654,Warburg Effect,metabolic,DB04034
SMP12443,Pentose Phosphate Pathway,metabolic,DB04034
SMP02112,L-lyxose Degradation,metabolic,DB04034
SMP02115,L-arabinose Degradation I,metabolic,DB04034
SMP12094,Calvin-Benson Cycle,metabolic,DB04034
SMP00031,Pentose Phosphate Pathway,metabolic,DB04034
SMP00520,Transaldolase deficiency,disease,DB04034
SMP02345,xylitol degradation,metabolic,DB04034
SMP02406,Riboneogenesis,metabolic,DB04034
SMP00518,Glucose-6-phosphate dehydrogenase deficiency,disease,DB04034
SMP00519,Ribose-5-phosphate isomerase deficiency,disease,DB04034
SMP00814,Ascorbate metabolism,metabolic,DB04034
SMP02117,Xylose Degradation I,metabolic,DB04034
SMP63588,Pentose Phosphate Pathway,metabolic,DB04034
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB04038
SMP02381,Steroid Biosynthesis ,metabolic,DB04038
SMP02440,Cholesterol biosynthesis and metabolism CE(16:0),metabolic,DB04038
SMP02435,Cholesterol biosynthesis and metabolism CE(14:0),metabolic,DB04038
SMP02438,Cholesterol biosynthesis and metabolism CE(12:0),metabolic,DB04038
SMP02441,Cholesterol biosynthesis and metabolism CE(18:0),metabolic,DB04038
SMP12021,Flavonoid Biosynthesis (Dihydroflavonol Biosynthesis),metabolic,DB04066
SMP12024,Flavanone Biosynthesis,metabolic,DB04066
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB04074
SMP02388,Valine Degradation,metabolic,DB04074
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB04074
SMP00173,Beta-Ketothiolase Deficiency,disease,DB04074
SMP00810,L-alanine metabolism,metabolic,DB04074
SMP02460,Valine Degradation,metabolic,DB04074
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB04074
SMP00521,3-hydroxyisobutyric acid dehydrogenase deficiency,disease,DB04074
SMP00522,3-hydroxyisobutyric aciduria,disease,DB04074
SMP00848,Pantothenate and CoA Biosynthesis,metabolic,DB04074
SMP63689,"Valine, Leucine and Isoleucine Degradation",metabolic,DB04074
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB04074
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB04074
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB04074
SMP00199,Maple Syrup Urine Disease,disease,DB04074
SMP00236,Propionic Acidemia,disease,DB04074
SMP02364,Pantothenate and CoA Biosynthesis ,metabolic,DB04074
SMP00140,3-Methylglutaconic Aciduria Type III,disease,DB04074
SMP00200,Methylmalonic Aciduria,disease,DB04074
SMP00238,Isovaleric Aciduria,disease,DB04074
SMP00384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB04074
SMP00523,Isobutyryl-coa dehydrogenase deficiency,disease,DB04074
SMP00524,Isovaleric acidemia,disease,DB04074
SMP02355,Pyruvate metabolism,metabolic,DB04074
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB04076
SMP00537,Myoadenylate deaminase deficiency,disease,DB04076
SMP02088,purine ribonucleosides degradation,metabolic,DB04076
SMP00050,Purine Metabolism,metabolic,DB04076
SMP00144,Adenosine Deaminase Deficiency,disease,DB04076
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04076
SMP02220,Operon: glycine cleavage system inactivation III,signaling,DB04076
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB04076
SMP00427,Azathioprine Action Pathway,drug_action,DB04076
SMP00513,Xanthinuria type II,disease,DB04076
SMP02103,adenosine nucleotides degradation ,metabolic,DB04076
SMP02140,Operon: cytosine transport inactivation II,signaling,DB04076
SMP12052,AMP Degradation (Hypoxanthine Route),metabolic,DB04076
SMP00168,AICA-Ribosiduria,disease,DB04076
SMP00428,Mercaptopurine Action Pathway,drug_action,DB04076
SMP00430,Thioguanine Action Pathway,drug_action,DB04076
SMP00512,Xanthinuria type I,disease,DB04076
SMP02081,adenine and adenosine salvage I,metabolic,DB04076
SMP02204,Operon: de novo purine nucleotide biosynthesis inactivation,signaling,DB04076
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB04076
SMP00203,Molybdenum Cofactor Deficiency,disease,DB04076
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04076
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB04076
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB04076
SMP02089,purine deoxyribonucleosides degradation,metabolic,DB04076
SMP63668,Purine Metabolism,metabolic,DB04076
SMP02055,Thiazole Biosynthesis I ,metabolic,DB04120
SMP63632,Histidine Metabolism,metabolic,DB04151
SMP00927,purine nucleotides de novo biosynthesis,metabolic,DB04151
SMP00191,Histidinemia,disease,DB04151
SMP00044,Histidine Metabolism,metabolic,DB04151
SMP00001,Citrullinemia Type I,disease,DB04160
SMP00002,Carbamoyl Phosphate Synthetase Deficiency,disease,DB04160
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB04160
SMP00029,Selenoamino Acid Metabolism,metabolic,DB04160
SMP00033,Methionine Metabolism,metabolic,DB04160
SMP00045,Amino Sugar Metabolism,metabolic,DB04160
SMP00050,Purine Metabolism,metabolic,DB04160
SMP00055,Alanine Metabolism,metabolic,DB04160
SMP00058,Starch and Sucrose Metabolism,metabolic,DB04160
SMP00066,Biotin Metabolism,metabolic,DB04160
SMP00067,Aspartate Metabolism,metabolic,DB04160
SMP00072,Glutamate Metabolism,metabolic,DB04160
SMP00111,Cerivastatin Action Pathway,drug_action,DB04160
SMP00117,Pamidronate Action Pathway,drug_action,DB04160
SMP00131,Atorvastatin Action Pathway,drug_action,DB04160
SMP00144,Adenosine Deaminase Deficiency,disease,DB04160
SMP00172,Beta Ureidopropionase Deficiency,disease,DB04160
SMP00174,Biotinidase Deficiency,disease,DB04160
SMP00178,Dihydropyrimidinase Deficiency,disease,DB04160
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04160
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB04160
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04160
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB04160
SMP00313,Lactic Acidemia,disease,DB04160
SMP00322,Vasopressin Regulation of Water Homeostasis,signaling,DB04160
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB04160
SMP00341,Hypermethioninemia,disease,DB04160
SMP00354,Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,signaling,DB04160
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB04160
SMP00385,Homocarnosinosis,disease,DB04160
SMP00237,3-Methylcrotonyl Coa Carboxylase Deficiency Type I,disease,DB04183
SMP63591,Vitamin K Metabolism,metabolic,DB04183
SMP00138,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,disease,DB04183
SMP00521,3-hydroxyisobutyric acid dehydrogenase deficiency,disease,DB04183
SMP00522,3-hydroxyisobutyric aciduria,disease,DB04183
SMP63689,"Valine, Leucine and Isoleucine Degradation",metabolic,DB04183
SMP00016,Propanoate Metabolism,metabolic,DB04183
SMP00032,"Valine, Leucine and Isoleucine Degradation",metabolic,DB04183
SMP00173,Beta-Ketothiolase Deficiency,disease,DB04183
SMP00198,Malonic Aciduria,disease,DB04183
SMP00137,2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,disease,DB04183
SMP00139,3-Methylglutaconic Aciduria Type I,disease,DB04183
SMP00141,3-Methylglutaconic Aciduria Type IV,disease,DB04183
SMP00199,Maple Syrup Urine Disease,disease,DB04183
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04183
SMP00236,Propionic Acidemia,disease,DB04183
SMP00464,Vitamin K Metabolism,metabolic,DB04183
SMP00140,3-Methylglutaconic Aciduria Type III,disease,DB04183
SMP00200,Methylmalonic Aciduria,disease,DB04183
SMP00238,Isovaleric Aciduria,disease,DB04183
SMP00384,Methylmalonate Semialdehyde Dehydrogenase Deficiency,disease,DB04183
SMP00502,Malonyl-coa decarboxylase deficiency,disease,DB04183
SMP00523,Isobutyryl-coa dehydrogenase deficiency,disease,DB04183
SMP00524,Isovaleric acidemia,disease,DB04183
SMP63656,Propanoate Metabolism,metabolic,DB04183
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB04193
SMP00340,Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),disease,DB04193
SMP02444,Threonine Metabolism,metabolic,DB04193
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB04193
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB04193
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB04193
SMP00837,threonine biosynthesis,metabolic,DB04193
SMP02310,Methionine metabolism and salvage,metabolic,DB04193
SMP02322,threonine metabolism,metabolic,DB04193
SMP02439,Methionine Metabolism,metabolic,DB04193
SMP63637,Methionine Metabolism,metabolic,DB04193
SMP00033,Methionine Metabolism,metabolic,DB04193
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB04193
SMP00341,Hypermethioninemia,disease,DB04193
SMP00834,methionine biosynthesis,metabolic,DB04193
SMP00992,Secondary Metabolites: threonine biosynthesis from aspartate,metabolic,DB04193
SMP02309,Cysteine Metabolism,metabolic,DB04193
SMP00239,Saccharopinuria/Hyperlysinemia II,disease,DB04207
SMP00528,Hyperlysinemia II or Saccharopinuria,disease,DB04207
SMP00571,Pyridoxine dependency with seizures,disease,DB04207
SMP00527,"Hyperlysinemia I, Familial",disease,DB04207
SMP63635,Lysine Degradation,metabolic,DB04207
SMP00186,Glutaric Aciduria Type I,disease,DB04207
SMP02337,lysine metabolism,metabolic,DB04207
SMP00037,Lysine Degradation,metabolic,DB04207
SMP00719,2-aminoadipic 2-oxoadipic aciduria,disease,DB04207
SMP02434,Lysine Metabolism,metabolic,DB04207
SMP12025,Flavonol Biosynthesis,metabolic,DB04216
SMP02372,Ubiquinone Biosynthesis ,metabolic,DB04242
SMP63685,Ubiquinone Biosynthesis,metabolic,DB04242
SMP00065,Ubiquinone Biosynthesis,metabolic,DB04242
SMP00997,Secondary Metabolites: Ubiquinol biosynthesis,metabolic,DB04242
SMP02050,Secondary Metabolites: Ubiquinol biosynthesis 2,metabolic,DB04242
SMP63658,Pyrimidine Metabolism,metabolic,DB04252
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB04252
SMP00175,Canavan Disease,disease,DB04252
SMP63597,Aspartate Metabolism,metabolic,DB04252
SMP00046,Pyrimidine Metabolism,metabolic,DB04252
SMP00192,Hypoacetylaspartia,disease,DB04252
SMP00067,Aspartate Metabolism,metabolic,DB04252
SMP00172,Beta Ureidopropionase Deficiency,disease,DB04252
SMP00178,Dihydropyrimidinase Deficiency,disease,DB04252
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB04252
SMP00817,Fatty acid Metabolism,metabolic,DB04257
SMP00808,inner membrane transport,metabolic,DB04257
SMP00778,Nitrogen metabolism,metabolic,DB04261
SMP02040,Uracil degradation III,metabolic,DB04261
SMP02111,cyanate degradation,metabolic,DB04261
SMP00983,Secondary Metabolites: Glyoxylate cycle,metabolic,DB04272
SMP01025,TCA cycle (ubiquinol-9)  ,metabolic,DB04272
SMP02295,The Oncogenic Action of Fumarate,disease,DB04272
SMP00546,Congenital lactic acidosis,disease,DB04272
SMP00547,Fumarase deficiency,disease,DB04272
SMP00548,Mitochondrial complex II deficiency,disease,DB04272
SMP00551,Pyruvate dehydrogenase deficiency (E2),disease,DB04272
SMP01023,TCA cycle (ubiquinol-7)  ,metabolic,DB04272
SMP02414,TCA Cycle ,metabolic,DB04272
SMP00057,Citric Acid Cycle,metabolic,DB04272
SMP00466,Transfer of Acetyl Groups into Mitochondria,metabolic,DB04272
SMP01018,TCA cycle (ubiquinol-2),metabolic,DB04272
SMP02298,Glutaminolysis and Cancer,disease,DB04272
SMP02426,Glutamine Metabolism,metabolic,DB04272
SMP63681,Transfer of Acetyl Groups into Mitochondria,metabolic,DB04272
SMP00549,2-ketoglutarate dehydrogenase complex deficiency,disease,DB04272
SMP00654,Warburg Effect,metabolic,DB04272
SMP01026,TCA cycle (ubiquinol-10)  ,metabolic,DB04272
SMP02037,TCA cycle (ubiquinol-0),metabolic,DB04272
SMP02304,TCA Cycle,metabolic,DB04272
SMP02336,Glyoxylate cycle,metabolic,DB04272
SMP63477,Citric Acid Cycle,metabolic,DB04272
SMP00550,Pyruvate dehydrogenase deficiency (E3),disease,DB04272
SMP00802,TCA cycle,metabolic,DB04272
SMP01019,TCA cycle (ubiquinol-3),metabolic,DB04272
SMP01020,TCA cycle (ubiquinol-4),metabolic,DB04272
SMP01021,TCA cycle (ubiquinol-5) ,metabolic,DB04272
SMP01022,TCA cycle (ubiquinol-6) ,metabolic,DB04272
SMP01024,TCA cycle (ubiquinol-8)  ,metabolic,DB04272
SMP02035,glycolate and glyoxylate degradation II,metabolic,DB04272
SMP63693,Tryptophan Metabolism,metabolic,DB04275
SMP00063,Tryptophan Metabolism,metabolic,DB04275
SMP02114,Ribose Degradation,metabolic,DB04286
SMP00003,Argininosuccinic Aciduria,disease,DB04299
SMP00006,Tyrosine Metabolism,metabolic,DB04299
SMP00057,Citric Acid Cycle,metabolic,DB04299
SMP00168,AICA-Ribosiduria,disease,DB04299
SMP00207,Prolidase Deficiency (PD),disease,DB04299
SMP00428,Mercaptopurine Action Pathway,drug_action,DB04299
SMP00430,Thioguanine Action Pathway,drug_action,DB04299
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB04299
SMP00512,Xanthinuria type I,disease,DB04299
SMP01018,TCA cycle (ubiquinol-2),metabolic,DB04299
SMP01904,2-Oxopent-4-enoate metabolism ,metabolic,DB04299
SMP02047,purine nucleotides de novo biosynthesis 2,metabolic,DB04299
SMP02298,Glutaminolysis and Cancer,disease,DB04299
SMP02420,Proline Metabolism,metabolic,DB04299
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB04299
SMP00360,Hyperprolinemia Type II,disease,DB04299
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB04299
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB04299
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB04299
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB04299
SMP00427,Azathioprine Action Pathway,drug_action,DB04299
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB04299
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB04299
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB04299
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB04299
SMP00513,Xanthinuria type II,disease,DB04299
SMP00812,arginine metabolism,metabolic,DB04299
SMP00927,purine nucleotides de novo biosynthesis,metabolic,DB04299
SMP00936,Oxidative phosphorylation,metabolic,DB04299
SMP01025,TCA cycle (ubiquinol-9)  ,metabolic,DB04299
SMP02041,Phenylethylamine metabolism,metabolic,DB04325
SMP00039,Glycerolipid Metabolism,metabolic,DB04326
SMP00064,Fructose and Mannose Degradation,metabolic,DB04326
SMP00128,Gluconeogenesis,metabolic,DB04326
SMP00531,"Glycogenosis, Type VII. Tarui disease",disease,DB04326
SMP00573,"Glycogenosis, Type IB",disease,DB04326
SMP00574,"Glycogenosis, Type IC",disease,DB04326
SMP00840,Galactitol and galactonate degradation,metabolic,DB04326
SMP00846,fucose and rhamnose degradation,metabolic,DB04326
SMP00856,Quorum Sensing,signaling,DB04326
SMP00859,Glycolysis,metabolic,DB04326
SMP00930,fructose metabolism,metabolic,DB04326
SMP01041,"phospholipid biosynthesis I (CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) )",metabolic,DB04326
SMP01042,phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/19:0cycv8c)),metabolic,DB04326
SMP01046,phospholipid biosynthesis (CL(14:0/15:0cyclo/17:0cycw7c/14:0),metabolic,DB04326
SMP01048,phospholipid biosynthesis CL(14:0/16:0/14:0/16:0),metabolic,DB04326
SMP01051,phospholipid biosynthesis CL(14:0/16:0/14:0/19:0cycv8c),metabolic,DB04326
SMP01053,phospholipid biosynthesis CL(14:0/16:0/18:1(9Z)/14:0),metabolic,DB04326
SMP01057,phospholipid biosynthesis CL(14:0/16:1(9Z)/14:0/19:0cycv8c),metabolic,DB04326
SMP01058,phospholipid biosynthesis CL(14:0/16:1(9Z)/18:1(9Z)/14:0),metabolic,DB04326
SMP01065,phospholipid biosynthesis CL(14:0/18:1(9Z)/19:0cycv8c/14:0),metabolic,DB04326
SMP01066,phospholipid biosynthesis CL(14:0/19:0cycv8c/14:0/17:0cycw7c),metabolic,DB04326
SMP01071,phospholipid biosynthesis CL(15:0cyclo/14:0/17:0cycw7c/14:0),metabolic,DB04326
SMP01072,phospholipid biosynthesis CL(15:0cyclo/14:0/17:0cycw7c/17:0cycw7c),metabolic,DB04326
SMP01076,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/16:1(9Z)),metabolic,DB04326
SMP01085,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/18:1(9Z)),metabolic,DB04326
SMP01091,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/19:0cycv8c),metabolic,DB04326
SMP01098,phospholipid biosynthesis  CL(15:0cyclo/15:0cyclo/18:1(9Z)/15:0cyclo),metabolic,DB04326
SMP01102,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/19:0cycv8c),metabolic,DB04326
SMP01103,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/14:0),metabolic,DB04326
SMP01105,phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/16:0),metabolic,DB04326
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB04335
SMP00537,Myoadenylate deaminase deficiency,disease,DB04335
SMP02088,purine ribonucleosides degradation,metabolic,DB04335
SMP00050,Purine Metabolism,metabolic,DB04335
SMP00144,Adenosine Deaminase Deficiency,disease,DB04335
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04335
SMP00168,AICA-Ribosiduria,disease,DB04335
SMP00428,Mercaptopurine Action Pathway,drug_action,DB04335
SMP00430,Thioguanine Action Pathway,drug_action,DB04335
SMP00512,Xanthinuria type I,disease,DB04335
SMP02081,adenine and adenosine salvage I,metabolic,DB04335
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB04335
SMP00427,Azathioprine Action Pathway,drug_action,DB04335
SMP00513,Xanthinuria type II,disease,DB04335
SMP02083,adenine and adenosine salvage II,metabolic,DB04335
SMP02103,adenosine nucleotides degradation ,metabolic,DB04335
SMP12052,AMP Degradation (Hypoxanthine Route),metabolic,DB04335
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB04335
SMP00203,Molybdenum Cofactor Deficiency,disease,DB04335
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04335
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB04335
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB04335
SMP63668,Purine Metabolism,metabolic,DB04335
SMP00223,Non Ketotic Hyperglycinemia,disease,DB04343
SMP00352,Primary Hyperoxaluria Type I,disease,DB04343
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB04343
SMP00055,Alanine Metabolism,metabolic,DB04343
SMP00313,Lactic Acidemia,disease,DB04343
SMP02336,Glyoxylate cycle,metabolic,DB04343
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB04343
SMP02428,Glycine Metabolism,metabolic,DB04343
SMP12066,Urate Degradation to Glyoxylate,metabolic,DB04343
SMP63626,Glycine and Serine Metabolism,metabolic,DB04343
SMP00350,Pyruvate Carboxylase Deficiency,disease,DB04343
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB04343
SMP00847,glycolate and glyoxylate degradation,metabolic,DB04343
SMP00983,Secondary Metabolites: Glyoxylate cycle,metabolic,DB04343
SMP12467,Butanoate Metabolism,metabolic,DB04343
SMP00004,Glycine and Serine Metabolism,metabolic,DB04343
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB04343
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB04343
SMP00244,Sarcosinemia,disease,DB04343
SMP02035,glycolate and glyoxylate degradation II,metabolic,DB04343
SMP02320,glycine metabolism,metabolic,DB04343
SMP63586,Alanine Metabolism,metabolic,DB04343
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB04348
SMP00035,Bile Acid Biosynthesis,metabolic,DB04348
SMP00317,Familial Hypercholanemia (FHCA),disease,DB04348
SMP00720,27-Hydroxylase Deficiency,disease,DB04348
SMP63601,Bile Acid Biosynthesis,metabolic,DB04348
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB04348
SMP00316,Zellweger Syndrome,disease,DB04348
SMP00318,Congenital Bile Acid Synthesis Defect Type III,disease,DB04348
SMP00821,cysteine biosynthesis ,metabolic,DB04370
SMP12004,Arginine and Proline Metabolism,metabolic,DB04388
SMP00363,Ornithine Aminotransferase Deficiency (OAT Deficiency),disease,DB04388
SMP00020,Arginine and Proline Metabolism,metabolic,DB04388
SMP00208,Prolinemia Type II,disease,DB04388
SMP00361,Hyperprolinemia Type I,disease,DB04388
SMP00207,Prolidase Deficiency (PD),disease,DB04388
SMP02303,Glutamate Metabolism,metabolic,DB04388
SMP02420,Proline Metabolism,metabolic,DB04388
SMP00188,Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),disease,DB04388
SMP00360,Hyperprolinemia Type II,disease,DB04388
SMP00362,Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),disease,DB04388
SMP00504,"Creatine deficiency, guanidinoacetate methyltransferase deficiency",disease,DB04388
SMP00505,Hyperornithinemia with gyrate atrophy (HOGA),disease,DB04388
SMP00506,Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],disease,DB04388
SMP00507,L-arginine:glycine amidinotransferase deficiency,disease,DB04388
SMP00815,proline metabolism,metabolic,DB04388
SMP02297,Proline Metabolism ,metabolic,DB04388
SMP02416,Arginine Metabolism,metabolic,DB04388
SMP63596,Arginine and Proline Metabolism,metabolic,DB04388
SMP00940,sulfur metabolism (butanesulfonate),metabolic,DB04401
SMP00943,sulfur metabolism (isethionate),metabolic,DB04401
SMP00944,sulfur metabolism (methanesulfonate),metabolic,DB04401
SMP00123,Betaine Metabolism,metabolic,DB04401
SMP12047,Glycine Betaine Biosynthesis I,metabolic,DB04401
SMP00941,sulfur metabolism (propanesulfonate),metabolic,DB04401
SMP00942,sulfur metabolism (ethanesulfonate),metabolic,DB04401
SMP02313,Sarcosine Oncometabolite Pathway ,disease,DB04401
SMP12048,Glycine Betaine Biosynthesis II,metabolic,DB04401
SMP63600,Betaine Metabolism,metabolic,DB04401
SMP00927,purine nucleotides de novo biosynthesis,metabolic,DB04418
SMP02047,purine nucleotides de novo biosynthesis 2,metabolic,DB04418
SMP02377,purine nucleotides de novo biosynthesis ,metabolic,DB04418
SMP00364,Lesch-Nyhan Syndrome (LNS),disease,DB04457
SMP00537,Myoadenylate deaminase deficiency,disease,DB04457
SMP00365,Gout or Kelley-Seegmiller Syndrome,disease,DB04457
SMP00427,Azathioprine Action Pathway,drug_action,DB04457
SMP00513,Xanthinuria type II,disease,DB04457
SMP00050,Purine Metabolism,metabolic,DB04457
SMP00144,Adenosine Deaminase Deficiency,disease,DB04457
SMP00220,Xanthine Dehydrogenase Deficiency (Xanthinuria),disease,DB04457
SMP00168,AICA-Ribosiduria,disease,DB04457
SMP00428,Mercaptopurine Action Pathway,drug_action,DB04457
SMP00430,Thioguanine Action Pathway,drug_action,DB04457
SMP00512,Xanthinuria type I,disease,DB04457
SMP00167,Adenylosuccinate Lyase Deficiency,disease,DB04457
SMP00203,Molybdenum Cofactor Deficiency,disease,DB04457
SMP00210,Purine Nucleoside Phosphorylase Deficiency,disease,DB04457
SMP00535,Adenine phosphoribosyltransferase deficiency (APRT),disease,DB04457
SMP00536,Mitochondrial DNA depletion syndrome,disease,DB04457
SMP63668,Purine Metabolism,metabolic,DB04457
SMP00342,Hereditary Coproporphyria (HCP),disease,DB04461
SMP63655,Porphyrin Metabolism,metabolic,DB04461
SMP00024,Porphyrin Metabolism,metabolic,DB04461
SMP00344,Acute Intermittent Porphyria,disease,DB04461
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB04461
SMP00346,Porphyria Variegata (PV),disease,DB04461
SMP02363,Porphyrin Metabolism ,metabolic,DB04461
SMP00973,Lac Operon  Inactivation 1,signaling,DB04465
SMP00457,Lactose Degradation,metabolic,DB04465
SMP00580,GLUT-1 deficiency syndrome,disease,DB04465
SMP63634,Lactose Synthesis,metabolic,DB04465
SMP00182,Galactosemia,disease,DB04465
SMP00458,Lactose Intolerance,disease,DB04465
SMP00971,Lac Operon ,signaling,DB04465
SMP00972,Lac Operon Inactivation 2,signaling,DB04465
SMP00043,Galactose Metabolism,metabolic,DB04465
SMP00841,galactose metabolism,metabolic,DB04465
SMP63625,Galactose Metabolism,metabolic,DB04465
SMP63633,Lactose Degradation,metabolic,DB04465
SMP00444,Lactose Synthesis,metabolic,DB04465
SMP00579,Congenital disorder of glycosylation CDG-IId,disease,DB04465
SMP00808,inner membrane transport,metabolic,DB04465
SMP00903,galactose degradation/Leloir Pathway,metabolic,DB04465
SMP02073,salvage pathways of pyrimidine deoxyribonucleotides,metabolic,DB04485
SMP00046,Pyrimidine Metabolism,metabolic,DB04485
SMP02075,pyrimidine deoxyribonucleosides degradation,metabolic,DB04485
SMP63658,Pyrimidine Metabolism,metabolic,DB04485
SMP00202,MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),disease,DB04485
SMP12077,Pyrimidine Deoxyribonucleosides Salvage,metabolic,DB04485
SMP00172,Beta Ureidopropionase Deficiency,disease,DB04485
SMP00178,Dihydropyrimidinase Deficiency,disease,DB04485
SMP00219,UMP Synthase Deficiency (Orotic Aciduria),disease,DB04485
SMP01038,fatty acid oxidation (octanoate),metabolic,DB04519
SMP00793,Lipoic Acid Metabolism,metabolic,DB04519
SMP00456,Fatty Acid Biosynthesis,metabolic,DB04519
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB04519
SMP63613,Fatty Acid Biosynthesis,metabolic,DB04519
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB04522
SMP00223,Non Ketotic Hyperglycinemia,disease,DB04522
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB04522
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB04522
SMP63626,Glycine and Serine Metabolism,metabolic,DB04522
SMP00004,Glycine and Serine Metabolism,metabolic,DB04522
SMP00179,Dihydropyrimidine Dehydrogenase Deficiency (DHPD),disease,DB04522
SMP00242,Dimethylglycine Dehydrogenase Deficiency,disease,DB04522
SMP00244,Sarcosinemia,disease,DB04522
SMP00060,Pyruvate Metabolism,metabolic,DB04524
SMP00559,Pyruvate kinase deficiency,disease,DB04524
SMP02079, biotin-carboxyl carrier protein assembly,metabolic,DB04524
SMP63661,Pyruvate Metabolism,metabolic,DB04524
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04524
SMP00334,Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),disease,DB04524
SMP02325,Biosynthesis of unsaturated fatty acids (tetracosanoyl-CoA),metabolic,DB04524
SMP02329,Biosynthesis of unsaturated fatty acids (docosanoyl),metabolic,DB04524
SMP00558,"Primary hyperoxaluria II, PH2",disease,DB04524
SMP00919,fatty acid biosynthesis,metabolic,DB04524
SMP02324,Biosynthesis of unsaturated fatty acids,metabolic,DB04524
SMP02346,Biosynthesis of unsaturated fatty acids (icosanoyl),metabolic,DB04524
SMP02347,Biosynthesis of unsaturated fatty acids (stearoyl),metabolic,DB04524
SMP00016,Propanoate Metabolism,metabolic,DB04524
SMP00196,Leigh Syndrome,disease,DB04524
SMP00198,Malonic Aciduria,disease,DB04524
SMP00818,Palmitate Biosynthesis ,metabolic,DB04524
SMP00819,fatty acid elongation -- saturated,metabolic,DB04524
SMP02058,Palmitate Biosynthesis 2,metabolic,DB04524
SMP12076,Phenolic Malonylglucosides Biosynthesis,metabolic,DB04524
SMP00212,Pyruvate Dehydrogenase Complex Deficiency,disease,DB04524
SMP00456,Fatty Acid Biosynthesis,metabolic,DB04524
SMP00502,Malonyl-coa decarboxylase deficiency,disease,DB04524
SMP02355,Pyruvate metabolism,metabolic,DB04524
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB04524
SMP12021,Flavonoid Biosynthesis (Dihydroflavonol Biosynthesis),metabolic,DB04524
SMP12024,Flavanone Biosynthesis,metabolic,DB04524
SMP63613,Fatty Acid Biosynthesis,metabolic,DB04524
SMP63656,Propanoate Metabolism,metabolic,DB04524
SMP02445,Tryptophan metabolism,metabolic,DB04532
SMP02353,Tryptophan metabolism,metabolic,DB04532
SMP00835,tryptophan metabolism,metabolic,DB04532
SMP01930,tryptophan metabolism II,metabolic,DB04532
SMP00092,Rosuvastatin Action Pathway,drug_action,DB04540
SMP00119,Fluvastatin Action Pathway,drug_action,DB04540
SMP00387,CHILD Syndrome,disease,DB04540
SMP00509,Hyper-IgD syndrome,disease,DB04540
SMP00577,Corticosterone methyl oxidase I deficiency (CMO I),disease,DB04540
SMP00720,27-Hydroxylase Deficiency,disease,DB04540
SMP63601,Bile Acid Biosynthesis,metabolic,DB04540
SMP00095,Alendronate Action Pathway,drug_action,DB04540
SMP00107,Zoledronate Action Pathway,drug_action,DB04540
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB04540
SMP00371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB04540
SMP00372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,disease,DB04540
SMP00511,Wolman disease,disease,DB04540
SMP00575,11-beta-hydroxylase deficiency (CYP11B1),disease,DB04540
SMP00578,Corticosterone methyl oxidase II deficiency - CMO II,disease,DB04540
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB04540
SMP00089,Pravastatin Action Pathway,drug_action,DB04540
SMP00112,Risedronate Action Pathway,drug_action,DB04540
SMP00209,Hypercholesterolemia,disease,DB04540
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB04540
SMP00316,Zellweger Syndrome,disease,DB04540
SMP00318,Congenital Bile Acid Synthesis Defect Type III,disease,DB04540
SMP00576,21-hydroxylase deficiency (CYP21),disease,DB04540
SMP00717,Apparent mineralocorticoid excess syndrome,disease,DB04540
SMP00718,3-Beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB04540
SMP00111,Cerivastatin Action Pathway,drug_action,DB04540
SMP00117,Pamidronate Action Pathway,drug_action,DB04540
SMP00130,Steroidogenesis,metabolic,DB04540
SMP00131,Atorvastatin Action Pathway,drug_action,DB04540
SMP00373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,disease,DB04540
SMP12445,Fructose Metabolism,metabolic,DB04551
SMP00177,Cystathionine Beta-Synthase Deficiency,disease,DB04553
SMP00721,3-Phosphoglycerate dehydrogenase deficiency,disease,DB04553
SMP00957,propanoate metabolism,metabolic,DB04553
SMP02310,Methionine metabolism and salvage,metabolic,DB04553
SMP02439,Methionine Metabolism,metabolic,DB04553
SMP63637,Methionine Metabolism,metabolic,DB04553
SMP00029,Selenoamino Acid Metabolism,metabolic,DB04553
SMP00033,Methionine Metabolism,metabolic,DB04553
SMP00201,Methylmalonic Aciduria Due to Cobalamin-Related Disorders,disease,DB04553
SMP00221,Methionine Adenosyltransferase Deficiency,disease,DB04553
SMP00341,Hypermethioninemia,disease,DB04553
SMP02309,Cysteine Metabolism,metabolic,DB04553
SMP02430,Isoleucine Biosynthesis ,metabolic,DB04553
SMP63628,Homocysteine Degradation,metabolic,DB04553
SMP00214,S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,disease,DB04553
SMP00222,Glycine N-methyltransferase Deficiency,disease,DB04553
SMP00223,Non Ketotic Hyperglycinemia,disease,DB04553
SMP00455,Homocysteine Degradation,metabolic,DB04553
SMP00484,Dimethylglycine Dehydrogenase Deficiency,disease,DB04553
SMP00502,Malonyl-coa decarboxylase deficiency,disease,DB04553
SMP00838,isoleucine biosynthesis,metabolic,DB04553
SMP63656,Propanoate Metabolism,metabolic,DB04553
SMP63678,Threonine and 2-Oxobutanoate Degradation,metabolic,DB04553
SMP00016,Propanoate Metabolism,metabolic,DB04553
SMP00198,Malonic Aciduria,disease,DB04553
SMP00452,Threonine and 2-Oxobutanoate Degradation,metabolic,DB04553
SMP00485,"Hyperglycinemia, non-ketotic",disease,DB04553
SMP00570,"Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type",disease,DB04553
SMP02375,isoleucine biosynthesis ,metabolic,DB04553
SMP02382,Sulfur metabolism,metabolic,DB04553
SMP00700,Lornoxicam Action Pathway,drug_action,DB04557
SMP00701,Phenylbutazone Action Pathway,drug_action,DB04557
SMP00707,Salsalate Action Pathway,drug_action,DB04557
SMP00710,Acetaminophen  Action Pathway,drug_action,DB04557
SMP00098,Ketorolac Action Pathway,drug_action,DB04557
SMP00101,Suprofen Action Pathway,drug_action,DB04557
SMP00116,Valdecoxib Action Pathway,drug_action,DB04557
SMP00289,Diflunisal Action Pathway,drug_action,DB04557
SMP00353,Leukotriene C4 Synthesis Deficiency,disease,DB04557
SMP00703,Trisalicylate-choline Action Pathway,drug_action,DB04557
SMP00075,Arachidonic Acid Metabolism,metabolic,DB04557
SMP00106,Meloxicam Action Pathway,drug_action,DB04557
SMP00109,Mefenamic Acid Action Pathway,drug_action,DB04557
SMP00358,Fc Epsilon Receptor I Signaling in Mast Cells,signaling,DB04557
SMP00698,Magnesium salicylate Action Pathway,drug_action,DB04557
SMP00702,Nepafenac Action Pathway,drug_action,DB04557
SMP00708,Salicylate-sodium Action Pathway,drug_action,DB04557
SMP63593,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB04557
SMP00018,Alpha Linolenic Acid and Linoleic Acid Metabolism,metabolic,DB04557
SMP00084,Etodolac Action Pathway,drug_action,DB04557
SMP00086,Ibuprofen Action Pathway,drug_action,DB04557
SMP00093,Diclofenac Action Pathway,drug_action,DB04557
SMP00102,Bromfenac Action Pathway,drug_action,DB04557
SMP00692,Antipyrine Action Pathway,drug_action,DB04557
SMP00693,Antrafenine Action Pathway,drug_action,DB04557
SMP00696,Fenoprofen Action Pathway,drug_action,DB04557
SMP00697,Flurbiprofen Action Pathway,drug_action,DB04557
SMP00699,Lumiracoxib Action Pathway,drug_action,DB04557
SMP00706,Tenoxicam Action Pathway,drug_action,DB04557
SMP00709,Salicylic Acid Action Pathway,drug_action,DB04557
SMP00031,Pentose Phosphate Pathway,metabolic,DB04564
SMP00520,Transaldolase deficiency,disease,DB04564
SMP00518,Glucose-6-phosphate dehydrogenase deficiency,disease,DB04564
SMP00519,Ribose-5-phosphate isomerase deficiency,disease,DB04564
SMP63588,Pentose Phosphate Pathway,metabolic,DB04564
SMP30880,Estrone Metabolism,metabolic,DB04573
SMP63696,Estrone Metabolism,metabolic,DB04573
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB04574
SMP63690,Sulfate/Sulfite Metabolism,metabolic,DB04574
SMP30880,Estrone Metabolism,metabolic,DB04574
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB04574
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB04574
SMP63696,Estrone Metabolism,metabolic,DB04574
SMP00041,Sulfate/Sulfite Metabolism,metabolic,DB04574
SMP00532,Sulfite oxidase deficiency,disease,DB04574
SMP00565,Aromatase deficiency,disease,DB04574
SMP00577,Corticosterone methyl oxidase I deficiency (CMO I),disease,DB04652
SMP00566,17-alpha-hydroxylase deficiency (CYP17),disease,DB04652
SMP63672,Steroidogenesis,metabolic,DB04652
SMP00130,Steroidogenesis,metabolic,DB04652
SMP00373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,disease,DB04652
SMP00576,21-hydroxylase deficiency (CYP21),disease,DB04652
SMP00717,Apparent mineralocorticoid excess syndrome,disease,DB04652
SMP00718,3-Beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB04652
SMP00371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB04652
SMP00372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,disease,DB04652
SMP00575,11-beta-hydroxylase deficiency (CYP11B1),disease,DB04652
SMP00578,Corticosterone methyl oxidase II deficiency - CMO II,disease,DB04652
SMP63622,Glutathione Metabolism,metabolic,DB04701
SMP00143,5-Oxoprolinuria,disease,DB04701
SMP00337,Glutathione Synthetase Deficiency,disease,DB04701
SMP00500,5-oxoprolinase deficiency,disease,DB04701
SMP00015,Glutathione Metabolism,metabolic,DB04701
SMP00183,Gamma-Glutamyltransferase Deficiency,disease,DB04701
SMP00501,Gamma-glutamyl-transpeptidase deficiency,disease,DB04701
SMP00577,Corticosterone methyl oxidase I deficiency (CMO I),disease,DB04704
SMP00566,17-alpha-hydroxylase deficiency (CYP17),disease,DB04704
SMP63672,Steroidogenesis,metabolic,DB04704
SMP00130,Steroidogenesis,metabolic,DB04704
SMP00373,Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,disease,DB04704
SMP00576,21-hydroxylase deficiency (CYP21),disease,DB04704
SMP00717,Apparent mineralocorticoid excess syndrome,disease,DB04704
SMP00718,3-Beta-Hydroxysteroid Dehydrogenase Deficiency,disease,DB04704
SMP00371,Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,disease,DB04704
SMP00372,Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,disease,DB04704
SMP00575,11-beta-hydroxylase deficiency (CYP11B1),disease,DB04704
SMP00578,Corticosterone methyl oxidase II deficiency - CMO II,disease,DB04704
SMP00095,Alendronate Action Pathway,drug_action,DB04714
SMP00107,Zoledronate Action Pathway,drug_action,DB04714
SMP00511,Wolman disease,disease,DB04714
SMP02384,Terpenoid backbone biosynthesis,metabolic,DB04714
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB04714
SMP00089,Pravastatin Action Pathway,drug_action,DB04714
SMP00112,Risedronate Action Pathway,drug_action,DB04714
SMP00209,Hypercholesterolemia,disease,DB04714
SMP00974,Secondary metabolites: methylerythritol phosphate and polyisoprenoid biosynthesis,metabolic,DB04714
SMP02381,Steroid Biosynthesis ,metabolic,DB04714
SMP00111,Cerivastatin Action Pathway,drug_action,DB04714
SMP00117,Pamidronate Action Pathway,drug_action,DB04714
SMP00131,Atorvastatin Action Pathway,drug_action,DB04714
SMP00508,Cholesteryl ester storage disease,disease,DB04714
SMP00510,Mevalonic aciduria,disease,DB04714
SMP02440,Cholesterol biosynthesis and metabolism CE(16:0),metabolic,DB04714
SMP12043,Plastoquinol-9 Biosynthesis,metabolic,DB04714
SMP63670,Steroid Biosynthesis,metabolic,DB04714
SMP00092,Rosuvastatin Action Pathway,drug_action,DB04714
SMP00119,Fluvastatin Action Pathway,drug_action,DB04714
SMP00387,CHILD Syndrome,disease,DB04714
SMP00509,Hyper-IgD syndrome,disease,DB04714
SMP00991,Secondary metabolites: isoprenoid biosynthesis (nonmevalonate pathway),metabolic,DB04714
SMP00997,Secondary Metabolites: Ubiquinol biosynthesis,metabolic,DB04714
SMP02050,Secondary Metabolites: Ubiquinol biosynthesis 2,metabolic,DB04714
SMP12042,Epoxysqualene Biosynthesis,metabolic,DB04714
SMP12049,Farnesene Biosynthesis,metabolic,DB04714
SMP00023,Steroid Biosynthesis,metabolic,DB04714
SMP00079,Ibandronate Action Pathway,drug_action,DB04714
SMP00082,Simvastatin Action Pathway,drug_action,DB04714
SMP12440,C5-Branched Dibasic Acid Metabolism,metabolic,DB04734
SMP58741,Methapyrilene H1-Antihistamine Action,drug_action,DB04819
SMP62894,Thenalidine H1-Antihistamine Action,drug_action,DB04826
SMP61047,Flunarizine H1-Antihistamine Action,drug_action,DB04841
SMP00366,Nebivolol Action Pathway,drug_action,DB04861
SMP31697,Nilotinib Inhibition of BCR-ABL,drug_action,DB04868
SMP00421,Vatalanib Action Pathway,drug_action,DB04879
SMP60058,Bepotastine H1-Antihistamine Action,drug_action,DB04890
SMP00279,Ximelagatran Action Pathway,drug_action,DB04898
SMP00600,Irinotecan Metabolism Pathway,drug_metabolism,DB05482
SMP00433,Irinotecan Action Pathway,drug_action,DB05482
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB05804
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB05804
SMP00565,Aromatase deficiency,disease,DB05804
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB05804
SMP00685,Alvimopan Action Pathway,drug_action,DB06274
SMP59114,Levocetirizine H1-Antihistamine Action,drug_action,DB06282
SMP31698,Bosutinib Inhibition of BCR-ABL,drug_action,DB06616
SMP57583,Mepyramine H1-Antihistamine Action,drug_action,DB06691
SMP00288,Aprotinin Action Pathway,drug_action,DB06692
SMP00713,Arbekacin Action Pathway,drug_action,DB06696
SMP00651,Artemether Metabolism Pathway,drug_metabolism,DB06697
SMP60744,Betahistine H1-Antihistamine Action,drug_action,DB06698
SMP00636,Venlafaxine Metabolism Pathway,drug_metabolism,DB06700
SMP00700,Lornoxicam Action Pathway,drug_action,DB06725
SMP00426,Fluoxetine Action Pathway,drug_action,DB06731
SMP00646,Fluoxetine Metabolism Pathway,drug_metabolism,DB06731
SMP00690,Ketobemidone  Action Pathway,drug_action,DB06738
SMP62881,Alcaftadine H1-Antihistamine Action,drug_action,DB06766
SMP00933,glycerol metabolism III (sn-glycero-3-phosphoethanolamine),metabolic,DB06770
SMP00934,glycerol metabolism IV (glycerophosphoglycerol),metabolic,DB06770
SMP00854, hexuronide and hexuronate degradation,metabolic,DB06770
SMP00932,glycerol metabolism II,metabolic,DB06770
SMP00935,glycerol metabolism V (glycerophosphoserine),metabolic,DB06770
SMP00315,Cerebrotendinous Xanthomatosis (CTX),disease,DB06777
SMP00035,Bile Acid Biosynthesis,metabolic,DB06777
SMP00317,Familial Hypercholanemia (FHCA),disease,DB06777
SMP00720,27-Hydroxylase Deficiency,disease,DB06777
SMP63601,Bile Acid Biosynthesis,metabolic,DB06777
SMP00314,Congenital Bile Acid Synthesis Defect Type II,disease,DB06777
SMP00316,Zellweger Syndrome,disease,DB06777
SMP00318,Congenital Bile Acid Synthesis Defect Type III,disease,DB06777
SMP00702,Nepafenac Action Pathway,drug_action,DB06802
SMP30406,Androstenedione Metabolism,metabolic,DB07375
SMP63688,Androstenedione Metabolism,metabolic,DB07375
SMP63594,Androgen and Estrogen Metabolism,metabolic,DB07447
SMP00356,17-beta Hydroxysteroid Dehydrogenase III Deficiency,disease,DB07447
SMP00565,Aromatase deficiency,disease,DB07447
SMP00068,Androgen and Estrogen Metabolism,metabolic,DB07447
SMP00006,Tyrosine Metabolism,metabolic,DB07718
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB07718
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB07718
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB07718
SMP02352,Tyrosine metabolism,metabolic,DB07718
SMP00206,Phenylketonuria,disease,DB07718
SMP02442,Phenylalanine metabolism,metabolic,DB07718
SMP02457,Tyrosine metabolism,metabolic,DB07718
SMP63684,Tyrosine Metabolism,metabolic,DB07718
SMP00218,Tyrosinemia Type I,disease,DB07718
SMP00429,Disulfiram Action Pathway,drug_action,DB07718
SMP00826,tyrosine biosynthesis,metabolic,DB07718
SMP63471,Isoquinoline Alkaloid Biosynthesis,metabolic,DB07718
SMP63649,Phenylalanine and Tyrosine Metabolism,metabolic,DB07718
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB07718
SMP00169,Alkaptonuria,disease,DB07718
SMP00190,Hawkinsinuria,disease,DB07718
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB07718
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB07718
SMP12043,Plastoquinol-9 Biosynthesis,metabolic,DB07718
SMP00095,Alendronate Action Pathway,drug_action,DB07780
SMP00107,Zoledronate Action Pathway,drug_action,DB07780
SMP00342,Hereditary Coproporphyria (HCP),disease,DB07780
SMP00511,Wolman disease,disease,DB07780
SMP02384,Terpenoid backbone biosynthesis,metabolic,DB07780
SMP02436,Cholesterol biosynthesis and metabolism CE(10:0),metabolic,DB07780
SMP00089,Pravastatin Action Pathway,drug_action,DB07780
SMP00112,Risedronate Action Pathway,drug_action,DB07780
SMP00209,Hypercholesterolemia,disease,DB07780
SMP00953,Porphyrin metabolism,metabolic,DB07780
SMP00974,Secondary metabolites: methylerythritol phosphate and polyisoprenoid biosynthesis,metabolic,DB07780
SMP02381,Steroid Biosynthesis ,metabolic,DB07780
SMP63655,Porphyrin Metabolism,metabolic,DB07780
SMP00111,Cerivastatin Action Pathway,drug_action,DB07780
SMP00117,Pamidronate Action Pathway,drug_action,DB07780
SMP00131,Atorvastatin Action Pathway,drug_action,DB07780
SMP00508,Cholesteryl ester storage disease,disease,DB07780
SMP00510,Mevalonic aciduria,disease,DB07780
SMP02440,Cholesterol biosynthesis and metabolism CE(16:0),metabolic,DB07780
SMP63670,Steroid Biosynthesis,metabolic,DB07780
SMP00092,Rosuvastatin Action Pathway,drug_action,DB07780
SMP00119,Fluvastatin Action Pathway,drug_action,DB07780
SMP00345,Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,disease,DB07780
SMP00346,Porphyria Variegata (PV),disease,DB07780
SMP00387,CHILD Syndrome,disease,DB07780
SMP00509,Hyper-IgD syndrome,disease,DB07780
SMP00997,Secondary Metabolites: Ubiquinol biosynthesis,metabolic,DB07780
SMP02050,Secondary Metabolites: Ubiquinol biosynthesis 2,metabolic,DB07780
SMP02363,Porphyrin Metabolism ,metabolic,DB07780
SMP12042,Epoxysqualene Biosynthesis,metabolic,DB07780
SMP12071,"Gibberellin Biosynthesis III (Non C-3, Non C-13 Hydroxylation)",metabolic,DB07815
SMP12069,Gibberellin Biosynthesis I (Early C-3 Hydroxylation),metabolic,DB07815
SMP00456,Fatty Acid Biosynthesis,metabolic,DB07930
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB07930
SMP63613,Fatty Acid Biosynthesis,metabolic,DB07930
SMP63693,Tryptophan Metabolism,metabolic,DB07950
SMP00063,Tryptophan Metabolism,metabolic,DB07950
SMP01037,fatty acid oxidation (myristate),metabolic,DB08231
SMP00456,Fatty Acid Biosynthesis,metabolic,DB08231
SMP02360,Fatty Acid Biosynthesis ,metabolic,DB08231
SMP63613,Fatty Acid Biosynthesis,metabolic,DB08231
SMP00369,Tyrosinemia Type 2 (or Richner-Hanhart syndrome),disease,DB08327
SMP00370,Tyrosinemia Type 3 (TYRO3),disease,DB08327
SMP00006,Tyrosine Metabolism,metabolic,DB08327
SMP00494,"Tyrosinemia, transient, of the newborn",disease,DB08327
SMP00206,Phenylketonuria,disease,DB08327
SMP02457,Tyrosine metabolism,metabolic,DB08327
SMP63684,Tyrosine Metabolism,metabolic,DB08327
SMP00218,Tyrosinemia Type I,disease,DB08327
SMP00429,Disulfiram Action Pathway,drug_action,DB08327
SMP63649,Phenylalanine and Tyrosine Metabolism,metabolic,DB08327
SMP00008,Phenylalanine and Tyrosine Metabolism,metabolic,DB08327
SMP00169,Alkaptonuria,disease,DB08327
SMP00190,Hawkinsinuria,disease,DB08327
SMP00498,Dopamine beta-hydroxylase deficiency,disease,DB08327
SMP00533,Monoamine oxidase-a deficiency (MAO-A),disease,DB08327
SMP12043,Plastoquinol-9 Biosynthesis,metabolic,DB08327
SMP63467,Indole Alkaloid Biosynthesis,metabolic,DB08653
SMP63693,Tryptophan Metabolism,metabolic,DB08653
SMP00063,Tryptophan Metabolism,metabolic,DB08653
SMP02445,Tryptophan metabolism,metabolic,DB08653
SMP02362,Oxidative phosphorylation,metabolic,DB08689
SMP00932,glycerol metabolism II,metabolic,DB08689
SMP00935,glycerol metabolism V (glycerophosphoserine),metabolic,DB08689
SMP00931,glycerol metabolism,metabolic,DB08689
SMP00934,glycerol metabolism IV (glycerophosphoglycerol),metabolic,DB08689
SMP00802,TCA cycle,metabolic,DB08689
SMP00933,glycerol metabolism III (sn-glycero-3-phosphoethanolamine),metabolic,DB08689
SMP02370,pyrimidine metabolism ,metabolic,DB08689
SMP00815,proline metabolism,metabolic,DB08689
SMP00936,Oxidative phosphorylation,metabolic,DB08689
SMP00959,pyrimidine metabolism,metabolic,DB08689
SMP02297,Proline Metabolism ,metabolic,DB08689
SMP01018,TCA cycle (ubiquinol-2),metabolic,DB08690
SMP12058,Cytokinins Degradation,metabolic,DB08768
SMP57584,Antazoline H1-Antihistamine Action,drug_action,DB08799
SMP57585,Chloropyramine H1-Antihistamine Action,drug_action,DB08800
SMP57582,Dimetindene H1-Antihistamine Action,drug_action,DB08801
SMP59716,Isothipendyl H1-Antihistamine Action,drug_action,DB08802
SMP00735,Metiamide Action Pathway,drug_action,DB08805
SMP00734,Roxatidine acetate Action Pathway,drug_action,DB08806
SMP00657,Bopindolol Action Pathway,drug_action,DB08807
SMP00670,Bupranolol Action Pathway,drug_action,DB08808
SMP00733,Temocapril Action Pathway,drug_action,DB08836
SMP00732,Temocapril Metabolism Pathway,drug_metabolism,DB08836
SMP00812,arginine metabolism,metabolic,DB08838
SMP31700,Ponatinib Inhibition of BCR-ABL,drug_action,DB08901
SMP58931,Chlorcyclizine H1-Antihistamine Action,drug_action,DB08936
SMP58903,Chlorphenoxamine H1-Antihistamine Action,drug_action,DB09007
SMP59881,Acrivastine H1-Antihistamine Action,drug_action,DB09488
SMP58916,Phenyltoloxamine H1-Antihistamine Action,drug_action,DB11160
SMP58769,Thonzylamine H1-Antihistamine Action,drug_action,DB11235
SMP60170,Bilastine H1-Antihistamine Action,drug_action,DB11591
SMP60235,Rupatadine H1-Antihistamine Action,drug_action,DB11614
SMP62623,Latrepirdine H1-Antihistamine Action,drug_action,DB11725
SMP60204,Ebastine H1-Antihistamine Action,drug_action,DB11742
SMP31699,Bafetinib Inhibition of BCR-ABL,drug_action,DB11851
SMP60230,Mizolastine H1-Antihistamine Action,drug_action,DB12523
SMP51038,Lafutidine H2-Antihistamine Action,drug_action,DB12770
SMP59044,Oxatomide H1-Antihistamine Action,drug_action,DB12877
SMP63629,Inositol Metabolism,metabolic,DB13178
SMP00011,Inositol Metabolism,metabolic,DB13178
SMP63630,Inositol Phosphate Metabolism,metabolic,DB13178
SMP00182,Galactosemia,disease,DB13178
SMP00462,Inositol Phosphate Metabolism,metabolic,DB13178
SMP00582,Joubert syndrome,disease,DB13178
SMP02394,Inositol Phosphate Metabolism ,metabolic,DB13178
SMP63651,Phosphatidylinositol Phosphate Metabolism,metabolic,DB13178
SMP00043,Galactose Metabolism,metabolic,DB13178
SMP00463,Phosphatidylinositol Phosphate Metabolism,metabolic,DB13178
SMP02397,Inositol Metabolism ,metabolic,DB13178
SMP12029,"D-myo-Inositol (1,4,5)-Trisphosphate Biosynthesis",metabolic,DB13178
SMP63625,Galactose Metabolism,metabolic,DB13178
SMP56811,Dexchlorpheniramine H1-Antihistamine Action,drug_action,DB13679
SMP62895,Tritoqualine H1-Antihistamine Action,drug_action,DB13711
